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SUMMARY
This thesis is concerned with (1) the identification
of membrane receptors on alveolar macrophages, particularly
those for histamine, and (2) some of the metabolic changes
which the cell undergoes following incubation with histamine,
either in free solution or when bound to particles.
In preliminary experiments, in which some of the
variables associated with the "rosette technique" were
examined, it was shown that alveolar macrophages bind
IgG-coated erythrocytes (EAG) as well as sheep cells
sensitized with IgM and whole serum as a source of complement
(EA^"C3"). Therefore, lung macrophages, like most other
leucocytes, appear to bear "immunological receptors" for
IgG and complement (presumably C3).
The "rosette technique" was then employed for the
identification of histamine receptors on various guinea pig
leucocytes using histamine coupled as a rabbit serum albumin
conjugate (H-RSA) to formalised ox red cells. It was found
that the number of "histamine rosettes" varied from 60-81%
for alveolar macrophages, 14-73% for peritoneal macrophages,
14-30% for blood monocytes, 27-48% for lymph node cells,
7-24% for blood lymphocytes and 0-29% for peritoneal and
blood neutrophils. Virtually no histamine rosettes were
formed with eosinophils or basophils. The percentage of
rosette-forming target cells was directly related to the
concentration of erythrocyte-bound H-RSA. Free histamine
partially inhibited rosette formation by alveolar macrophages
-3 -5 -1
in a dose-dependent fashion from 10 to 10 moles.1 , and
ii
complete inhibition was achieved by the H-RSA conjugate.
In contrast, amines closely related to histamine such as
L-histidine and the major histamine catabolites,
imidazoleacetic acid, 1,4-methylhistamine, l-methyl-4-
imidazoleacetic acid and N-acetylhistamine, had no
inhibitory effect.
The histamine Hl-receptor antagonists, mepyramine and
chlorpheniramine, and the Hl-receptor agonist, 2-(2-aminoethyl)
thiazole, inhibited rosette formation by alveolar macrophages
in a dose-dependent fashion. In contrast, the H2-receptor
antagonists, burimamide and metiamide, and the H2-receptor
agonists, Dimaprit and 4-methylhistamine, were inactive.
These- experiments suggested that (1) compared to other
leucocytes, histamine receptors are particularly well
expressed on the alveolar macrophage, (2) these receptors
have a high degree of specificity for histamine in that
other amines, closely related chemically, did not inhibit
rosette formation, and (3) the binding of histamine to the
alveolar macrophage membrane is HI- and not H2-receptor
dependent.
Experiments were then undertaken to determine whether
free histamine, or histamine bound to particles, interacted
with its membrane receptor to initiate the "respiratory
burst" in alveolar macrophages. Superoxide anion formation
(Og) and chemiluminescence, recognized features of the
"respiratory burst" of phagocytic cells, were generated by
alveolar macrophages following incubation with H-RSA bound
to zymosan (H-RSAZ) (and also H-RSA linked to a number of
other inert particles such as Sephadex and polystyrene beads).
The degree of 02 generation and light emission was comparable
to that achieved with serum treated zymosan (STZ). Superoxide
formation by alveolar macrophages was related to the concentra¬
tion of histamine conjugate bound to the zymosan particles as
well as the time of incubation. As with histamine rosettes,
Og production generated by H-RSAZ in alveolar macrophages also
appeared to be dependent on HI-, but not H2-, histamine
receptors. Chemiluminescence induced by H-RSAZ was also
time- and dose-dependent and totally inhibitible by superoxide
dismutase indicating that the 0^ formation and the burst of
light emission are closely related events in the alveolar
macrophage. Histamine in free solution did not appear to
promote Og generation or chemiluminescence in alveolar
macrophages.
Studies were then undertaken in an attempt to determine
whether histamine influenced the release of the lysosomal
enzyme, ^-glucuronidase, following incubation of alveolar
macrophages with complement-coated zymosan. Histamine
induced a small, but significant, increase in STZ-induced
^-glucuronidase release but had no apparent effect on the
elaboration of the cytoplasmic enzyme, lactic dehydrogenase.
Experiments to determine whether this was an HI- and/or H2-
effect were inconclusive. H-RSAZ alone did not appear to
influence ^-glucuronidase release.
The general conclusion of this work is that there is a
direct relationship between histamine and lung macrophages
but that for the initiation of the "respiratory burst"
histamine requires to be bound to particles to achieve
appreciable biological effects. Since histamine is known
to bind to a number of plasma proteins ("histaminopexy")
these observations may be of significance both physio¬
logically, in the regulation of oxygen-dependent killing
by lung macrophages, and also in disease states where high
concentrations of histamine in bronchial secretions may




In this thesis experiments concerned with the presence
of receptors for histamine and the metabolic effects on the
alveolar macrophage are described.
As an introduction, the literature relating to the
biology of mononuclear phagocytes in general and alveolar
macrophages in particular is reviewed.
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CHAPTER I - INTRODUCTION
I
SECTION A - THE ALVEOLAR MACROPHAGE
1.0 HISTORICAL BACKGROUND
In 1824 Alison described "darkening of the lungs of
miners" which was attributed to excessive inhalation of coal
dust particles. Virchow (1847) was the first to observe
lung cells containing blood pigments from patients with
mitral stenosis. Since then many studies have been reported
on "particle containing" lung cells but the origin of these
materials was for many years unclear (for review, see
Bertalanffy, 1964). Some attributed them to an endogenous
pigment, whereas others believed them to be the result of
inhalation. Knauf (1867), and later Von Ins (1876),
conducted inhalation experiments and observed the uptake of
dye and dust by cells in the alveolar spaces. Von Ins
referred to them as "dust cells". However, it was not
until 1884 when Metchnikoff first described the process of
phagocytosis that it was appreciated that the material
contained in lung macrophages was probably the result of
ingestion of foreign material.
In 1924 (Aschoff) the concept of the reticuloendothelial
system was developed and included in this "body system" was
the macrophage. It was not until relatively recently that
there was general agreement to separate macrophages from
reticular and endothelial cells and a new classification was
introduced on the basis of their common origin, morphology
and function. Thus the macrophage cells were grouped
together into one system - the Mononuclear Phagocyte System

















Tissues - Connective tissue (histiocytes)
Liver (Kupffer cells)
Lung (alveolar macrophages)
Lymph nodes (free and fixed
macrophages)
Bone marrow (macrophages)





2.0 ORIGIN AND KINETICS
It has been established that the alveolar macrophage
is derived from the haemopoietic stem cell in the bone marrow,
released into the blood and transported to the lung as a
mononuclear leucocyte (Pinckett et al, 1966; Virolainen,
1968; Godleski and Brain, 1972; Blusse Van Oud Alblas and
Van Furth, 1979). Some authors have reported that in the
pulmonary compartment, monocytes may undergo a period of
maturation before entering the air spaces as alveolar
macrophages (Bowden and Adamson, 1972; Vijeyaratnam and
Corrin, 1972). Others, however, have found no evidence of
cell division or development in the pulmonary interstitium.
Both pulmonary alveolar macrophages (located in the alveolar
air spaces) and pulmonary tissue macrophages (located in the
interstitial tissue) are non-dividing cells (Blusse Van Oud
Alblas and Van Furth, 1979). In the steady state, 15% of
monocytes leaving the circulation became alveolar macrophages
with a life span of approximately one month (Blusse Van Oud
Alblas and Van Furth, 1979; Godleski and Brain, 1972). The
pulmonary macrophages may be eliminated through the airways
(Brain, 1970; Hilding, 1963; Spritzer et al, 1968) or via
the lymphatic system (Lauwrerijus and Baert, 1977; Sorokin
and Brain, 1975).
The precise kinetics of the monocyte/macrophage system
in normal conditions is unclear. It has been reported that
alveolar macrophages in pulmonary inflammatory reactions
were also bone marrow-derived (Velo and Spector, 1973).
Seric substances which stimulated and inhibited monocyto¬
poiesis during experimental peritoneal inflammation have
been demonstrated (Van Waarde et al, 1978).
e
3.0 STRUCTURE AND CHARACTERISTICS
The structure of alveolar macrophages, as shown by
light microscopy and metachromatic stains, is highly
characteristic. They have considerable heterogeneity in
size within the same and different species. The cells
are rounded, or slightly oval, with an excentric nucleus.
By the light microscope or phase contrast freshly prepared
alveolar macrophages have many dark granules of varying size
and density. The ultrastructure of lung macrophages
(Karrer, 1958) shows many similarities to mononuclear
phagocytic cells from other tissues including lymph node,
peritoneal cavity, liver etc. (Cohn, 1968). The cytoplasm
contains numerous mitochondria, abundant rough endoplasmic
reticulum, a prominent Golgi apparatus and many.dense
lysosomes. When lung macrophages were fixed in situ the
cell membrane was found to be extensively augmented by
microvilli. Phagocytic vacuoles were prominent and
contained carbon, iron and other inert particles (Kilburn,
1974).
Mononuclear phagocytic cells can be distinguished
and separated from other leucocytes, particularly lymphocytes,
by their capacity to adhere to glass surfaces forming mono¬
layers. Monocytes/macrophages also stain characteristically
with non-specific esterases. Under appropriate in vitro
conditions alveolar macrophages have been shown to divide




In the guinea pig, alveolar macrophages differed from
peritoneal macrophages and polymorphonuclear cells in their
metabolic requirements (Oren et al, 1963). For instance,
the alveolar macrophages derived their energy mainly through
aerobic respiration while the other cells studied utilized
anaerobic pathways as their primary energy source. This
observation applied to both resting and actively phagocytosing
cells. In rabbit alveolar macrophages, maximal phagocytic
activity occurred only under aerobic conditions and glycolysis
played a secondary role (Ouchi et al, 1965). However, other
authors have found that in human alveolar macrophages both
oxidative and glycolytic energy sources were required for
maximal particle uptake (Cohen and Cline, 1971).
4.2 Biosynthetic activity
The synthesis of protein by macrophages has been shown
to be associated primarily with the production of digestive
enzymes and secretory products (Cohn, 1968; Cohn and
Wiener, 1963a,b; Cohn and Benson, 1965a). Synthesis of
proteins in the rough endoplasmic reticumum was demonstrated
by electron microscopic autoradiography. After assembly
the proteins were then transported to the Golgi apparatus
and packaged into small Golgi vesicles which represent the
primary lysosomes (Cohn et al, 1966). The fusion of this
primary organelle with phagosomes forms the secondary
lysosomes (Cohn et al, 1966). Following endocytic stimulus,
either phagocytic (solid particles) or pinocytic (uptake of
soluble), the number of lysosomes in macrophages and their
acid hydrolase content increased (Cohn and Benson, 1965b).
This response was related to the type of particle or
substance ingested and was abrogated by inhibition of
protein synthesis. The increase in enzymatic activity
was non-specific since no particular enzyme was induced
by a determined stimulus (Axline and Cohn, 1970).
5.0 MACROPHAGE PLASMA MEMBRANE
5.1 Structure
The macrophage plasma membrane consists of a bilayer
of phospholipids in which proteins are embedded forming
bridges between the cytoplasm and extracellular fluid.
This structure has been termed "fluid mosaic membrane"
(Singer and Nicolson, 1972). This model system is based
on the rotational freedom and translational mobility of
individual proteins and lipid molecules (Singer, 1974;
Thrasher et al, 1973a). From this concept plasma membranes
may be considered as non-uniform structures. Therefore,
there may be areas of both poor and rich endocytic activities
and areas of different surface receptors which could be
regarded as evidence of surface topography. The
distribution and mobility of these membrane constituents
is not always random and in some circumstances subcellular
structures act to direct the movement of particular membrane
components (Berlin et al, 1974).
5.2 Surface receptors
5.2.1 Receptors for Fc portion of IgG
Fc receptors have been found in several cells including
those of the monocyte/macrophage system. These receptors
appear to be "stable" during long term culture conditions
(Rabinovitch and De Stefano, 1973a; Gordon and Cohn, 1971).
Immunoglobulin can be bound to the cell either free, or in
the form of antigen-antibody complexes (Berken and Benacerraf,
1966; Uhr and Phillips, 1966; Arend and Mannik, 1972).
When antigen-antibody complexes were used, binding could be
detected at lower concentrations of antibody than when
antibody alone was used (Phillips-Quagliata et al, 1971;
Arend and Mannik, 1972). The activation of rabbit
alveolar macrophages with multiple intravenous injections
of complete Freund*s adjuvant resulted in an increase in
the numbers of receptor sites for IgG per cell (Arend and
Mannik, 1973). Rabbit alveolar macrophage Fc receptors
were more effectively inhibited by aggregated human IgG
than unaltered immunoglobulin (Daughaday and Douglas, 1976).
The chemical nature of Fc receptors is, at present,
ill understood. It is stable to treatment with trypsin
and other proteolytic enzymes such as papain and pronase
but its integrity is apparently dependent on intact
sulphydryl and phospholipid structures (LoBuglio and
Reinehard, 1970).
It has been demonstrated that alveolar macrophages
differ from peritoneal macrophages in the avidity of Fc
receptors for immune complexes (Rhodes, 1975). Normal
peritoneal macrophages possessed a three-fold greater mean
avidity for sensitized erythrocytes than normal alveolar
macrophages but the latter showed a greater range of
receptor avidities than peritoneal macrophages. In vitro
cultures of both macrophage populations increased Fc receptor
activities (Rhodes, 1975).
5.2.2 Complement receptors
In human and rabbit alveolar macrophages receptors for
C3b and C3d complement components have been identified (Lay
and Nussenzweig, 1968; Reynolds et al, 1975).
In contrast to Fc receptors the receptor for the third
complement component was destroyed by trypsin and required
2+
Mg ions for binding C3-coated particles (Lay and
Nussenzweig, 1968).
A different role for IgG and complement receptors
on macrophages has been reported. Complement receptors
may be primarily involved with particle attachment to the
cell and IgG receptors might mediate attachment and
ingestion of particles (Griffin et a1, 1975a; Mantovani
et al, 1972). However, when activated lung and peritoneal
macrophages were exposed to C3-coated particles both
attachment and ingestion occurred (Shurin and Stossel, 1978;
Griffin et al, 1975a).
5.2.3 Surface antigens
The macrophage membrane possesses specific surface
antigens which react with the IgG fraction of heterologous
anti-macrophage serum (Panijel and Cayeux, 1968; Unanue,
1968; Despont and Crucheud, 1969; Hirsch et al, 1969;
Leibovich and Ross, 1975; Holland et al, 1972). Attachment
to the macrophage membrane occurred by means of the Fab
region (Holland et al, 1972).
Anti-macrophage serum prepared from peritoneal cells
selectively inhibited the attachment and ingestion of
opsonized erythrocytes and mycoplasma and labelled haemo-
cyanine in vitro, but phagocytosis of polystyrene particles
and zymosan was not affected (Holland et al, 1972; Unanue,
1968). Experiments in vitro have demonstrated that in the
presence of complement the antiserum is cytotoxic for
macrophages (Unanue, 1968). In the absence of complement,
antiserum-treated cells showed susceptibility to killing and
phagocytosis by untreated normal macrophages, indicating
that membrane changes occurred by which treated cells are
no longer recognized by untreated macrophages (Leibovich
and Rossi, 1975). However, the anti-macrophage serum
cytotoxicity and its ability to inhibit phagocytosis
decreased significantly after prolonged incubation
(Gallily and Schroit, 1975). The mechanisms involved
appear to be a result of shedding of macrophage antigens
from the membrane and their subsequent combination with
serum, since cells were able to react with fresh anti¬
serum re-establishing phagocytic inhibition (Schroit et al
1973).
A rabbit antiserum, specific against rat alveolar
macrophages, has also been prepared (Martinez and Montfort
1973). This antiserum did not react with rat blood
monocytes or peritoneal macrophages but showed a high
percentage of cross-reaction with rat tissue macrophages,
i.e. liver, spleen, lymph node, bone marrow.
5.2.4 Receptors for lymphocytes
Guinea pig alveolar, peritoneal exudate, resident
peritoneal and splenic macrophages bound thymocytes and
lymph node lymphocytes through their membranes with no
evidence of cytoplasm contact as revealed by electron
microscopy and phase contrast cinematography studies
(Lipsky and Rosenthal, 1973; Salvin et al, 1971). No
selectivity for T or B lymphocyte binding was observed.
The interaction required viable and metabolically active
macrophages, but not lymphocytes, and it was dependent on
the presence of divalent cations. The binding was
abolished by trypsinization of the macrophages but not of
the lymphocytes. The macrophage-lymphocyte interaction
was temperature- and time-dependent with a maximal effect
after 60 min of incubation (Rosenthal et al, 1976).
5.2.5 Receptors for T lymphocyte products (MIF)
Macrophage inhibitory factor (MIF) released by T
lymphocytes has been reported to act on alveolar macrophages
(Warr and Martin, 1973; Reynolds et al, 1974; Moore and
Myrvick, 1974).
The interaction of MIF with macrophage membrane was
abolished by trypsin or chymotrypsin treatment (David and
David, 1972). Neuraminidase destroyed MIF activity
indicating that sialic acid groups were probably crucial
for its function (Remold and David, 1971). The macrophage
membrane MIF "receptors" apparently contain a carbohydrate
component since the action of lymphokine was inhibited by
both a-LFucose and LFucosidase (Remold, 1973).
Guinea pig peritoneal macrophages incubated with the
specific esterase inhibitors, diisopropyl fluorophosphate
and soybean trypsin inhibitor showed an increased response
to subthreshold doses of MIF (Remold, 1974). A similar
enhancement of MIF activity was formed when macrophages
were previously treated with a specific plasma esterase
inhibitor, ocg-macroglobulin and pure antithrombin III (AT III)
but little or no effect with a^-antitrypsin or CI esterase
inhibitor (Remold and Rosenberg, 1974). These experiments
suggested the existence of enzymes on the macrophage
membrane which modulate the cell response to MIF.
5.3 Topography of plasma membrane
In rabbit alveolar macrophages, the topography of
plasma membrane has been studied, using the transport system
lysine and nucleoside as markers (Tsan and Berlin, 1971a,b;
Berlin, 1973). During phagocytosis up to 50% of plasma
membrane was internalized and the transport systems remained
intact (Tsan and Berlin, 1971b). However, when the membrane
structure was disrupted by pretreatment of cells with
colchicine or vinblastine the transport system activity
decreased during phagocytosis (Ukena and Berlin, 1972;
Berlin et al, 1974). These observations led to the
conclusion that topographic areas maintained by colchicine-
and vinblastine-sensitive structures exist in the macrophage
membrane. This structure, probably microtubules, excluded
transport carriers from phagocytic areas.
Syngeneic erythrocytes attached to the plasma membrane
of murine peritoneal macrophages were not internalized
during phagocytosis of latex particles by these cells
(Griffin and Silverstein, 1974). These findings reinforce
the view that specific areas of plasma membrane may have
limited activities.
5.4 Control of macrophage plasma membrane movement
Two systems, the microtubules and the microfilaments,
apparently control the phagocyte plasma membrane movements.
These structures may be involved in functions of the cells
such as chemotaxis, endocytosis and release of chemical
products.
The ultrastructure and organization of these systems
has been defined (Reaven and Axline, 1973). Microfilaments
are found below the plasma membrane. The major portion of
microtubules is found in close apposition to organelles and
radiate throughout all parts of the cytoplasm, penetrating
the microfilaments and attaching to the plasma membrane
(Reaven and Axline, 1973). Microtubules are apparently
composed of tubulin protein (Cohn, 1975) and microfilaments
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of actin and njtosyn-like proteins (Stossel, 1976). Four
different contractile proteins have been isolated from
rabbit pulmonary macrophages (Hartwig and Stossel, 1975;
Stossel and Hartwig, 1975, 1976).
Studies with substances which alter microtubule
(colchicine and vinblastine) and microfilament (cytochalasin
B) activities revealed that microfilaments are apparently
involved in random locomotion, chemotaxis and phagocytosis.
The activation of microfilaments would produce the movement,
and activation of microtubules its direction. Thus
colchicine-treated cells did not respond to chemotactic
stimulus but random movement was increased (Allison et al,
1971). Cytochalasin B inhibition of macrophage spreading,
random locomotion, chemotaxis and phagocytosis, but enhance¬
ment of lysosomal enzyme release, have been reported (Rabinovitch
and De Stefano, 1973b; Allison et al, 1971; Zigmond and
Hirsch, 1972; Becker and Showell, 1974; Zurier et al, 1973a).
Microtubules may also be important in the release of enzymes
from the cells (Becker and Showell, 1974; Zurier et al,
1973b; Ackerman and Beebe, 1975).
In studies on binding of fluorescein Concanavalin A
on rabbit alveolar macrophage membrane, a random distribution
of the lectin around the cell was found. However, when
cells were pretreated with colchicine a capping (aggregation
at one pole) of Concanavalin A was observed (Oliver and Berlin,
1976).
It would appear, therefore, that these two structures,
microtubules and microfilaments, govern the movements of the
cell and maintain the polarity and organization of the
plasma membrane.
6.0 ROLE OF THE ALVEOLAR MACROPHAGE IN DEFENCE OF THE LUNG
Alveolar macrophages have been identified as the major
defence of the lung against inhaled bacteria or foreign
particles (Goldstein et al, 1974; Morrow, 1973; Green and
Kass, 1964). In this function of "clearance" the phagocyte
must distinguish accurately between foreign material to be
removed and the normal tissue constituents. This distinction
is probably due to an interaction at the phagocyte's plasma
membrane by which various materials are "recognized".
Recognition is followed by an appropriate response, i.e.
mobilization of macrophages towards the site of invasion,
attachment, ingestion and destruction of the particle, all
of which are essential events in host defence.
These functions of macrophages in non-specific defence
are described below.
6.1 Chemotaxis and chemokinesis
Studies in vivo and in vitro indicate that mononuclear
phagocytic cells undergo locomotion, either directional to
the attractant (chemotaxis) or non-directional (chemokinesis)
(for review see Wilkinson, 1976).
Several substances which attract mononuclear phagocytes
in vivo and in vitro have been described. Thus, C5a, a
cleavage product of the fifth component of complement
(Snyderman et al, 1971), a lymphokine released by stimulated
lymphocytes (Ward et al, 1969, 1970; Snyderman et al, 1972;
Altman et al, 1973), factors derived from bacteria (Ward, 1968),
casein (Wilkinson, 1972) and Corynebacterium parvum (Wilkinson
et al, 1973) have been shown to be chemotactic for guinea pig
peritoneal macrophages and human monocytes. The rabbit
alveolar macrophage, however, appeared not to respond to
agents with chemotactic activity for peritoneal macrophages
or polymorphonuclear cells (Ward, 1968).
The way in which these different chemotactic factors
stimulated the movement in cells is still poorly understood.
Microfilaments and microtubules appear to play a role.
Cytochalasin B, which disrupts microfilaments, inhibited
locomotion in macrophages (Allison et a1, 1971). Colchicine
which depolymerizes microtubules, has been shown to increase
random migration of cells but they lost the directionality
of movement (Allison et al, 1971).
2+ 2+
Divalent cations, Ca and Mg , may also be important.
Thus in- media free of these cations, monocyte migration is
depressed but not abolished (Wilkinson, 1975).
Substances that increase intracellular levels of
cyclic AMP inhibited motility, whereas with agents that raise
the levels of intracellular cyclic GMP enhancement has been
reported (Estensen et al, 1973). However, no change in
intracellular levels of cyclic nucleotides in response to
initiation of chemotaxis has been observed (Stossel, 1974).
6.2 Attachment and ingestion
The phagocytic process involves two simultaneous but
separate phases, attachment and ingestion (Rabinovitch, 1967)
The attachment of the cell to the particle is followed by
the formation of microprojections of plasma membrane around
the particle and membrane fusion (ingestion).
The attachment may involve non-immunological or
immunological mechanisms (Jones, 1975a). The latter are
related to the presence of receptors for immunoglobulins
and complement in the macrophage membrane. Little is
known about the factor which governs non-receptor-mediated
attachment of particles. Physical properties of the
particle and of the macrophage membrane may be important.
Thus phagocytosis was enhanced when particles were more
hydrophobic or when phagocytic cells were more hydrophilic
(Van Oss and Gillman, 1972; Thrasher et al, 1973b). Even
more, it has been suggested that immunological attachment
is governed by the same forces as non-immunological
recognition, since opsonizing antibody and complement bound
to bacteria or other particles increase their surface hydro-
phobicity (Vann Oss et al, 1974).
If attachment is followed by ingestion, an invagination
of the surface membrane is produced, with an extension of
pseudopodia which fuse and completely enclose the particle,
forming an intracellular vacuole known as "phagosome".
Evidence suggesting that the signal to phagocytose a particle
is initiated by the particle itself has been produced.
Thus when Fc-coated erythrocytes (EA) attached to macrophages
were externally "blocked" (partially opsonized) the ingestion
was inhibited, suggesting that a "zipper-like" movement of
the membrane around the particle was necessary for
phagocytosis (Griffin et al, 1975b, 1976).
Ingestion of particles is an energy-dependent event,
presumably necessary for moving the plasma membrane into
apposition with the particle. A network of polymerized
microfilaments, immediately sub-adjacent to the ingested
particle, has been observed (Reaven and Axline, 1973).
In rabbit alveolar macrophages, inhibition of endocytosis,
but not attachment by cytochalasin B, has been reported
(Malawista et al, 1971). It appears that microtubules
are not essential for phagocytosis in guinea pig alveolar
macrophages (Ackerman and Beebe, 1975).
The adenylate cyclase system has been associated, in
polymorphonuclear and mononuclear cells, with the process
of phagocytosis (Manganiello et al, 1971; Bourne et al,
1971; Cox and Karnovsky, 1973). However, in both cells
a different effect has been observed. In polymorphonuclear
cells, phagocytosis was not accompanied by an increase in
cyclic AMP (Stossel et al, 1970; Seyberth et al, 1973;
Schmidt-Gayk et al, 1975). Moreover, if cyclic AMP
concentration was increased, by addition of drugs, particle
uptake was diminished (Stossel et al, 1971; Bourne et al,
1971; Cox and Karnovsky, 1973). In rabbit alveolar
macrophages a significant increase in cyclic AMP during
phagocytosis of latex bead particles has been observed
(Seyberth, 1973). Also, an increase in particle uptake
after preincubation of alveolar macrophages with dibutyryl
cAMP has been reported (Schmidt-Gayk, et al, 1975).
However, other authors have found no increase in rabbit
alveolar macrophage cyclic AMP during phagocytosis
(Manganiello et al, 1971).
6.2.1 Metabolic changes during phagocytosis
Exposure of phagocytic cells to an appropriate
stimuli is followed by a series of co-ordinated metabolic
events denominated the "respiratory burst" (Babior, 1978).
In early work, it was demonstrated that phagocytic
cells increased their oxygen consumption during phagocytosis
(Baldridge and Gerard, 1933). Later it was shown that most
of the oxygen uptake by polymorphonuclear cells during
phagocytosis was converted to hydrogen peroxide, an agent
with a known bactericidal capacity (Iyer et al, 1961).
The authors related the respiratory burst with the micro¬
bicidal activity of the cells (Iyer et al, 1961). These
events, first described in polymorphonuclear cells, have
also been demonstrated in mononuclear phagocytes including
alveolar macrophages (Oren et al, 1963; Ouchi et al, 1965;
Romeo et al, 1973b; Rossi et al, 1975; Klebanoff and
Haman, 1975). The metabolic burst is stimulated by only
attachment, or perturbation by surface agents, of the
phagocytic cell membrane. No ingestion of the particle
is required (Graham et al, 1967; Romeo et al, 1973a;
Goldstein et al, 1975).
Simultaneously with the increase in oxygen consumption
and hydrogen peroxide production, an increase in superoxide
radical activity and in glucose oxidation has been
demonstrated. Both metabolic pathways of glucose oxidation
were increased. However, in lung macrophages the hexose
monophosphate shunt (HMP)/tricarboxylic acid cycle activity
ratio was lower than in peritoneal macrophages and poly¬
morphonuclear cells, which is consistent with their higher
content of mitochondria (Rossi et al, 1975). The initial
events of metabolic activity in all mononuclear phagocytes
was characterized by an enhancement of the HMP activity
(West et al, 1968; Rossi et al, 1975).
The stimulation of the enzyme NADPH oxidase might
initiate the respiratory burst (Fig. 1). The increase in
"RESPIRATORY BURST"






Enzymes and products of the "respiratory burst" in
phagocytic cells. (1) Nicotinamide adenine dinucleotide
phosphate oxidoreductase; (2) glucose-6-phosphate de¬
hydrogenase; (3) 6-phosphogluconate dehydrogenase;
(4) glutathione reductase; (5) glutathione peroxidase;
(6) superoxide dismutase; (7) catalase; (8) peroxidase.
Og, superoxide radical; H2®2' hydrogen peroxide; OH*,
hydroxyl radical; * Og, singlet oxygen; 0C1~, hypochlorite
anion. (Modified from P. Beswick, Ph.D. Thesis.)
HMP is probably secondary to the increase in NADP. There
are two sources for NADP. The 0^ forming system in which
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NADPH is the electron donor and the glutathione peroxidase-
glutathione reductase system (Vogt et al, 1971).
The amount of hydrogen peroxide found in macrophages
is only a small percentage of 0^ consumed (Rossi et al.
1975). Several systems of hydrogen peroxide disposal have
been described in mononuclear cells, catalase (Gee et al.
1970), glutathione cycle (Vogt et al, 1971), a peroxidase,
similar but not identical to the myeloperoxidase of
neutrophils (Romeo et al, 1973c) and the peroxidation of
unsaturated fatty acids (Mason et al, 1972). All these
systerfis may be responsible for the high rate of hydrogen
peroxide disappearance observed in these cells. In
Cv'cJe.
alveolar macrophages the glutathione'has been described
to be quantitatively more important (Gee et al, 1971).
6.2.2 Role of the "respiratory burst"
The increase in oxygen consumption and glucose
oxidation in phagocytic cells may provide the energy (ATP)
necessary for their activities and movements. On the
other hand, the metabolic burst produces metabolites with
microbicidal and cytotoxic properties. Thus Klebanoff
(1967a,b) described the "triad" of hydrogen peroxide,
myeloperoxidase and a halide (Cl~, I~) to be highly bacteri¬
cidal. This system first described in polymorphonuclear
cells, has also been reported to operate in alveolar
macrophages (Paul et al, 1973). In addition, superoxide
radical, singlet oxygen and hydroxyl radical might also
play a bactericidal and cytotoxic role (Babior et al, 1973;
Babior et al, 1975; Krinsky, 1974; Simchowitz and
Spilberg, 1979).
6.3 Degranulation
During phagocytosis, the metabolic events which were
initiated in the outer surface of the membrane, are
internalized when the invagination is produced. This
newly formed vacuole fuses with the lysosome membrane which
secretes its enzymatic content into its lumen. This process
has been termed "degranulation".
The fusion of the phagosome with the lysosome is
apparently an essential microbicidal mechanism. Thus
studies in vitro have demonstrated a survival of Mycobacterium
tuberculosis. Listeria monocytogenes and Toxoplasma gondii
inside the phagocytic cells, when the fusion of lysosome with
the phagocytic vacuole was inhibited (Armstrong and D*Arcy
Hart, 1971; Jones, 1975b).
In peritoneal and alveolar macrophages the presence
of several lysosomal hydrolytic enzymes has been reported
(i.e. (3-glucuronidase, acid phosphatase, cathepsin, acid
ribonuclease, esterase, lipase) (Cohn and Wiener, 1963a).
In vitro, the release of lysosomal enzymes into the culture
medium during phagocytosis of different particles has been
observed (Cohn and Wiener, 1963b; Cardella et al, 1974;
Davies et al, 1974a; Ackerman and Beebe, 1974). It has
been suggested that this phenomenon may also occur in vivo,
producing an inflammatory reaction (Davies and Allison,
1976), since the release of lysosomal enzymes has been
observed during phagocytosis of substances known to produce
chronic inflammation (Davies et al, 1974b; Page et al, 1974).
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The role of microtubules, microfilaments and cyclic
nucleotides in regulating the process of degranulation has
been studied. Cytochalasin B inhibited phagocytosis and
increased enzyme release in alveolar macrophages (Ackerman
and Beebe, 1975). Colchicine acting on microtubules
inhibited both phagocytosis and degranulation (Ackerman and
Beebe, 1975). The same authors found that cyclic nucleotides
and their dibutyryl analogues had no appreciable effect on
(3-glucuronidase release by guinea pig alveolar macrophages.
However, in mouse peritoneal macrophages, an inhibition
with cyclic AMP and an increase with cyclic GMP of lysosomal
enzyme release has been reported (Weissmann et al, 1971b).
7.0 SECRETORY FUNCTION OF MACROPHAGES
The precise role of macrophages (including alveolar
macrophages) in chronic inflammatory reactions is largely
unknown. The capacity of these cells to influence the
surrounding medium might be due to the production and
secretion of several chemical mediators. In addition to
lysosomal enzymes secreted during phagocytosis of different
substances and by stimulation of T lymphocyte products
(Pantalon and Page, 1975), macrophages are able to release
other chemical substances with probable participation in
inflammatory reactions. These substances are analysed
below.
7.1 Neutral proteinases
It has been demonstrated that macrophages are able to
secrete several neutral proteinases that may play an important
role in both the destruction and repair phases of the chronic
inflammatory process. These enzymes include:
(a) Plasminogen activator which catalyzes plasminogen to
plasminf, a potent fibrinolytic enzyme. It is induced
during macrophage activation by non-specific stimulus, i.e.
latex phagocytosis, Concanavalin A, thioglycollate, phorbol
myristate (Unkeless et al, 1974) or by immunologically
specific stimulation by a T lymphocyte product (Gordon et al,
1978).
(b) Collagenase is present in normal alveolar macrophages
(Senior et al, 1972) but only in stimulated peritoneal
macrophages (Wahl et al, 1974). Its secretion can be
induced in vitro culture by exposing the cells to bacterial
lipopolysaccharide (Wahl et al, 1974).
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(c) Elastase has also been demonstrated to be synthesized
and released by macrophages including alveolar macrophages
(Ackerman and Beebe, 1974). This enzyme may play an
important role in pulmonary pathology.
7.2 Lysozyme
Lysozyme is synthesized and secreted by several
mononuclear phagocytic cells (Heise and Myrvik, 1967;
Gordon et al. 1974; McClelland et al., 1975). It may
have a bactericidal role and possibly destroys dead
bacterial cell walls.
7.3 Complement components
The snythesis of C2 by guinea pig peritoneal
macrdphages (Wyatt, 1972) and C4 by guinea pig peritoneal
lung, and liver mononuclear cells, has been reported
(Littleton et al, 1970).
7.4 Other products
Other products secreted by macrophages include
pyrogen (Hahn et al, 1967) and interferon (Acton and Myrvik,
1966).
7.5 Summary
In suiranary, macrophages under different stimuli have
shown the capacity of synthesis and secretion of several
chemical mediators. Through these products, macrophages
may be able to modify their surrounding medium and participate
in functions such as specific and non-specific immunity and
in some pathological conditions such as chronic inflammatory
reactions.
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8.0 ROLE OF THE ALVEOLAR MACROPHAGE IN SPECIFIC IMMUNITY
It is well established that macrophages participate in
the production of antibody and in the regulation of lymphoid
cell functions, but the precise mechanism of these complex
interactions is not understood (for recent review see
Nelson, 1976).
Most of the work has been with macrophages other than
those from the respiratory tract (i.e. spleen, lymph node,
peritoneal cavity). The role of the alveolar macrophage
in these immunological mechanisms has received relatively
little attention. However, the lung has been recognized
as an organ capable of mounting a local immune response
following exposure to antigen (reviewed by Kaltreider, 1976).
A comparison of the alveolar macrophages with other
mononuclear phagocytes in terms of specific immunity is
discussed below.
8.1 Role of macrophages in antibody-mediated immunity
Several studies in vivo and in vitro have demonstrated
that macrophages from the spleen, peritoneal cavity and
lymph nodes are required for the development of a primary
antibody response (Sabin, 1939; Fishman, 1959; Gallily
and Feldman, 1967; Unanue, 1972; Katz and Benacerraf, 1972).
In vitro, the macrophages appear to participate mainly in
response to T cell-dependent antigens. Thus certain
antigens, i.e. bovine serum albumin (Mitchison, 1969),
haemocyanine from Maia squinado (Unanue and Askonas, 1968a),
sheep or burro erythrocytes (Mosier, 1967; Pierce, 1969;
Shortman and Palmer, 1971), viruses (Fishman, 1961;
Bluestein and Pierce, 1973), might be considered as
macrophage- as well as T cell-dependent. At the present
time the "helper" role of macrophages in antibody production
can be summarized as follows: (1) antigen modification;
(2) direct contact with lymphocytes, and (3) indirect
influence on lymphocytes by the release of macrophage-
derived chemical mediators. These putative functions are
discussed individually below.
8.1.1 (a) Antigen modification ("handling") by
macrophages
Studies in vitro have demonstrated that macrophages
were able to "take up" and modify a number of different
antigens (Unanue, 1972). Most of the radiolabelled antigens
which' penetrate the macrophage were destroyed. Some escaped
degradation and were released from the cells (Unanue and
Askonas, 1968b). Small quantities of undegraded antigen
adhered to the macrophage membrane and were capable of
reacting with specific antibodies (Unanue et al, 1969).
This macrophage-bound antigen was shown to be highly
immunogenic. Furthermore, macrophage-bound antigen
evoked a primary antibody response in vitro (Pierce et al,
1974; Seeger and Oppenheim, 1970).
Soluble antigens which are potentially tolerogenic
can be rendered immunogenic after uptake and concentration
by macrophages. Thus macrophages may appear to have the
capacity to eliminate "tolerogenicity" (Mosier, 1975).
8.1.1. (b) "Handling" by alveolar macrophages
The role of the alveolar macrophage in antibody
formation is less clear. Studies in vitro suggested that
alveolar macrophages from the dog were able to process
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certain antigens, i.e. ragweed and keyhole limpet haemo-
cyanide, in a comparable way to that described for other
macrophages (Pruzanski et al, 1976). That is to say, a
certain amount of material remained membrane-bound. On
the other hand, the complete degradation of bacterial
antigens, with loss of its immunogenic capacity, by BCG-
stimulated rabbit alveolar macrophages was reported (Cohn,
1964, 1968). These findings are not necessarily mutually
exclusive since the experimental conditions were different.
Thus the interaction of the alveolar macrophage with
putative antigens might result either in complete elimination
or "immunogenicity"; pathological lung reactions might be a
consequence of a failure of such mechanisms (Mackaness, 1971).
8.1.2 Macrophage-lymphocyte interaction
The sequence of events in the interaction between
macrophages and lymphocytes in the stimulation of the
antibody response remains controversial. One view is that
macrophage-bound antigen triggers specific T cells which in
turn become activated to regulate the expression of a B
cell response to that antigen (Unanue, 1972; Katz and
Unanue, 1973). Alternatively, antigens might first
interact with T cells (which release a T cell immunoglobulin,
IgT) which are cytophilic for macrophages. IgT bound to
macrophages would then stimulate B cells for specific
antibody production (Feldman, 1972). In both situations
macrophages are apparently essential. Thus the interaction
between macrophages, T cells, B cells and antigens is an
absolute requirement for development of an optimal antibody
response in vitro (Pierce, 1973; Unanue, 1972; Claman and
Mosier, 1972; Katz and Benacerraf, 1972).
The macrophage-lymphocyte interaction has been shown
to occur both by physical contact between these cells and
also by release of chemical mediator^ from the macrophages.
Several different macrophages, including those from
the respiratory tract, are able to interact physically with
both T and B lymphocytes either in the presence or absence
of antigen. Ultrastruetural studies revealed a broad area
of cell to cell contact (Lipsky and Rosenthal, 1973)
suggesting a receptor-like mechanism (discussed in relation
to macrophage membrane).
8.1.3 Macrophage-derived factor
Several macrophage-derived soluble factors, able to
modify the antibody response, have been described. These
chemical mediators help lymphocytes or replace the need for
macrophages in lymphocyte cultures. These factors can act
on the antigen or on lymphocytes.
8.1.3 (a) Macrophage-derived factor acting on
antigen ("solubilizing" factor)
This factor has been identified in supernatants of
peritoneal macrophage cultures. The supernatant was able
to restore the immune response of mouse spleen cells to
sheep erythrocytes (SRBC) previously depressed by removal of
macrophages (Hoffman and Button, 1971; Calkins and Golub,
1972; Wood and Gaul, 1974). Also, macrophage supernatant-
treated sheep red cells were able to stimulate the production
of anti-sheep red cell antibody in the absence of macrophages
or supernatant (Hoffman and Button, 1971). This macrophage-
derived factor appears to act by "solubilizing" SRBC and
conferring them with an immunogenic capacity, since
"solubilized" SRBC by sonication acted in the same way
(macrophage-independent) (Feldman and Palmer, 1971).
This macrophage-derived factor might be associated with
lysolecitfane released into the culture medium by
activation of phospholipase A. This enzyme is known to
be present in large amounts in stimulated macrophages
(Rosenstreich and Oppenheim, 1976; Munder and Modolell,
1973). Lysolecitine and phospholipase are both highly
membrane active substances and are able to produce red
cell lysis (Seljelid, 1975).
8.1.3 (b) Macrophage-derived factors acting on
lymphocytes
8.1.3 (b)(i) Viability promoting factor
Studies in vitro have demonstrated that peritoneal
exudate macrophages or adherent cells from the spleen
enhanced the survival of lymphoid cells in culture and had
an essential participation in the antibody response to sheep
red cells (Shortman and Palmer, 1971). This effect could
be substituted by 2-mercaptoethanol indicating that a soluble
factor derived from macrophages was probably acting on
lymphocytes. Therefore, macrophages might be able to play
a trophic role in supplying factor(s) which may maintain
lymphoid cell viability (Chen and Hirsch, 1972).
8.1.3 (b)(ii) Lymphocyte activating factor (LAF)
or mitogenic protein (MP)
It was shown that cultures of mouse peritoneal exudate
macrophages and human leucocytes secreted a factor which, in
the presence of antigen or mitogens, potentiated cell
division of thymocytes and to a lesser extent T and B
lymphocytes. It has been termed lymphocyte activating
factor (Gery et al, 1972) or mitogen protein (Unanue, 1978).
This substance(s) has been characterized and its function
studied (Unanue, 1978). It is a low molecular weight
protein with no apparent enzymatic activity. It is heat
labile (Gery and Handschumacher, 1974; Unanue, 1978). The
release of this factor(s) was increased by stimulation with
endotoxin PHA or irradiation of macrophages ija vivo (Geiger
et al, 1973). Highly pure preparations of "mitogenic
protein" stimulated proliferation of thymocytes in the
absence of antigens (Calderon et al, 1975).
8.1.3 (b)(iii) Macrophage-derived factor acting on
B cell differentiation
Spleen cells from immunized mice, incubated with
macrophage culture fluid, differentiated into plaque forming
cells in the absence of antigen and T cells (Calderon et al,
1975). This finding was interpreted as representing immune
(memory) B cells differentiating into antibody-secreting
cells in the presence of a macrophage-derived factor.
8.1.3 (b)(iv) Factor increasing or suppressing
antibody production in vitro
Another factor found in macrophage culture fluid
enhanced or decreased antibody production when added to
spleen lymphoid cells in vitro. This activity required
immune spleen cells and the same antigen used for priming
T and B cells (Calderon et al, 1975; Unanue, 1978). In
these experiments spleen cells from mice immunized several
weeks before harvesting for in vitro culture responded by
an increase in antibody production. In freshly primed
mice the antibody response could be enhanced or suppressed
depending upon the amount of macrophage culture fluid.
Therefore, this macrophage-derived factor increased or
decreased antibody production following incubation with
antigen, although the magnitude of these modifications was
dependent upon the immune status of the spleen cells.
8.2 Role of macrophages in cell-mediated immunity
Macrophages are also required for the maturation or
development of cell-mediated immunity in vivo and in vitro
(Bloch and Nordin, 1960; Seeger and Oppenheim, 1972; Wahl
et al, 1975). As in antibody production, macrophages are
also intimately involved in antigen binding and activation
of T lymphoid cells for the production of mediators by the
specifically sensitized cell (Rosenstreich and Oppenheim,
1976). T lymphocytes, after stimulation with specific
antigen or mitogen, release biological mediators (or
lymphokines) with a great variety of effects, e.g.
attraction and activation of macrophages. These inter¬
actions among T lymphocytes and macrophages confer on the
latter a non-specific increase in their anti-bacterial,
anti-viral and anti-tumoural capacities and induce them
to secrete biologically active substances. Although the
activation of macrophages requires a lymphocyte-dependent
specific antigen recognition, macrophages acquire a non¬
specific activity (Krahenbuhl and Remington, 1971;
Remington et al, 1972; Simon and Sheagren, 1971, 1972;
Mackaness, 1969).
8.2.1 Role of macrophages in lymphocyte responses
to mitogens in vitro
Mitogens, such as phytohaemagglutinin (PHA) and
Concanavalin A (Con A) are able to stimulate T lymphocyte
proliferation in vitro. In macrophage-depleted lymphocyte
cultures a reduced, but not absent, response to PHA and
Con A has been observed. However, it was markedly enhanced
by the re-addition of mononuclear phagocytic cells (Lorhmann
et al, 1974). If highly purified T lymphocytes were
stimulated with mitogens, in the absence of macrophages, no
detectable response was observed. On the other hand,
activity was restored by the addition of syngeneic
macrophages or their supernatant. Although mitogens were
able to bind T cells, the proliferation did not occur unless
macrophages or a macrophage-derived soluble factor was
present. Furthermore, macrophage-bound PHA was also
capable of stimulating purified T lymphocytes (Rosenstreich
and Oppenheim, 1976). Therefore, lymphocytes can be
activated directly by macrophage-bound mitogens or through
a two "step" process, i.e. the binding of mitogen to
lymphocytes and the activation through the lymphocyte
activating factor (LAF) previously described (Rosenstreich
and Oppenheim, 1976).
8.2.2 Alveolar macrophages and lymphocyte response
to mitogens in vitro
The role of the alveolar macrophage in lymphocyte
response to mitogens has not been studied extensively and
the work which has been reported has used several different
species. For instance, guinea pig alveolar macrophages
greatly enhanced the response of lymph node lymphocytes to
PHA and Con A (Gorenberg and Daniele, 1978). When highly
purified alveolar macrophages, resident peritoneal and
glycogen-induced peritoneal macrophages were compared in
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their effect as accessory cells in mitogen-stimulated
lymphocyte proliferation, the alveolar macrophage showed
a higher stimulatory effect than both types of peritoneal
macrophage. Furthermore, the presence of alveolar
macrophages in the cell culture was not necessary since if
both populations (lymphocytes and alveolar macrophages)
were separated by a filter, a stimulatory effect was also
obtained. This suggested that the effect was produced
through a soluble diffusible factor. However, when
peritoneal cells were studied, its presence in the cell
culture was required, i.e. the effect could not be
obtained with factor alone indicating a qualitative as
well as a quantitative difference in the activating factor
in both macrophage populations (Gorenberg and Daniele, 1978).
In contrast, in rats and dogs a factor with a
suppressor effect on lymphocyte mitogen-stimulated
proliferation from purified alveolar macrophages has been
described (Holt, 1979a; Ansfield et al, 1979). When canine
cells were studied a decreased response to mitogens of
lung lymphocytes compared to blood lymphocytes was
observed. This inhibitory effect was due to both an
inherent hyporesponsiveness of lung lymphocytes and a
suppressor effect of alveolar macrophages. The same
inhibitory effect was obtained when blood lymphocytes
were mitogen-stimulated in the presence of alveolar
macrophages (Ansfield et al, 1979).
In the rat, two different populations of alveolar
macrophages have been described; one strongly adherent
which also had an inhibitory effect on mitogen-stimulated
lymphocyte proliferation and another weakly adherent
population which stimulated lymphocyte proliferation to
mitogens (Holt, 1979b). These data are not necessarily
contradictory since both stimulatory and inhibitory activity
in lymphocyte proliferation by other macrophage supernatants
have been previously described (Calderon and Unanue, 1975;
Calderon et al, 1974; Keller, 1975; Nelson, 1973).
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9.0 MACROPHAGE ACTIVATION
The concept of macrophage activation was first
introduced to indicate the adaptive changes produced in
those cells which enable them to express enhanced resistance
to infection. However, not only anti-bacterial properties
are increased in activated macrophages. They also show
augmentation in anti-viral and anti-tumour activities as
well as secretion of biological substances. These latter
products are not normally secreted, i.e. plasminogen
activator, collagenase and elastase (Gordon, 1977; Gordon
et al, 1978).
Activated peritoneal macrophages showed morphological,
biochemical and physiological changes. They exhibited
increased adherence, spreading and ruffled membranes
(Blanden, 1968), decreased membrane permeability (Diengdoh
and Turk, 1967), increased pinocytic (Edelson et al, 1975)
and phagocytic capacities (Bianco et al, 1975) and an
increased number of phagolysosomes and endocytic vesicles
(Cohn and Benson, 1965c). Stimulation of metabolism
includes an increase in glucose oxidation and oxygen
consumption increase in hexosemonophosphate shunt (Nathan
et al, 1971) and NADPH oxidation (Poulter and Turk, 1975a,b),
and an augmentation of superoxide anion production (Johnston
et al, 1978). However, no increase in hydrogen peroxide
was reported (Nathan and Root, 1977), an observation which
may be related to the relatively high content of hydrogen
peroxide disposal system in macrophages.
Inflammatory macrophages obtained from the peritoneal
cavity had increased amounts of lysosomal enzymes within
the large phagolysosomes (Cohn and Benson, 1965c; Cohn, 1968
Cohn, 1978). Also, BCG-activated alveolar macrophages
exhibited increased levels of acid phosphatase, lysozyme
and lipase as compared to alveolar macrophages from
unstimulated rabbits (Cohn and Wiener, 1963a). In vitro,
lymphokine-activated macrophages had no increase in (3-
glucuronidase activity after 1 hr contact (Poulter and
Turk, 1975a). However, an increase in this enzyme was
observed after 3 days contact (Poulter and Turk, 1975b)
suggesting that there are subtle sequences in activation.
Another property of activated macrophages is their
capacity to recognize and destroy neoplastic cells. Such
activated macrophages can be obtained in vivo from animals
infected with bacteria (BCG or Listeria) or certain protozoan
(Toxoplasma gondii) infections or from animals stimulated
with complete Freund's adjuvant or killed Corynebacterium
parvum (Hibbs et al, 1972; Remington et al, 1975;
Meltzer et al, 1975). In vitro macrophages can be
activated and induced to be cytotoxic to tumour cells by
a product of sensitized T cells secreted in the presence
of sensitizing antigen (Piessens et al, 1975; Lohmann-
Nattes, 1976). This macrophage cytotoxic factor (MCF)
was shown to bind allogeneic and syngeneic macrophages
rendering them cytotoxic (Evans et al, 1972; Zembale et al,
1973).
The functional criteria frequently used to distinguish
normal from activated macrophages have been the increased
capacity of killing of intracellular organisms (Mackaness,
1962, 1964), inhibition and/or killing of tumour cells
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(Evans, 1975) and inhibition and/or stimulation of
lymphocyte proliferation (Nelson, 1973; Keller, 1975).
There is some evidence, however, that activated macrophages
characterized by one functional criterion do not always
possess the other functional characteristic as well (Wing
et al, 1977). Thus some expressions of activation can
be manifested before others. This may indicate that
activation occurs in "steps" and that the number of these
steps is determined by the appropriate activating factor
which in turn decided the particular biological role
(North, 1978).
In summary, macrophages play an important role in
the induction of the immune response and are a principal
effector cell in cell-mediated immunity. Also, they
actively participate in anti-bacterial, anti-tumoural and
anti-viral defence of the organism.
The role of the alveolar macrophage in the immuno¬
logical response is poorly understood. However, it is
reasonable to assume that its influence is almost certainly
comparable to other well known activities in defence
against bacteria in the lungs, since airways are constantly
invaded by a great variety of antigens.
SECTION B - HISTAMINE
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1.0 HISTAMINE
Histamine (2-aminoethylimidazol) is a low molecular
weight pharmacological agent formed in most tissues. It
is stored within mast cells or blood basophils as a heparin
protein complex in metachromatic granules of these cells.
It is released by a wide variety of specific and non-specific
stimuli. These include cold, trauma, burns, infection and
in antigen-antibody reactions mediated by homocytotropic
antibody. Certain substances, i.e. compound 48/80, release
histamine by their selective interaction with the mast cell
membrane.
1.1 Synthesis and metabolism of histamine
Histamine is synthesized by the decarboxylation of
the amino acid L-histidine by the action of the enzyme,
histamine decarboxylase (Fig. 2). In several species
including man, guinea pig, rat and rabbit, histamine is
metabolized by two routes. However, the importance of these
routes varies among species. In one pathway, histamine is
methylated to 1,4-methylhistamine by the enzyme, histamine
N-methyltransferase. Methylhistamine is subsequently
deaminated by monoaminoxidase to form 1,4-methyl imidazole-
acetic acid. In the other pathway, histamine is deaminated
by diaminoxidase ("true histaminase") to form imidazole-
acetic acid which can be excreted or previously conjugated
as ribosyl imidazoleacetic acid. N-methyltransferase is
associated with mononuclear cells whereas "true histaminase"
is present predominantly in granulocytes (Zeiger et al, 1976).
Studies with labelled histamine have shown that the


































Pathways of synthesis and metabolism of histamine
in man (after Schayer, 1959).
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has largely disappeared from plasma and appeared in almost
all tissues as metabolites within minutes after intravenous
administration. Only a small percentage of the labelled
histamine was formed unchanged in the urine (Schayer, 1959).
1.2 "Histaminopexy"
Studies in vitro in human and rat serum have demonstrated
that histamine had the capacity to bind to a small polypeptide
of 1,000-5,000 M.W. The amine attached predominantly to
albumin from which it could be liberated after papain
digestion or during the process of coagulation (Geese et al,
1972). This phenomenon called "histaminopexy" may have
relevance to the results described later in this thesis.
1.3 Histamine antagonists
Since histamine has been shown to participate in a
number of physiological and pathological states there have
been numerous studies on the development of histamine
antagonists. The first group of histamine antagonists
(pyrilamine maleate, diphenhydramine, mepyramine,
chlorpheniramine, etc.) were able to "block" only some of
the actions of histamine. Later these drugs were
designated HI histamine antagonists (Ash and Schild, 1966).
It was not until 1972 that a second group of histamine
antagonists, H2, were discovered (burimamide, metiamide,
cimetidine) (Black et al, 1972) which antagonised histamine
effects unaffected by the HI antagonists (or "classic anti¬
histamines"). Thus at the present time it is thought that
the activities of histamine are mediated by two different
types of tissue receptors (HI and H2), the ratio of
distribution of both types of receptor varying in different
organs (Black et al, 1972; Chand and Eyre, 1975).
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1.4 Role of histamine
The first pharmacological activity of histamine was
reported by Dale and Laidlaw in 1919. They observed that
when this drug was applied locally it produced an inflammatory
reaction with redness, swelling and oedema. Following
injection it produced "anaphylactic-like" symptoms, i.e.
hypotension, tachycardia, increased capillary permeability
with loss of plasma through the capillary epithelium and
haemoconcentration accompanied by a fall in body temperature.
Histamine also was found to produce an increase in gastric
and pancreatic secretion and constriction of smooth muscle
of bronchus, stomach, duodenum and urinary bladder.
Another role proposed for histamine is in regulation of
the microcirculation (Schayer, 1965). According to this
view, histamine would be synthesized, but not stored,
continually in the small blood vessels and upon accumulation
relaxes the precapillary sphincters. Cyclic accumulation
of histamine and "wash out" would account for the spontaneous
opening and closing of small blood vessels in the vascular
bed.
Histamine synthesis has been found to be increased
in tissues undergoing rapid growth or repair such as the
foetus, regenerating liver, granulating tissue of wounds
and in certain tumours (Kahlson and Rosengren, 1968).
The participation of histamine in hypersensitivity
reactions is well known. In these pathological conditions
it is released with other mediators (slow reacting substance
of anaphylaxis (SRS-A) and eosinophil chemotactic factor of
anaphylaxis (ECF-A)) when mast cells or basophils
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specifically sensitized with IgE (or equivalent tissue-
sensitized antibody) interact with antigen.
Further studies have shown that histamine may
apparently function as a regulator as well as a mediator
of hypersensitivity. Thus histamine inhibited histamine
release from basophils probably by increasing cyclic AMP
(Bourne et al, 1971), an effect mediated through the H2-
receptors (Lichtenstein and Gillespie, 1973). In
addition, ECF-A (Kay and Austen, 1971) and histamine
(Turnbull and Kay, 1976; Jones and Kay, 1977) will promote
directional migration of eosinophils in vitro and their
accumulation to skin sites in vivo. Eosinophils in turn
have a regulatory role by their histamine inhibitor
content and their inhibition of mast cell regranulation
(Jones and Kay, 1976). Also, histamine induced the
release of an eosinophil immobilizing factor from non¬
adherent mononuclear cells (Kownatzki et al, 1977).
A probable regulatory role of histamine in the
immune response by increasing cyclic AMP in immunological
cells, mainly through an H2-receptor, has been reported
(Bourne et al, 1974). Thus an inhibition of antibody
production (Melmon et al, 1974), antigen-induced lymphocyte
proliferation (Artis et al, 1975), release of MIF (Rocklin,
1976) and lymphocyte-mediated cytotoxicity (Henney et al,
1972) have been demonstrated. Also interesting was the
report that lymphocytes increased their functional
histamine receptors with maturation (Roszkowski et al,
1977) and after primary immunization (Plaut et al, 1973b).
Histamine may also play a role in acute inflammatory
reactions by inhibiting the enzyme release from poly-
morphonuclear cells (Zurier et al_, 1974; Busse and Sosman,
1976).
Histamine, therefore, has important physiological and
pathological roles. Its participation in inflammatory and
hypersensitivity reactions is well known. On the other
hand, its role in the immune response needs further
investigation.
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Action Species Mediated Reference








Increases cAMP in: -
Leucocytes Human H2 Lichtenstein and
Gillespie, 1973, 1975
Lymphocytes -
from spleen, lymph Mouse H2 Roszkowski et al,
node and thymus 1977
Neutrophils Human H2 Busse and Sosman,
1976
Lung slices Human ? Beaven, 1976
Brain slices Guinea pig HI & H2 Baudry et al, 1975
Inhibits antibody Mouse H2? Melmon et al, 1974
production in
vitro
Inhibits T cell- Mouse H2 Henney et al, 1972;
mediated cytolysis Plaut et al, 1973b
in vitro
Inhibits MIF Guinea pig H2 Rocklin, 1976
release from
lymphocytes
Inhibits enzyme Human H2 Zurier et al, 1974;
release from Busse and Sosman,
neutrophils 1976
CHAPTER II - AIMS OF THE PRESENT STUDY
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The respiratory tract is constantly exposed to a variety
of particles including micro-organisms, allergens and
potentially toxic pollutants. The airways and lung parenchyma
possess several mechanisms for clearing particles such as
respiratory cilia and the cough reflex. However, it is well
recognized that alveolar macrophages are probably the major
defence system since these cells are phagocytic, can kill
various micro-organisms and, unlike other leucocytes, appear
to function optimally in an aerobic environment.
It is known that activation of the "respiratory burst"
in phagocytic cells, including alveolar macrophages, is
achieved by a number of agents, both soluble and particulate,
many of which bind to the plasma membrane (for example,
particles opsonized with complement) through cell surface
receptors. This suggests that there may be a close associa¬
tion between "membrane recognition." of certain exogenous
stimuli and the enzyme which initiates the primary oxygen-
consuming reaction (also thought to be membrane-bound and
probably "NADPH oxidase"). The "respiratory burst" is
associated with the production of a number of partial reduction
products of oxygen which themselves have microbicidal
capacities. These include the superoxide radical, singlet
oxygen and hydrogen peroxide.
Previous studies had indicated that human and mouse
leucocytes bind particles to which histamine had been coupled
covalently suggesting the presence of "histamine receptors" on
certain white cells (Melmon et al, 1974; Kedar and Bonavida,
1974; Saxon et al, 1977). Furthermore, these studies
indicated that "histamine receptors" appeared to be parti¬
cularly well expressed on mono ells.
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The release of histamine and other pharmacological
agents from sensitized lung fragments following challenge
with specific antigen is well known. The lung is a major
site for histamine storage and high concentrations of histamine
have been found in the sputum in pulmonary disorders associated
with immediate-type hypersensitivity (Turnbull et al, 1977).
For these reasons it seemed important to establish the
presence of "histamine receptors" on the alveolar macrophage
and to compare the expression of these receptors with other
blood leucocytes.
Since, as will be shown, histamine receptors were parti¬
cularly well expressed on lung macrophages, experiments were
then cqnducted to determine whether histamine bound to
particles initiates the respiratory burst in phagocytic cells
in a comparable way to particles opsonized with complement.
Experiments were also carried out to determine whether
histamine influenced the release of lysosomal enzymes
following incubation of alveolar macrophages with serum-
treated zymosan since it had been shown that, in neutrophils,
histamine decreases lysosomal enzyme release during phago¬
cytosis through a mechanism probably dependent on intracellular
levels of cyclic nucleotides. At the same time, studies were
also performed to see whether histamine, bound to particles,
influenced lysosomal enzyme release per se, i.e. that histamine
could trigger its membrane receptor for lysosomal enzyme
release in the same way that complement-coated particles can
initiate this secretory process.
Thus the main questions can be summarized as follows:
(1) Do alveolar macrophages have receptors for histamine
and how do these compare with other cell types?
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(2) Does stimulation of histamine receptors in alveolar
macrophages initiate biochemical mechanisms
associated with the respiratory burst?
(3) Does histamine influence the release of lysosomal
enzymes by phagocytosing alveolar macrophages and
what are the effects of particle-bound histamine
per se on enzyme release?
CHAPTER III - MATERIALS AND METHODS
55
SECTION A - BUFFERS, REAGENTS AND PURIFICATION
OF CELLS
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1.0 BUFFERS AND SOLUTIONS
2+
1.1 Dextrose-gelatin-veronal buffer (DGVB ) was prepared
freshly each day by mixing equal volumes of isotonic veronal
buffered saline (containing 0.0015 M Ca2+, 0.0005 M Mg2+ and
0.1% gelatin veronal buffer (GVB2+» and 5% dextrose in water
o i o+ o+
containing equal concentrations of Ca and Mg (D5W )
as described by Nelson et al, 1966.
2-
1.2 Gelatin veronal buffer (GVB ) was prepared as for
GVB2+ but without Mg2+ and Ca2+.
1.3 0.01 M EDTA GVB2" - a stock solution of 0.086 M EDTA,
pH 7.4, was prepared and kept at 4°C. To prepare 0.01 M
2- o_
EDTA GVB this stock solution was diluted in GVB
1.4 Phosphate buffered saline (PBS), pH 7.2, was prepared
by dissolving 8.5 g NaCl, 1.07 g Na2HPC>4 and 0.39 g NaHgPOj
in 1 litre of distilled water.
1.5 Buffer standard solution (BSS ) , pH 7.4, was prepared
by dissolving 8.0 g NaCl (0.136 M), 0.28 g KC1 (0.0026 M),
1.44 g Na2HP04.2H20 (0.0081 M), 0.2 g KH2PC>4 (0.0014 M),
0.133 g CaC1.6H20 (0.0006 M) and 0.203 g MgCl2.6H20 (0.0009 M)
in 1 litre of distilled water. This solution was supplemented
with 5.5 mM glucose when used as incubating medium.
1.6 Tyrode's buffer was prepared by mixing 40 ml of Tyrode's
A (see below) with 1 g NaHCOg, 1 g D-glucose, 1 ml 20% CaClg
and 0.4 ml 25% MgClg in 1 litre of distilled water. The pH
was adjusted to 7.4.
Tyrode's A, a stock solution containing 200 g NaCl,
5 g KC1, 1.625 g NaH2P04.2H20 in 1 litre of distilled water,
was prepared and stored at 4°C.
57
1.7 Acetate buffer 0.1 M - a stock solution was prepared
by dissolving 5.79 g CHgCOONa. 3^0 in distilled water;
3.25 ml of glacial acetic acid and distilled water were
added up to a final volume of 1 litre. The pH was adjusted
to 4.5 with 0.1 N acetic acid.
1.8 Glycine buffer 0.2 M was prepared by mixing 15.014 g
glycine and 11.69 g NaCl in 1 litre of distilled water.
The final pH, 10.4, was adjusted with NaOH 10 M.
1.9 Potassium phosphate (KH^PO^/KJBPO^) buffer 0.1 M
was prepared by mixing 0.1 M solution of each constituent
to a final pH of 7.4.
1.10 Buffered saline solution was prepared by dissolving
9 g NaCl in 1 litre of distilled water and buffered to pH
7.2-7.4 with Hepes.
1.11 Lysis solution - a hypotonic solution containing
0.155 M NH4C1, 0.01 M KHCOg and 0.0001 M EDTA was prepared
and pH adjusted to 7.4.
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2.0 CHEMICALS AND REAGENTS
Materials were obtained as follows. Histamine
dihydrochloride, rabbit serum albumin, l-ethyl-3(3-dimethyl-
aminopropyl) carbodiimide HC1 (ECDI), L-histidine, phenol-
phthalein glucoromide, sodium pyruvate, NADHg, theophylline,
cytochalasin B, {3-glucuronidase, bovine serum albumin and
Luminol (Sigma, London); Hepes (Wellcome Laboratories,
Beckenham, Kent); mepyramine maleate, phenolphthalein
(May and Baker Ltd., Dagenham, Essex); chlorpheniramine
(Allen and Hanburys Ltd., London); imidazoleacetic acid
dihydrochloride (ImAA), 1,4-methylhistamine dihydrochloride
(1,4-MeHm), N-acetylhistamine (N-AcBm) and l-methyl-4-
imidazoleacetic acid dihydrochloride (1,4-MeImAA) (Calbiochem,
California, U.S.A.); Ficoll, Sephadex G-10, Sepharose 4B
(Pharmacia, London); sodium diatrizoate (45% Hypaque)
(Winthrop, Surbiton-on-Thames, Surrey); zymosan, chicken
egg albumin (Koch Light Laboratories Ltd., Colnbrook, Bucks.);
superoxide dismutase (SOD), cytochrome C (Miles Laboratories
Ltd., Stoke Poges, Berks.); latex 0.81 p. (Difco Laboratories,
West Molesay, Surrey); medium 199 without phenol red (Flow
Laboratories Ltd., Irvine, Ayrshire); burimamide, metiamide,
4-methylhistamine dihydrochloride (4-MeHm), 2-(2-aminoethyl)
thiazole dihydrochloride (2-AET) and S ^3-(N,N dimethylamino
propyl] isothiourea (Dimaprit) were a gift from Smith, Kline
and French Laboratories Ltd., Welwyn Garden City, Herts.
All other reagents were B.D.H. (Poole, Dorset) 'Analar*
grade.
3.0 PREPARATION OF HISTAMINE RABBIT SERUM ALBUMIN
CONJUGATE (H-RSA)
The H-RSA conjugate was prepared using the procedure
described by Kedar and Bonavida (1974) with minor modifica¬
tions. Briefly, 1.4 g histamine dihydrochloride, 200 mg
rabbit serum albumin (RSA) and 1.2 g ECDI were incubated in
20 ml of PBS for 1 hr at room temperature with intermittent
shaking. The resulting solution was dialysed at 4°C against
5 litres of PBS which was changed three times over a 48 hr
period. The controls which were prepared in parallel under
the same conditions were (1) RSA^^j (200 mg of RSA and
1.2 g of ECDI in 20 ml PBS) and (2) RSAu (200 mg of RSA in
20 ml of PBS). The dialysed preparations were stored at
-20°C in 1 ml aliquots and used for up to 10 weeks after
preparation.
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4.0 PREPARATION OF CELLS
4.1 Human alveolar macrophages were obtained from patients
in which an exploratory bronchoscopy using a fiberoptic
bronchoscope was performed. The lungs were washed through
the bronchoscope with 50 ml sterile saline four or five times.
The fluid recovered was centrifuged at 500 g for 5 min and
cell pellets washed twice in BSS , and counted in a haemo-
cytometer.
4.2 Guinea pig cells
Dunkin-Hartley strain guinea pigs weighing between
250-400 g of either sex were used throughout.
4.2.1 Alveolar macrophages were obtained by tracheo¬
bronchial lavage (Myrvik et al. 1961) with 10 ml Hepes
buffered saline, pH 7.2-7.4, 10-12 times, from guinea pigs
anaesthetized with intraperitoneal sodium pentobarbital
(40 mg/kg). Prior to removing the lungs, the animals were
exsanguinated by cutting the abdominal aorta, in order to
minimize the amount of blood in the lungs. The macrophages
were purified by density centrifugation on Ficoll-Hypaque
(d = 1.08 g.ml"*) (Bdyum, 1968) at 650 g for 30 min at 4°C.
Cells at the interface were washed twice in PBS or BSS, and
kept on ice until being rewashed in the appropriate medium
and brought to the final incubation concentration used.
These preparations routinely contained over 90% of alveolar
macrophages with lymphocytes providing the major contamination.
4.2.2 Peritoneal macrophages and eosinophils were
obtained by lavage of normal guinea pigs using 20 ml PBS
containing heparin (4 units/ml). They were used either
unpurified or following density centrifugation on Ficoll
Hypaque as described above.
4.2.3 Peritoneal neutrophils were harvested by lavage
as described above 3 hr following the intraperitoneal
administration of 20 ml glycogen (1 mg/ml) in PBS.
4.2.4 Blood monocytes, neutrophils, lymphocytes and
eosinophils were obtained by puncture of the abdominal aorta
and collected into heparinized tubes (5 units/ml). Erythro¬
cytes were sedimented in 3% gelatin for 15 min at room
temperature. The leucocyte-rich supernatant was removed,
washed three times in PBS and the cells counted to a final
g
concentration of 5 x 10 /ml in PBS.
4.2.5 Lymph node cells were collected from the para-
tracheal lymph nodes by gently teasing with a scalpel and
filtering the resultant cell suspension through a stainless
steel sieve (120 wires per inch). The cells were then
washed twice in PBS and adjusted to a final concentration
of 5 x 106/ml.
4.2.6 Bone marrow basophils were obtained from the
humeri, tibiae and fibulae of guinea pigs given whole
sheep*s blood (1:1 with Alsever*s solution) on 12 successive
days as previously described (Dvorak et al, 1974).
If any of the preparations described above contained
unacceptable numbers of contaminating erythrocytes, these
were lysed by suspending the cells for 5 min at 0°C in ice
cold lysis solution (see 1.11), washing several times in PBS
and readjusting the cell count to 5 x 10 /ml. The viability
of these cells was always greater than 95% as judged by
trypan blue exclusion.
SECTION B - RECEPTOR ASSAYS
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1.0 COMPLEMENT ROSETTE ASSAY
1.1 Sensitization with IgM (EA^ab)
About 5 ml of sheep red cells (in Alsever's solution)
were washed twice (at approximately 750 g for 10 min at 4°C)
in 0.15 M NaCl, once in 0.01 M EDTA GVB2" and the cell
9
concentration adjusted to 1 x 10 cells/ml in the same
solution. To these calibrated red cells the IgM fraction
obtained from rabbit anti-sheep red cell serum was added in
amounts causing optimal sensitization necessary for complement
fixation as calculated by determining the optimal haemolysis
titre. The mixture was incubated at 37°C for 30 min in a
shaking water bath and at 0°C for 30 min with frequent
mixing.. The cells were then washed once in 0.01 M EDTA
GVB2"* and twice in DGVB2+. These cells were kept in DGVB2+
at 4°C for up to one week and were washed daily with DGVB2+.
1.2 Preparation of complement-coated sheep red blood
cells (EAC)
Equal amounts of and diluted (1/750 in DGVB2+)
fresh guinea pig serum (as a source of complement) were
mixed and incubated for 30 min at 37°C in a shaking water
bath. Following the incubation, the erythrocytes were spun
o o.
down and adjusted to 1 x 10 red cells/ml in DGVB
1.3 EAC rosette formation
Equal amounts (0.1 ml) of EAC and alveolar macrophage
g
suspensions (2 x 10 cells/ml in M199) were mixed, centrifuged
at 500 g for 5 min and the pellets incubated at 37°C and 0°C
for different lengths of time (see Results).
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2.0 IMMUNOGLOBULIN ROSETTE ASSAY
2.1 Sensitization with IgG (EA^a^)
Red cells were coated with the IgG fraction of rabbit
anti-sheep red cell serum exactly as described for IgM
except that the IgG was used at the maximum subagglutinating
titre. After the final wash the sensitized cells were kept
in DGVB2+ at 4°C at a concentration of 1 x 10®/ml.
2.2 EA rosette formation
This procedure was the same as described previously for
EAC rosette formation (see 1.3).
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3-° HISTAMINE ROSETTE ASSAY
3.1 Preparation of H-RSA-coated ox red cells
Ox red cells were washed three times in PBS and
adjusted to a 50% suspension with 0.2% formal saline.
After 20 min at room temperature the cells were washed three
times in PBS and resuspended to the same concentration, i.e.
50%. Two and one half millilitres of various dilutions
(usually 1:60) of H-RSA (or RSAECDI or RSAU> were mixed with
0.25 ml of formalized ox cells in PBS and 20 mg of ECDI in
1 ml of PBS and incubated for 45 min at room temperature with
intermittent agitation. The red cells were then washed
three times in PBS and adjusted to a final concentration of
Q
2.5 x 10 cells/ml in the same buffer.
3.2 Histamine rosette formation
Duplicate 0.1 ml volumes of leucocyte suspensions
0
(5 x 10 /ml) were mixed with an equal volume of red cells
(2.5 x 10®/ml), centrifuged at 500 g for 5 min at 4°C and
incubated, usually for 15 min (See Results), at 0°C or,
where necessary, at 37°C.
3.3 Inhibition of histamine rosette formation
This was studied as follows: 0.1 ml volumes of
suspensions containing alveolar macrophages were centrifuged
at 500 g for 5 min at 0°C and the supernatants discarded.
The test agents freshly prepared, or PBS, were added to the
leucocyte pellets, resuspended and incubated for 15 min at
37°C or 0°C. Then the red cell suspension was added,
centrifuged for 5 min at 500 g and incubated for 15 min
at 0°C. The samples were then treated as described above.
The effect of the test agents on cell viability was assessed
by trypan blue exclusion before and after treatment.
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4.° PREPARATION AND COUNTING OF ROSETTE SLIDES
4.1 Preparation
The EA, EAC and histamine rosette slides were prepared
in identical fashion. After incubation the cell pellets
were resuspended by gently agitating and diluted with an
equal volume of 2% formal saline. Smears were made in
duplicate from each suspension and dried in air (using a
hairdryer).
4.2 Staining
Alveolar macrophages were stained with either May
Grunwald/Giemsa or by the non-specific esterase technique
described by Yam, Li and Crosby (1971) with methyl green
as counterstain. All other cell types were identified by
the May Grunwald/Giemsa stain.
4.3 Counting
The percentage of rosettes (those cells binding three
or more erythrocytes) was counted by light microscopy in
200 random leucocytes at a magnification of x 40 (areas of
cell clumping being excluded).
The percentage inhibition of rosette formation was
calculated as (& ^ x 100 where 'a* and ,b* represent the
percentage of leucocyte rosettes in preparations pre-
incubated with PBS or inhibitor, respectively.
SECTION C - SUPEROXIDE RADICAL AND
CHEMILUMINESCENCE ASSAYS
1.0 ASSAY FOR SUPEROXIDE RADICAL PRODUCTION (0»)
The method used was slightly modified from that
described by Weening et al (1975). This is an indirect
assay in which the superoxide produced by the cells is
estimated by measuring the reduction of cytochrome C by
the radical. The specificity of this reaction for
superoxide was assessed using the enzyme, superoxide
dismutase (SOD) which specifically catalyzes the conversion
of Og to HgOg. In the presence of SOD, therefore, any
cytochrome C reduction is assumed to be due to reducing
agents other than Og.
Results were expressed as n moles of superoxide
g
dismutase inhibitable cytochrome C reduced per 10 cells.
1.1 Preparation of incubation mixture
1.1.1 Cells
Alveolar macrophages separated as previously described
6
were used at a final concentration of 2.4 x 10 cell/ml in
2+
BSS supplemented with glucose.
1.1.2 Preparation of serum treated zymosan (STZ)
and histamine treated zymosan (H-RSAZ)
Both agents were freshly prepared for each experiment
by incubating 10 mg of Z with 1 ml of fresh guinea pig serum
(STZ) or 1 ml of H-RSA (H-RSAZ) or control RSAj.qDI (RSAZ),
neat or diluted in PBS for 45 min at 37°C in a shaking water
bath with frequent mixing. After incubation the prepara¬
tions were washed twice in buffered saline solution or PBS
and readjusted to the starting volume.
1.1.3 Preparation of H-RSA bound to other particles
Sepharose 4B, Sephadex G-10 and Amberlite G-50 (10 mg)
were incubated with 1 ml of neat H-RSA washed and re¬
constituted in PBS under the same conditions as described
for H-RSAZ.
Latex was diluted to obtain a final concentration of
10"^ particles/ml of H-RSA and then treated as for the
other particles except that the centrifugation g was at a
higher speed (3000 g for 15 min) and that the washed beads
were reconstituted in terms of particle numbers rather than
weight.
1.1.4 Preparation of Cytochrome C
This was freshly prepared just before use and kept on
ice. The concentration used in routine experiments was
12.4 rrjg cytochrome C/ml of buffered saline solution,
although other concentrations were tested in preliminary
studies (see Results).
1.1.5 Preparation of superoxide dismutase (SOD)
The enzyme was dissolved in distilled water to a
concentration of 2.8 mg/ml (84 jiM) and kept at -20°C. In
earlier studies other concentrations similarly prepared
were also tested (see Results).
1.2 Incubating conditions
The final incubation mixture in a total volume of 1 ml
g
in 3 ml plastic tubes contained: 2 x 10 alveolar macro¬
phages, 1 mg of STZ, H-RSAZ, RSAZ, other particles or saline
when unstimulated cells were studied and 100 pM of cyto¬
chrome C. Assays were performed in triplicate: two tests
in the absence of, and one in the presence of SOD (4.2 pM).
All samples were kept on ice while components were added
and then simultaneously transferred to a 37°C shaking water
bath (180 cycles/min) to initiate the incubation.
Unless stated otherwise, the incubation time was 30 min.
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Reactions were stopped by placing the tubes on ice and then
centrifuging for 5 min at 1000 g (except latex containing
tubes which were centrifuged for 15 min at 300 g).
1.3 Histamine antagonist inhibitory assay
Mepyramine, chlorpheniramine, burimamide and metiamide
were dissolved in BSS, pH 7.4, added (0.1 ml) to the cells
—5 -5
to give final concentrations of 5 x 10 , 2 x 10 and
-5 -1
0.8 x 10 mol/1 (or BSS alone in controls) and pre-
incubated for 30 min at 37°C. The stimulating agents
(STZ etc.) and cytochrome C were then added and incubation
performed as described above.
1.4 Determination of Op
0g activity was measured in the supernatant of
duplicate samples as cytochrome C reduction (calculated from
the decrease in absorbence at 550 nm, -using an extinction
coefficient of 21.1 nM"~* cm~* on addition of excess potassium
ferricyanide) using a Pye Unicam SP 1800 UV spectrophotometer.
Any reduction occurring in the presence of SOD was subtracted
from these values. The total amount of cytochrome C was
calculated in some experiments upon the addition of sodium
dithiouite.
0g was expressed as nmoles of superoxide dismutase
inhibitable cytochrome C reduction. When the antagonists
were tested inhibition (%) was expressed as previously
described (Section B, 4.3).
1.5 Determination of chemiluminescence
Chemiluminescence was measured using a slightly
modified version of the technique described by Hatch et al
(1968). Briefly, 0.1 ml of various dilutions of H-RSAZ
or controls (RSAZEqjjj, RSAZ, H-RSA, RSA, Z, 10 ^ mol, 1
histamine and STZ) was mixed with 0.5 ml of 0.2 nM solution
of luminol in BSS, and brought to 37°C in a darkened
incubator. Two million alveolar macrophages contained in
0.4 ml of BSS supplemented with 1 mg/ml (5.5 nM) of
glucose were added to this mixture and counting commenced
immediately. Experiments were performed in polypropylene
minivials (Searle) contained in glass scintillation vials
with pre-bored screwcaps (Koch-Light) which were pretreated
at 37°C for 18 hr. During the preparation of incubation
mixtures all manipulations were performed in the dark and
at 37°C. Counts were recorded at room temperature on a
Beckman LS 250 liquid scintillation counter operating in
the *out of coincidence* mode (see Henderson and Kaliner,
1978), using a minimal iso-set module adjusted to detect
approximately the lower third of the tritium energy
spectrum. The counting mode was set to record infinite
sequential 0.2 min total count readings at a preset error
of 0.2%. All assays were monitored until peak luminescence
had been reached.
The incubation conditions described above were
developed and established in our laboratory and were shown
to be optimal for chemiluminescence by guinea pig alveolar
macrophages (D.G. Jones, unpublished observations).
SECTION D - B-GLUCURONIDASE AND LACTIC
DEHYDROGENASE MEASUREMENTS
1.0 B-GLUCURONIDASE AND LACTIC DEHYDROGENASE (LDH) ASSAYS
1.1 Preparation of the incubation mixture
1.1.1 Preparation of cells
Alveolar macrophages obtained as previously described
(Section B, 4.2.1) were brought to a final concentration of
3.0 x 10® cells/ml in M199 without phenol red, pH 7.2-7.4.
1.1.2 Preparation of STZ and H-RSAZ
These were prepared as previously described (Section C,
1.1.2).
1.1.3 Cytochalasin B
This was prepared as a stock solution of 1 mg/ml in
dimethylsulphoxide.
1.1.4 Theophylline
This was freshly prepared in M199 (without phenol red)
-3 -1
at a concentration of 5 x 10 mol.l
1.1.5 Histamine, histamine agonists and antagonists
These were prepared as 1 ml stock solutions at a
-2 -1
concentration of 10 mol.l in distilled water and stored
at -20°C. The stock solutions were diluted just before use
-3
in M199 (no phenol red), pH 7.4, to concentrations of 10 ,
10~4 and 10~5 mol.l"1.
1.1.6 H-RSA and RSA
These were diluted 1:10, 1:100 or 1:1000 in M199
(without phenol red), pH 7.4.
1.2 Incubating conditions
g
0.8 ml alveolar macrophage suspensions (3.0 x 10
cells/ml in M199) were preincubated with cytochalasin B
(5 pi) for 5 min at 37°C. Histamine either "free" or
conjugate (H-RSA), control (RSA) or histamine agonists
(0.1 ml) were added and preincubated for a further 10 min.
STZ, H-RSAZ or RSAZ (0.1 ml) were then added, the mixture
gassed with 95% 0g and 5% COg for 10 sec, sealed and
incubated for a further 2 hr (unless stated otherwise) at
37°C in a shaking water bath and with frequent mixing.
When histamine antagonists were used the drugs were added
prior to histamine.
After incubation the mixtures were placed on ice,
centrifuged at 1000 g for 5 min and the supernatants assayed
for ^-glucuronidase LDH activity and, in some experiments,
total protein. The cell pellets were resuspended in 1 ml
M199 and sonicated on ice (3 cycles of 4 sec each) using an
MSE sonic disintegrator with amplitude setting at 14 microns
probe 3 mm.
Following centrifugation at 1000 g for 10 min
^-glucuronidase, LDH and protein (in some samples) were
measured in the supernatants. Total enzyme and protein
activity was calculated by the addition of supernatant and
pellet values. In later experiments the total LDH activity
was determined in triplicate sonicates of 1 ml suspensions
6
of untreated alveolar macrophages (2.5 x 10 cells/ml)
prepared as described above.
1.3 Determination of (3-glucuronidase
^-glucuronidase was assayed by the method of Talalay
et al (1946), using phenophthalein glucuronide as a
substrate. Briefly, 0.2 ml of cell supernatant, 0.6 ml
of 0.1 M acetate buffer, pH 4.5, and 0.1 ml of 0.01 M
phenophthalein glucuronide, pH 5.0, were incubated for
16 hr at 37°C while being shaken. The reaction was
stopped by the addition of 2 ml cold glycine buffer, pH 10.4
{3-glucuronidase, with no phenolphthalein glucuronide, was
used as blanket. The O.D. was read at 540 nm in a
spectrophotometer (Pye Unicam SP 1800 UV). A standard
curve using serial dilutions of phenolphthalein (50 to
500 p.g/ml) was prepared, cold glycine buffer added and
O.D. read at 540 nm.
The enzyme activity was expressed in international
units (IU) defined as |jmoles of phenolphthalein released
6
per min per 10 cells under the incubation conditions used
1.4 Determination of LDH
The activity of LDH was determined by measuring the
initial rate of oxidation of NADHg in the presence of
0.01 M sodium pyruvate at 340 nm which under these
conditions is a direct measure of the reaction of
pyruvate to lactate (Romberg and Pricer, 1951; Wroblewzki
and La Due, 1955).
The enzyme activity was again expressed in IU or
6
pmoles of NADHg oxidized per min per 10 cells.
1.5 Determination of protein
Protein was assayed by the Lowry method (Lowry et al,
1951) and expressed as pg/ml. A standard curve was
prepared using bovine serum albumin (BSA) (0 to 500 p.g/ml)
2.0 DETERMINATION OF HISTAMINE
Histamine was assayed biologically using the
atropinized guinea pig ileum, suspended in oxygenated
Tyrode's solution at 37°C as previously described
(Brocklehurst, 1960).
SECTION E - STATISTICAL ANALYSIS
1.0 STATISTICAL ANALYSIS
All experiments were performed at least three times
under the same conditions (unless stated otherwise) and the
mean, standard deviations and standard errors calculated.
The degree of significance was calculated from the
difference of means over the sum of standard errors
(Bradford Hill, 1966).
The significance of the effects of the various
inhibitory agents tested was determined by the paired t
test using values from treated and untreated assayed in
parallel.
CHAPTER IV - RESULTS
SECTION A - RECEPTORS ON ALVEOLAR MACROPHAGES
1.0 INTRODUCTION
The macrophage plasma membrane is essential for many
of its functions, e.g. pinocytosis, phagocytosis, cell
recognition and antigen binding. Some of these activities
are apparently mediated through surface receptors. The
exact chemical nature of receptors for opsonized particles
is not known but they can be readily visualized by methods
such as the "rosette technique" and immunofluorescence.
For instance, receptors for IgG and/or complement (C) on
many haemopoietic cells including macrophages can be
visualized by exposing the cells to either antibody-coated
red cells (EA) or complement-coated erythrocytes (EAC),
which attach to the target cell, forming characteristic
rosettes.
Receptors for the Fc portion of IgG and for C3b and
C3d have been demonstrated in mononuclear cells from a
variety of species. These include human monocytes and
alveolar macrophages (Daughaday and Douglas, 1976;
Reynolds et al, 1975), guinea pig alveolar macrophages
(Rhodes, 1975) and guinea pig and mouse peritoneal
macrophages (Rhodes, 1975; Griffin et al, 1975a).
In addition to receptors associated with phagocytosis,
receptors for endogenous hormones including p-adrenergic
catecholamines, prostaglandins and histamine have also been
demonstrated in human leucocytes and mouse lymphocytes
(Melmon et al, 1972).
Receptors for histamine on human leucocytes were
first visualized by linking the amine via a protein carrier
to Sepharose beads with subsequent incubation of this
complex with the leucocytes (Melmon et al, 1972). In this
form histamine presumably adheres to its membrane receptor
and cannot penetrate the cells by diffusion. It was claimed
that this binding was specific for histamine since it was
inhibited by several "classical" histamine antagonists
(diphenhydramine, tripelennamine, antazoline and pyrilamine).
In 1974 Kedar and Bonavida described a rosette
technique, using histamine linked to sheep red cells, for
identifying histamine receptors. They were able to show
the presence of receptors for histamine on mouse thymocytes,
peritoneal exudate leucocytes, spleen cells, bone marrow,
peripheral blood and lymph node cells. They also observed
a decrease in the percentage of rosettes in lymphoid cells
from animals immunized against tumour cells and in cells
from leukaemias, mastocytoma and plasmacytoma.
Later, using the same methodology, the presence of
histamine receptors in human lymphocytes was described
(Saxon et al, 1977). Approximately 30% of B lymphocytes
and 10% of T lymphocytes were found to form rosettes. The
subpopulation of T cells bearing receptors for histamine has
been associated with these cells having suppressor/cytotoxic
activity (Ballet and Merle, 1976).
Histamine receptors in the small intestinal smooth
muscle of cats have recently been isolated and partially
characterized. Their chemical composition was protein (58.7%)
phospholipid (30.8%), cholesterol (6.7%), RNA (2.8%),
hexosamine (0.8%) and sialic acid (0.1%). It was concluded
by the authors that the receptor-rich fraction was mainly
composed of cell membrane (Uchida and Takagi, 1977).
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The precise chemical relationship between histamine
receptors on smooth muscle and leucocytes has yet to be
established.
For the reasons stated in the introductory chapter
the principal aim of this thesis is to increase our knowledge
of the relationship between histamine and the alveolar
macrophage. This has involved a detailed investigation on
the presence and nature of receptors for histamine on lung
macrophages. These results are presented in this chapter.
However, at the time when these investigations commenced
there was also a paucity of information on receptors for
IgG and complement on alveolar macrophages. Therefore,
the results of these studies (i.e. on IgG and C receptors)
are also presented even though several reports on this
subject have appeared in the literature since that time
(Reynolds et al, 1975; Rhodes, 1975; Daughaday and Douglas,
1976).
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2.0 RECEPTORS FOR IgG ON GUINEA PIG ALVEOLAR MACROPHAGES
2.1 Time course and temperature
Receptors for IgG on guinea pig alveolar macrophages
were detected by the formation of rosettes using sheep red
blood cells sensitized with rabbit IgG (EA^ ).
The time course and effect of temperature are shown
in Fig. 3. The maximum percentage of rosettes (60.3 ± 1.4%)
was achieved after 15 min incubation at 0°C, although
52.0 ± 1.2% of rosettes were formed virtually instantaneously.
At 0°C a slight decrease in the number of rosettes was seen
up to 60 min (53.0 ± 0.8%).
When the incubations were performed at 37°C the initial
percentage of rosettes was similar but decreased after 5 min.
At 60 min only 15.3 ± 3.9% of rosetting cells were seen.





The effect of variation of time and temperature of




The points represent the mean values (± 1 S.E.) of
three experiments.
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3.0 RECEPTORS FOR COMPLEMENT ON GUINEA PIG ALVEOLAR
MACROPHAGES
3.1 Time course and temperature
Complement receptors were visualized on the alveolar
macrophage through the formation of rosettes with sheep red
blood cells sensitized with rabbit IgM (EA^ ) and coated
with guinea pig complement (EAC).
The time course and effect of temperature are shown
in Fig. 4. Receptors were expressed better (61.3 ± 1.4%)
at 37°C and after 15 min incubation. After 15 min at 0°C
the percentage of rosettes was 42.3 ± 3.3%. With an increase
in the incubation time up to 60 min the number of rosettes
formed at 0°C remained relatively constant (38.6 ± 4.0%),
but the number of rosetting cells incubated at 37°C markedly





The effect of variation of time and temperature of
incubation on rosette formation by guinea pig alveolar
macrophages with EAC.
The points represent the mean values (± 1 S.E.) of
three experiments.
4.0 RECEPTORS FOR HISTAMINE ON ALVEOLAR MACROPHAGES
4.1 Determination of optimal experimental conditions
In preliminary studies the optimal conditions for
detecting receptors for histamine on the alveolar macrophage
were determined.
Preparation of the red cell-conjugate complex depends
on several factors including (a) the species of red cell
used, (b) the concentration of the coupling agent (ECDI),
and (c) the concentration of histamine used in the formation
of the conjugate prepared with rabbit serum albumin (H-RSA).
(a) Red cells. In initial experiments extensive red
cell haemolysis was frequently a problem during the coupling
of H-RSA to the erythrocytes. In an attempt to minimize
this, red cells from several species including man, sheep
and ox (either untreated or stabilized by formalization)
were tested in the coupling reaction. Fresh (up to three
days old) ox cells which were formalized immediately before
use gave minimal haemolysis and, therefore, were used in all
subsequent studies.
(b) Concentration of ECDI. The degree of haemolysis
was also dependent on the amount of ECDI and conjugated
histamine used. It was important not to use ECDI that was
more than six weeks old even when stored at -20°C. When
H-RSA was coupled to formalized ox red cells at a concentra¬
tion of 40 mg/ml of ECDI the percentage of rosettes was
greater than 80%, but there was considerable haemolysis.
With H-RSA at a dilution of 1:80 the number of rosettes was
high but the loss of red cells through haemolysis was
excessive (Fig. 5). When the concentration of ECDI was
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Plate 1
Rosetting assay using light microscopy.
Guinea pig mononuclear cells formed rosettes with ox
red cells coated with histamine.
The slides were stained using a non-specific esterase
technique. Alveolar macrophages were stained dark brown




Rosetting assay using light microscopy.
Guinea pig mononuclear cells formed rosettes with ox
red cells coated with histamine.
The slides were stained by the May Grunwald Giemsa
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Dilution of H-RSA (#) RSA (O)
1:80
Fig. 5
The effect of dilutions of H-RSA or RSA on rosette
formation by guinea pig alveolar macrophages. A con¬
centration of ECDI of 40 mg/ml was used to couple H-RSA (•)
and RSA (O) to ox red cells. The plotted points represent
values obtained in one experiment.
reduced to 20 mg/ml the rosette-forming capacity of the
red cell-H-RSA complex was only slightly lowered, whereas
haemolysis was considerably reduced. Therefore, 20 mg/ml
ECDI was routinely used for the coupling reaction.
(c) Determination of the concentration of H-RSA. The
effect of varying the concentration of H-RSA coupled to
formalized ox red cells using 20 mg of ECDI on the percentage
of macrophage rosettes is shown in Fig. 6. The percentage of
rosettes with dilutions of 1:20 to 1:80 was very similar,
but considerably less rosettes were formed with 1:100 dilution.
RSA in the absence of histamine coupled to ox red cells
under identical conditions did not form rosettes.
Figure 7 shows one experiment in which different
dilutions of H-RSA between 1:40 and 1:100 (including those
between 1:80 and 1:100) were coupled to red cells and tested
for rosette formation. The percentage of rosettes decreased
relatively slowly between dilutions of 1:40 and 1:80 but
thereafter there was a sharp decrease.
In further experiments a concentration of 1:60 of
H-RSA was used.
(d) Time course. The time course of rosette formation
using ox red cells coupled to three different concentrations
of H-RSA is shown in Fig. 8. Rosette formation was virtually
instantaneous with only a small increase from 0 to 30 min
irrespective of the dilutions. At 1:60 the number of
rosettes was greater at 0.5 and 15 min when compared to the
other dilutions but at 30 min were virtually identical to
the 1:80 dilution.
100-,
? ? f P
1:20 MO 160 1:80 1:100
DILUTION OF H-RSA (•) or RSA (o)
ECDI
FiS- 6
The effect of dilutions of H-RSA or RSAECDI on rosette
formation by guinea pig alveolar macrophages. A concentra¬
tion of ECDI of 20 mg/ml was used to couple H-RSA (•) or
RSAECpj (O) to ox red cells.
Each point represents the mean values (± 1 S.E.) of
three experiments.
1:40 1:60 1:80 1:90 1:95 1:100
Dilution of HRSA (#) RSA (O)
Fig. 7
The effect of dilutions of H-RSA or RSA on rosette
formation by guinea pig alveolar macrophages. A con¬
centration of ECDI of 20 mg/ml was used to couple H-RSA (•)
and RSA (O) to ox red cells. The plotted points represent
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Fig- 8
The effect of incubation time on rosette formation by
guinea pig alveolar macrophages with red cells coated with
H-RSA dilutions of 1:60 (•), 1:80 (O) and 1:100 (A).
Each point represents the mean values (± 1 S.E.) of
three experiments.
I
(e) Effect of temperature. The effect of incubating
alveolar macrophages with histamine conjugate bound to ox red
cells at 37°C and 0°C is shown in Fig. 9. From different
dilutions of conjugated histamine 1:40, 1:60, 1:80 and 1:100
were coupled to ox red cells. Virtually no difference was
seen in the number of rosettes at both temperatures when
dilutions of 1:40, 1:60 and 1:80 were used. There was a
slight increase in the percentage of rosettes when cells
were incubated with ox red cells coupled to conjugated
histamine at 1:100 dilution at 37°C.
Using the optimal conditions, i.e. a 1:60 dilution of
H-RSA coupled to freshly formalized ox cells with 20 mg/ml
ECDI, the percentage of rosettes formed with guinea pig
alveolar macrophages was always between 60 and 80%.
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Fig. 9
The effect of incubation time and temperature on rosette
formation by guinea pig alveolar macrophages with red cells
coated with H-RSA dilutions 1:40, 1:60, 1:80 and 1:100.
The points represent the values obtained in one
experiment.
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5.0 SPECIFICITY OF HISTAMINE RECEPTORS
5.1 Inhibition of rosette formation by "free" and
"conjugated" histamine
Preincubation of alveolar macrophages with "free"
histamine both at 37°C or 0°C inhibited rosette formation in
— 3 _5 .j
a dose-dependent manner from 10 to 10 mol.l (Table II).
Although the inhibition was highly significant at all three
o -3 -5
doses at both temperatures (p <0.001 at 0 C, 10 to 10
mol.l"*, and at 37°C, 10"^ and 10"^ mol.l"*, and p <0.05 at
10"^ mol.l"*) the maximal effect (10~^ mol.l"*, 37°C) was
only 48%. In contrast, preincubation of the cells with
conjugated histamine completely inhibited rosette formation
at 1:60 dilution whereas the equivalent amount of RSA alone
or plus ECDI gave no inhibition when compared to the diluent
PBS.
5.2 Inhibition of rosette formation by L-histidine and
histamine metabolites
No inhibition in rosette formation was seen when
alveolar macrophages were preincubated with L-histidine or
the major histamine catabolites, ImAA, l-4MeHm, N-AcHm and
1,4-MeImAA (Fig. 10). All experiments were performed in
parallel with "free" histamine as a positive control.
5.3 Effect of HI- and H2-receptor antagonists
The effect of preincubation of cells with selective
histamine receptor antagonists is shown in Fig. 11.
Rosette formation was inhibited by the HI antagonists,
-4 -6 -1
mepyramine and chlorpheniramine, from 10 to 10 mol.l in
a dose-dependent manner. Preincubation with mepyramine at























































































































































Effects on rosette formation with guinea pig alveolar
macrophages by "free" histamine, L-histidine, imidazole-
acetic acid (ImAA), 1,4-methylhistamine (1,4-MeHm), 1,4-
methylimidazoleacetic acid (1,4-ImAA), N-acetyl histamine
(N-AcHm). Q'C (p) tfl 3}"CW
Each point represents the mean (± 1 S.E.) of four
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CONCENTRATION (moles 1 )
Fig. 11
Inhibition of rosette formation with guinea pig
alveolar macrophages by HI- (mepyramine and chlorpheniramine)
and H2- (burimamide and metiamide) receptor antagonists at
0°C (O) or 37°C (•).
Each point represents the mean (± 1 S.E.) of three
experiments.
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inhibition of 51.0 ± 5.9, 35.3 ± 7.6 and 24.5 ± 7.4 and a
degree of significance of p <0.01, <0.1 and not significant
respectively.
At 0°C and at the same doses of the antagonist a
percentage inhibition of 42.3 ± 6.5, 30.3 ± 2.1 and 16.6 ± 5.2
was obtained and a degree of significance of p <0.001, <0.001
and <0.01 respectively.
With chlorpheniramine the results were similar although
less difference was observed between temperatures. At 37°C
-4 -5 _6 -1
and concentrations of 10 , 10 and 10 mol.l a percentage
inhibition of 40.6 ± 8.4, 32.3 ± 9.3 and 20.0 ± 4.9 respectively
was seen. However it was significant only at the highest
doses (p <0.05).
At 0°C the inhibition of the percentage rosette formation
was 41.6 ± 0.6, 27.0 ± 4.1 and 15.0 ± 0.0 at doses of 10"^,
—5 — 6 — 1
10 and 10 mol.l" respectively and it was highly significant
(p <0.001) at all three doses.
No significant effect was seen with the H2 histamine
antagonists, burimamide and metiamide.
5.4 Effect of HI- and H2-receptor agonists
The effect of preincubation of alveolar macrophages with
HI- and H2- histamine receptor agonists either at 37°C or 0°C
is shown in Fig. 12.
The Hl-agonist, 2-AET, inhibited the rosette formation
-3 -5 -1
in a dose-dependent manner from 10 to 10 mol.l and it
was highly significant (p <0.001) at all three doses when
cells were preincubated at 0°C but only with the highest
doses (p <0.05) when the preincubation was performed at 37°C.
The maximum inhibition by 2-AET (33%) was less than that
-3 -1
produced by a comparable dose (10 mol.l ) of "free"
Fig. 12
Inhibition of rosette formation with guinea pig
alveolar macrophages by histamine, an HI agonist (2-2AET)
and the H2 agonists, 4-MeHm and Dimaprit. Experiments
were performed at 0°C (0) or 37°C (•).




The H2 histamine agonists, 4-MeHm and Dimaprit, under
the same conditions, gave no inhibition in the number of
rosettes.
105
6.0 HISTAMINE ROSETTE FORMATION BY VARIOUS GUINEA PIG
LEUCOCYTES
The percentage of histamine receptors in mononuclear
phagocytes, lymphocytes, neutrophils, eosinophils and
basophils is shown in Fig. 13.
In general, mononuclear cells formed more rosettes than
granulocytes. Among the mononuclear cells the alveolar
macrophage expressed the highest percentage of receptors.
Peritoneal cells showed a great variation in the number of
rosettes from one experiment to another, but generally formed
higher numbers than lymphoid cells.
Rosette formation did not appear to depend on the degree
of enrichment of cells, at least not by those leucocytes which
were examined.
The ranges of percentage of histamine rosettes for the
different cell types were alveolar macrophages 60-80%,
peritoneal macrophages 14-73%, blood monocytes 14-30%, lymph
node cells 27-48%, blood lymphocytes 7-24% and peritoneal
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Fig. 13
Histamine rosette formation by mononuclear phagocytes,
lymphocytes, neutrophils, eosinophils and basophils. In
some experiments cells were unfractionated (•) or enriched (0)
by centrifugation on Ficoll-Hypaque. A = alveolar; P =
peritoneal; B = blood; LN = lymph node; BM = bone marrow.
Each plotted point represents one duplicated experiment.
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7.0 DETECTION OF HISTAMINE RECEPTORS ON HUMAN ALVEOLAR
MACROPHAGES
Alveolar macrophages were obtained from lung washings
from three patients (S.D., J.T. and R.S.) on whom exploratory
bronchoscopy was performed. These were tested for their
capacity to form rosettes with conjugated histamine coupled
to ox red cells as indicators.
The alveolar macrophages from the three patients formed
rosettes (Table III). However, there was a difference in
percentage. J.T. formed 30% rosettes with dilutions of 1:40
and 1:60 of conjugated histamine either at 37°C or 0°C
incubation. S.D. had 60% rosetting cells with 1:60 dilution
of conjugated histamine and the percentage did not vary with
different times of incubation (0, 5, 15 and 30 min). The
alveolar macrophages from R.S. formed less rosettes (20%)
than the cells from the other two patients using the same
experimental conditions.
No rosette formation was observed when alveolar












J.T. 1:40 15 37° 29.0
J.T. 1:40 15 0° 31.7
J.T. 1:60 15 37° 24.0
J.T. 1:60 15 0° 31.5
S.D. 1:60 0 0° 61.5
S.D. 1:60 5 0° 60.0
S.D. 1:60 15 0° 62.5
S.D. 1:60 30 0° 64.0
R.S. 1:60 15 0° 20.0
TABLE III
The effect of dilutions of H-RSA, incubation time




Various guinea pig leucocytes were tested for their
capacity to bind histamine coupled as a rabbit serum albumin
conjugate (H-RSA) to formalized ox red cells. The percentage
of rosette-forming target cells was directly related to the
concentration of erythrocyte-bound H-RSA. Under optimal
experimental conditions the numbers of rosettes varied from
60 to 81% for alveolar macrophages, 14 to 73% for peritoneal
macrophages, 14 to 30% for blood monocytes, 27 to 48% for
lymph node cells, 7 to 24% for blood lymphocytes and 0 to 29%
for peritoneal and blood neutrophils. Virtually no histamine
rosettes were formed with eosinophils or basophils.
Free histamine partially inhibited rosette formation by
-3
alveolar macrophages in a dose-dependent fashion from 10 to
-5 -1
10 mol.l , and complete inhibition was achieved by the
H-RSA conjugate. In contrast, amines closely related to
histamine such as L-histidine and the major histamine
catabolites, ImAA, 1,4-MeHm, 1,4-MeImAA and N-AcHm, had no
inhibitory effect.
The histamine Hl-receptor antagonists, mepyramine and
chlorpheniramine, and the Hl-receptor agonist, 2-AET, all
inhibited rosette formation by alveolar macrophages in a
dose-dependent fashion. However, the H2-receptor antagonists,
burimamide and metiamide, and the H2-receptor agonists,
Dimaprit and 4-MeHm, were inactive.
These experiments suggest that (1) compared to other
leucocytes, histamine receptors are particularly well
expressed on the alveolar macrophage, (2) these receptors
have a high degree of specificity for histamine in that other
amines, closely related chemically, did not inhibit rosette
formation, and (3) the binding of histamine to the alveolar
macrophage membrane is HI- and not H2-receptor dependent.
In addition, preliminary experiments on the
identification of receptors for IgG and complement are
reported. These confirm previous observations on the
presence of these membrane markers on guinea pig alveolar
macrophages.
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The activation of the "respiratory burst" (see
Introduction) in stimulated macrophages and other phagocytes
is now well recognized and has been extensively studied.
Many agents, both particulate and soluble, have been
shown (1) to increase oxygen consumption, (2) to stimulate
the production of superoxide radical, (3) to increase the
activity of the hexose monophosphate shunt and (4) to generate
increased intracellular hydrogen peroxide. The particulate
agents include opsonized bacteria and zymosan (Karnovsky et al.
1975; Drath and Karnovsky, 1975; Hoidal et al, 1978a,b;
Lowrie and Aber, 1977) and (at least in neutrophils) latex
particles (Weening et al, 1974). Among the soluble
activating agents are phorbol myristate, the active principle
of croton oil (Hoidal et al, 1978a,b) and concanavalin A, a
lectin obtained from jack beans (Romeo et al, 1973a). The
latter is believed to bind to the cell surface by specific
glycoprotein receptors (Allen et al, 1971).
Activation, which usually follows exposure to the
stimulus for 30 to 60 sec (Babior, 1978; Romeo et al, 1973b),
requires contact of the stimulating agent with the phagocytic
surface, although the mechanism by which this contact initiates
the metabolic burst is not known.
The initial phase of activation is the formation of
superoxide radical by the one electron reduction of molecular
oxygen (Babior et al, 1973, 1976; Johnston et al, 1975;
Drath and Karnovsky, 1975).
The identity of the enzyme responsible for the primary
oxygen consuming reaction of the respiratory burst has been
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the subject of considerable controversy. It is generally
accepted that this enzyme catalyzes the reduction of oxygen
to superoxide anion through a pyridine nucleotide located
in the plasma membrane (Goldstein £t al, 1975a, 1977;
Briggs et al, 1977; Takanaka and O'Brien, 1975).
It has been suggested that the electron donor may be
either NADH or NADPH. However, the present evidence
indicates that in both polymorphonuclear and mononuclear
cells NADPH is the primary reducing agent (Babior, 1978;
Selvaraj and Sbarra, 1967; Romeo et al, 1971).
In neutrophils it has been shown that all the oxygen
consumed and superoxide radical produced are derived directly
from the activity of this "NADPHoxidase" and that about 50%
of the superoxide radical produced is converted to hydrogen
peroxide (Root and Metcalf, 1977). The rate of the super¬
oxide radical dismutation to hydrogen peroxide is accelerated
ten thousand-fold by the enzyme, superoxide dismutase
(Fridovich, 1972) which would also protect the cytosol from
damage by the radicals (Crapo and Tierney, 1974; Rister and
Baehner, 1975).
Another potential pathway for superoxide radical
utilization is the generation of singlet oxygen and hydroxyl
radical in the presence of hydrogen peroxide (Johnston and
Lehmeyer, 1976 ).
The production of singlet oxygen by phagocytic cells
was initially thought to be the cause of light emission
during phagocytosis (Allen et al, 1972; Johnston et al.
1976 ). However, other reports suggest that chemiluminescence
is probably the combined result of the reaction between the
114
particle and some or all of the oxidizing agents generated
(Cheson et al, 1976). Although chemiluminescence is a non¬
specific phenomenon, it has proved useful as an index of
phagocytic function since respiratory burst activity is
essential for light emission (Babior, 1978).
Human and guinea pig alveolar macrophages bound H-RSA
red cell complex by a receptor-like mechanism (Section A).
The membrane recognition mechanism might be comparable to that
of complement and immunoglobulin. Stimulation of both
receptors (C and Fc) initiated the respiratory burst in poly¬
morphonuclear cells (Goldstein et al, 1975a). Therefore, it
seemed important to study the metabolic response of alveolar
macrophages when their histamine receptors were stimulated.
In the present study the effect of histamine on the
oxidative metabolism of alveolar macrophages has been
assessed by examining its effects on both superoxide radical
production and the generation of chemiluminescence.
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2.0 STIMULATION OF Ol PRODUCTION BY SERUM TREATED
ZYMOSAN (STZ)
Although the assay had been previously developed in
human neutrophils, it was necessary to establish the optimal
baseline parameter in alveolar macrophages. These
preliminary experiments are described below: (1) STZ dose
response, (2) SOD concentration, (3) substrate (cytochrome C)
concentration, (4) incubation medium and (5) incubation time.
2.1 STZ dose response
The guinea pig alveolar macrophage gave a dose-dependent
production of superoxide radical when stimulated with
opsonized zymosan (Fig. 14). The maximum response was
6
obtained when cells (2 x 10 /ml) were incubated with zymosan
at a concentration of 1 mg/ml which represents approximately
10 particles/ml (this was equivalent to a cell/particle
ratio of 1:50). At a higher concentration (2 mg/ml) the
production of superoxide anion fell slightly from 39 ± 2.6
to 38.8 ± 3.6 nmoles of cytochrome C reduced. Below
1 mg/ml the amount of SOD inhibitable cytochrome C reduction
was directly proportional to the amount of STZ used to
stimulate the cell and even at concentrations 10 times less
than optimal, superoxide levels wer e significantly higher
(p <0.001) than unstimulated cells (25.3 ± 1.6 and 10.2 ± 1.4
nmoles cytochrome C reduced, respectively).
2.2 Effect of SOD
The production of superoxide radical by alveolar
macrophages was inhibited in the presence of SOD (Table IV).
To establish the amount of superoxide dismutase
necessary to produce maximal inhibition, concentrations of
11
Fig. 14
The effect of guinea pig complement-coated zymosan
(STZ) concentration on 0^ production by guinea pig alveolar
macrophages.
Each point represents the mean values (± 1 S.E.) of
five experiments.
Cytochrome C reduction
















The generation of 0g by unstimulated and STZ
stimulated guinea pig alveolar macrophages in the
presence of superoxide dismutase. The results
represent the mean values for a single experiment.
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the enzyme ranging from 0.84 to 5.88 |iM were tested. A
dose-dependent inhibition of the amount of cytochrome C
reduced was observed by increasing the concentration of SOD
from 0.84 to 3.30 pM, but above this no further decrease
occurred. A dose of 4.2 pM of SOD was chosen for further
studies. In all experiments performed using this dose the
percentage of inhibition was always greater than 95%.
2.3 Concentration of cytochrome C
The assay for superoxide anion depends on the reduction
of cytochrome C which must, therefore, be present in excess.
In order to determine this factor, sodium dithionite, a
powerful reducing agent, was added in some of the experiments.
The total amount of cytochrome C used (100 pM) was always
higher than that reduced in every sample.
6
In one experiment 2 x 10 cells/ml were stimulated in
the presence of different concentrations of cytochrome C.
A concentration of 1.2 mg/ml (100 pM) cytochrome C was
sufficient for that number of cells (Table V).
2.4 Effect of incubation medium
2.4.1 Generation of superoxide radical by alveolar
macrophages incubated in M199 and BSS
The capacity of alveolar macrophages to generate
superoxide anion under stimulated (STZ 1 mg/ml) or unstimulated
conditions was tested in two media, M199 without phenol red
and the BSS previously described in the Methods. The results
of the time course studies with these media are shown in
Table VI.
Under resting conditions the amount of superoxide
radical produced when cells were incubated in M199 was
Cytochrome C reduction
(nmoles/2 x 10® cells/30 min)
Serum Treated





. 1.5 8.5 44.5
1.8 9.9 44.5
TABLE V
The generation of Og" by unstimulated and STZ
stimulated guinea pig alveolar macrophages in the
presence of different concentrations of cytochrome C.
The results represent the mean values for a single








Ml99 BSS Ml99 BSS
15 11.8 ± 0.3 CO • 1+ 1.2 34.3 ± 0.7 +1<N•rHn 6.8
30 13.8 ± 1.8 5.9 ± 2.0 42.8 ± 1.8 43.9 ± 3.2
60 14.8 ± 1.8 00 • 1+ 0.3 42.0 ± 1.2 43.2 ± 2.1
TABLE VI
The effect of incubation time on 0^"generation by
guinea pig alveolar macrophages incubated in M199 and
BSS. The results represent the mean values (± 1 S.E.)
of three experiments.
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11.8 ± 0.3, 13.8 ± 1.8 and 14.8 ± 1.8 at 15, 30 and 60 min
respectively which was significantly higher (p <0.05) than
cells in BSS (3.4 ± 1.2, 5.9 ± 2.0 and 8.2 ± 0.3 nmoles
6
cytochrome reduction 2 x 10 cells/ml at 15, 30 and 60 min
respectively).
In cells stimulated with STZ the results were
essentially the same irrespective of whether the cells were
incubated in BSS (31.2 ± 6.8, 43.9 ± 3.2 and 43.2 ± 2.1) or
M199 (34.3 ± 0.7, 42.8 ± 1.8 and 42.0 ± 1.2 nmoles cytochrome C
reduced) for 15, 30 and 60 min. In both media the maximum
production of superoxide radical was reached at 30 min, after
which it reached a plateau.
2.4.2. Effect of adding serum and ovalbumin to the
incubation medium
The superoxide dismutase inhibitable cytochrome C
reduction produced by cells incubated in BSS alone or in the
presence of 10% fresh guinea pig serum or 0.5% ovalbumin is
shown in Fig. 15. Cells were stimulated with STZ (1 mg/ml)
or latex particles (0.1 ml) and after 30 min incubation at
37°C the superoxide radical produced was measured. Both
serum and ovalbumin significantly (p <0.001) increased the
superoxide dismutase inhibitable cytochrome C reduction in
unstimulated cells (from 7.5 ± 0.5 up to 13.2 ±0.6 and
20.8 ± 0.8 nmoles cytochrome C reduced respectively).
The amount of non-inhibitable superoxide dismutase
cytochrome C reduction was increased in the presence of serum
(up to 5.6 nmoles) indicating that serum contained other
reducing agents. Also in the absence of cells, cytochrome C



































UNST.STZ.LATEX UNST.STZ. LATEX UNST. STZ. LATEX
Fig. 15
The effect of serum (10%) and ovalbumin (0.5%) on
02 generation by unstimulated and STZ or latex particle
stimulated guinea pig alveolar macrophages.
The results represent the mean values (± 1 S.E.) of
three experiments.
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Cells stimulated with STZ produced similar amounts of
superoxide radical whether incubated in BSS alone or
supplemented with serum or ovalbumin (44.2 ± 1.0, 43.6 ± 1.6
and 44.5 ±0.8 respectively).
Less superoxide anion was produced when cells were
stimulated with latex particles (19.8 ± 4.2, 29.2 ± 2.1 and
34.0 ± 1.3) instead of STZ, under the same conditions. In
the presence of serum or ovalbumin the response was higher
than in its absence. However, only ovalbumin significantly
(p <0.01) increased the 0g production by latex-stimulated
alveolar macrophages.
2.5 Effect of preincubation
Cells were preincubated in BSS at 37°C for 30, 120 and
180 min in a shaking water bath. Cytochrome C and either
STZ or NaCl were then added to the suspension and the amount
of cytochrome C reduction measured after a further 30 min
incubation at 37°C. The results are shown in Fig. 16.
Preincubation decreased the capacity of unstimulated
and stimulated cells to generate superoxide and the magnitude
of the effect was directly related to the time used for pre¬
incubation.
Stimulated cells decreased the amount of cytochrome C
reduced from 42.9 ± 3.2 with no preincubation to 38.8 ± 3.3,
36.3 ± 2.9 and 21.1 ± 2.7 nmoles at 30, 120 and 180 min
respectively. However, the difference in the amount of 0g
produced was statistically significant (p <0.001) only after
180 min incubation.
In unstimulated cells the variation was from 12.3 ± 1.0
in control cells to 10.8 ± 0.4, 6.9 ± 1.0 and 5.0 ± 0.9 nmoles
cytochrome C reduced (at 30, 120 and 180 min respectively).
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Fig. 16
The effect of preincubation time on Og generation by
unstimulated (O) and STZ (•) stimulated guinea pig alveolar
macrophages.
Each point represents the mean values (± 1 S.E.) of
four experiments.
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The reduction in Og generated was highly significant after
120 min (p <0.01) and 180 min (p <0.001) incubation.
126
3.0 EFFECT OF HISTAMINE ON SUPEROXIDE RADICAL PRODUCTION
3.1 Effect of "free" histamine
These experiments were performed to determine the effects
-4 -5 -6 -1
of histamine at concentrations of 10 , 10 and 10 mol.l
on superoxide radical production by alveolar macrophages
either unstimulated or stimulated with STZ after 30 min
incubation at 37°C (Table VII). The cells and histamine
were preincubated for 15 min at 37°C prior to the addition
of STZ.
Resting cells in the presence of histamine produced
slightly higher amounts of superoxide radical (25.0 ± 1.8,
23.9 ± 2.2 and 23.5 ± 2.5 nmoles cytochrome C reduced/
2 x 10® cells/ml at 10-4, 10~® and 10~® mol.l-"'" respectively)
than controls without added amine (22.2 ± 2.1). This
increase was dose-dependent but only statistically significant
at 10-4 (p <0.05).
No reduction of cytochrome C by histamine in the absence
of cells was observed.
Stimulated cells produced less superoxide anion
(43.1 ± 2.5, 44.2 ± 1.8 and 44.0 ± 2.2 nmoles cytochrome C)
4 5 6 i
in the presence of histamine at 10- , 10" and 10- mol.l-
respectively than in its absence (47.3 ± 1.7). Also, the
-4 -1
difference was statistically significant at 10 mol.l
(p <0.02).
When considered in absolute terms, histamine had little
effect on 0g production by stimulated cells and no significant
increasing effect on unstimulated values. However, when
the appropriate control values (unstimulated cells) were
subtracted from the stimulated values and expressed as the
percentage decrease from control, histamine was found to have




(nmoles/2 x 10 cells/
Drug (M) 30 min) Inhibition (%)
Unstimulated STZ Treated
Cells
No drug 22.2 + 2.1 47.3 + 1.7
i
oH 25.0 + 1.8 43.1 + 2.5 30.8 + 5.8 (p <0.005)
10-5 23.9 ± 2.2 44.2 + 1.8 21.6 + 7.6 (p <0.05)
10-6 23.5 + 2.5 44.0 + 2.2 16.7 ± 8.1 (N.S.)
TABLE VII
The effect of preincubation with "free" histamine on 0~^'
generation by guinea pig alveolar macrophages. The results
represent the mean values (± 1 S.E.) of eight experiments.
The inhibition of 0g generation by histamine is expressed as
a percentage of the control.
i
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The percentage inhibition was statistically significant at
10"4 mol.l"1 (p <0.005) and at 10~5 mol.l"1 (p <0.05).
3.2 Effect of "conjugated" histamine
One experiment in which the effect of H-RSA on
superoxide radical production was studied is shown in Fig. 17.
Superoxide dismutase inhibitable cytochrome C reduction
was measured after 30 min incubation in the absence or
presence of H-RSA at different dilutions and in the presence
of RSA alone as control.
H-RSA produced a small and dose-dependent increase in
the production of superoxide radical (18.1, 14.5, 11.3 and
11.3 nmoles cytochrome C reduced at 1:40, 1:60, 1:80 and
1:100 dilutions respectively) compared to control RSA at
1:40 dilution (10.7) and unstimulated cells (9.9).
H-RSA was also tested for its effects on STZ-mediated
0" production. For this purpose 0.12 mg/ml of STZ was used
as a stimulant and H-RSA was added in 1:40 and 1:100 dilutions.
When cells were simultaneously challenged with STZ and
H-RSA the effect was additive, increasing from 21.8 nmoles
with STZ alone to 22.2 and 27.0 in the presence of H-RSA,
1:100 and 1:40 dilutions respectively.
3.3 Effect of "conjugated" histamine bound to zymosan
(H-RSAZ) - Dose response
Different dilutions of "conjugated" histamine bound to
zymosan prepared as previously described (see Methods) were
tested for their capacity to generate 0g by the alveolar
macrophage (Fig. 18).
Cells stimulated with H-RSAZ produced significantly



































The Og generation by guinea pig alveolar macrophages
when treated with H-RSA, RSA and STZ. H-RSA was used at
dilutions of 1:40 to 1:100, RSA at a dilution of 1:40 and
STZ at a concentration of 0.12 mg/ml.













































HRSA Hm RSAZ RSAZECD1 Z
Fig. 18
The generation of Og guinea pig alveolar macrophages
stimulated with H-RSAZ, STZ, H-RSA, "free" Hm, RSAZ,
RSAZecdi and Z.
The results represent the mean values (± 1 S.E.) of
four experiments.
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When H-RSAZ neat and 1:20 and 1:40 dilutions were
used the amount of 0^ produced was 36.0 ± 1.6, 39.4 ±2.3
g
and 32.3 ± 1.0 (nmoles cytochrome C reduced/2 x 10 cells)
respectively. All these values were significantly higher
(p <0.001) than controls (16.8 ± 4.0, 8.0 ± 2.3, 13.8 ± 2.6,
15.9 ± 2.5 and 12.8 ± 1.2 for H-RSA, histamine, RSAZ,
RSAZE£DI and zymosan respectively) but not statistically
different from STZ-mediated Og production (36.5 ± 2.1 nmoles).
H-RSAZ at 1:60, 1:80 and 1:100 dilutions also stimulated
Og production by alveolar macrophages (21.8 ± 3.3, 17.5 ± 3.1
and 16.6 ± 1.2 nmoles respectively) but this was not
significantly different from control values.
Although all controls used produced a higher reduction
of cytochrome C than unstimulated cells, the difference was
not statistically significant.
3.4 Effect of H-RSAZ - Time course
The time course of superoxide radical production by
alveolar macrophages stimulated with H-RSAZ and STZ compared
to controls is shown in Fig. 19.
The pattern of response was almost identical for the
two stimuli tested. Superoxide radical production rapidly
increased during the first 30 min, then levelled off between
30 and 60 min.
The amount of superoxide was 10.3 ± 1.5, 31.2 ± 6.8,
43.9 ±3.2 and 43.2 ±2.1 with STZ-treated cells and 11.5 ± 2.1,
30.7 ± 6.1, 39.1 ±5.3 and 39.8 ± 5.6 (nmoles cytochrome C
reduced) in H-RSAZ stimulated cells at 5, 15, 30 and 60 min
respectively. These values were all significantly higher




The effect of incubation time on 0^, generation by
guinea pig alveolar macrophages activated with H-RSAZ,
STZ, RSAZ, H-RSA and "free" Hm.
Each time point represents the mean (± 1 SaE.) of
four experiments.
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5.6 ± 2.0 and 8.2 ± 0.3 nmoles) or in the presence of
histamine (1.6 ± 0.3, 9.0 ± 4.6, 8.0 ± 2.3 and 7.3 ± 1.5)
measured at the appropriate times.
With RSAZ and H-RSA alone the amount of superoxide
detected was less than with H-RSAZ and STZ and did not
plateau even after 1 hr incubation.
RSAZg^jjj-stimulated alveolar macrophages produced
3.9 ± 0.4, 10.2 ±1.8, 22.8 ± 4.4 and 26.6 ± 4.0 nmoles
cytochrome C at 5, 15, 30 and 60 min. The amount of 0^
produced was significantly less (p <0.05) than with H-RSAZ
but statistically significantly higher (p <0.001 at 5 min,
p <0.01 at 30 min and p <0.001 at 60 min) than unstimulated
cells. H-RSA-trea-fced alveolar macrophages generated 0g
(5.0 ± 1.7, 10.8 ± 4.0, 16.8 ± 4.3 and 19.4 ± 3.3 nmoles
cytochrome C reduced at 5, 15, 30 and 60 min respectively).
However, all these values were significantly less (p <0.05)
than H-RSAZ and not higher than controls.
3.5 Effect of H-RSAZ on superoxide radical production by
human alveolar macrophages
Sufficient alveolar macrophages for metabolic studies
were obtained from the lung washings of only two patients
(S.D. and W.O.), who had undergone exploratory bronchoscopy.
In one patient (S.D.) cells were stimulated with H-RSAZ
and STZ in parallel and the results compared to unstimulated
cells and cells challenged with RSAZ as control (Table VIII).
Both H-RSAZ and STZ gave an increase in 0^ production of
23.6 and 39.8 (nmoles cytochrome C reduced) respectively
from levels of 8.5 and 11.3 nmoles in unstimulated and RSAZ-
treated cells. However, with STZ the amount of cytochrome C
reduced was much higher than H-RSAZ-treated cells.
Cytochrome C reduction
C








The generation of Og by human alveolar
macrophages stimulated with H-RSAZ, STZ and RSAZ.
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In the second patient (W.O.) only H-RSAZ was tested,
in duplicate, but the results were essentially similar to
those obtained with S.D. (26.0 nmoles of cytochrome C
6
reduced/2 x 10 cells/ml).
3.6 Effect of histamine antagonists
Several specific histamine receptor antagonists were
examined for their effect on H-RSAZ-mediated superoxide
production (Fig. 20).
The HI antagonists, chlorpheniramine and mepyramine,
gave a linear dose-dependent inhibition of 22.3 ± 3.8,
13.8 ± 3.6, 10.7 ± 4.4 and 24.4 ± 5.0, 19.0 ± 4.8, 12.8 ± 3.3
—5 —5 —5 —1
respectively at 5 x 10 , 2 x 10 and 0.8 x 10 mol.l
The inhibition was highly significant (p <0.005) with both
drugs at all concentrations.
The H2 antagonists, burimamide and metiamide, had
virtually no effect on superoxide radical.
None of the agents tested affected the production of
superoxide anion by unstimulated cells. Also, the agents
were not cytotoxic, as judged by trypan blue dye exclusion
of cells after incubation.
In order to determine whether the inhibition of superoxide
radical generation was a specific blocking effect of the
histamine receptor and not a non-specific interaction with
the cell membrane, cells were preincubated with the HI
histamine antagonists, mepyramine and chlorpheniramine, at
5 x 10"5 mol.l"1 and stimulated with H-RSAZ and STZ (Fig. 21).
Cells stimulated with H-RSAZ inhibited superoxide radical
production by 23.6 ± 3.1 % and 26.1 ± 1.5% with chlorpheniramine













































Inhibition of Og generation with H-RSAZ stimulated
guinea pig alveolar macrophages by HI- (mepyramine and
chlorpheniramine) and H2- (burimamide and metiamide) receptor
antagonists.











































HRSAZ STZ HRSAZ STZ HRSAZ STZ
Fig. 21
The generation of Og by H-RSAZ and STZ stimulated
guinea pig alveolar macrophages incubated with HI
(mepyramine and chlorpheniramine) histamine antagonists
at 5 x 10~5 mol.l"1.
The bars represent the mean values (± 1 S.E.) of two
experiments.
significant with both drugs (p <0.
stimulated with STZ the amount of
in the presence and absence of the
13a
02). When the cells were
0g generated was the same
HI antagonists.
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3.7 Conjugated histamine bound to other particles
Cells stimulated with conjugated histamine bound to
carriers other than zymosan also generated superoxide
radical (Table IX).
The particles used were of several types and sizes
and included (1) Sephadex G-10, a cross-linked dextrose gel
(40-120 pM), (2) Sepharose 4B, a bead-formed agarose gel
(60-140 |oM), (3) Amberlite CG-50, a cross-linked polystyrene
polymer (200-400 |iM), (4) latex (polystyrene) beads (1.1 pM).
These particles by themselves or following the addition
of rabbit serum albumin alone did not produce an appreciable
amount of superoxide anion.
The maximum superoxide dismutase inhibitable cyto¬
chrome C reduction was achieved with H-RSAZ (39.2) followed
by H-RSA-coated Sephadex G-10 (34.1 ± 0.9), Sepharose 4B
(29.3 ± 2.0), Amberlite CG-50 (29.3 ± 2.2) and latex
g(23.6 ± 0.7) (nmoles cytochrome C reduced/2 x 10 cells).
All H-RSA-coated particles generated significantly
higher (p <0.05) amounts of superoxide radical than particles




(nmoles/2 x 10 cells/30 min)
Particle Diameter HRSA RSA Neat
(|iM)
Latex 1.1 24.5 ±0.4 13.2 ± 2.5 15.8 ±0.9
Zymosan <10 38.0 ± 0.8 12.2 ±1.2 11.1 ±0.8
Sephadex G-10 40-120 32.6 ±0.9 11.1 ±0.8 9.2 ±0.6
Sepharose 4B 60-140 27.4 ±1.1 11.6 ±0.6 10.3 ±1.1
Amberlite CG-50 200-400 26.1 ±1.2 11.9 ±1.4 9.8 ±0.2
TABLE IX
The generation of 0by guinea pig alveolar macrophages
stimulated with coated (H-RSA and RSA) and uncoated
particles. The results represent the mean values (± 1 S.E.)
of three experiments.
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4.0 CHEMILUMINESCENCE PRODUCED BY ALVEOLAR MACROPHAGES
STIMULATED WITH HISTAMINE AND SERUM TREATED ZYMOSAN
4.1 Dose response and time course
Both H-RSAZ and STZ produced light emission from
stimulated alveolar macrophages. Conjugated histamine,
at different dilutions, bound to a fixed amount of zymosan
(10 mg/ml) gave a dose-dependent chemiluminescence which was
maximal at a dilution of 1:10 (Fig. 22).
The peak of light emission was reached at 6-10 min
after stimulation with all doses of the agents studied.
No chemiluminescence was observed with the controls,
-4 -1
RSAZ, H-RSA and histamine at 10 mol.l
Superoxide dismutase (4.2 pM ) completely abolished































The effect of incubation time on chemiluminescence by
guinea pig alveolar macrophages activated with different
dilutions of H-RSAZ. The results are expressed in counts
per minute.
The figure is representative of six experiments.
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5.0 SUMMARY
Activation of the respiratory burst in phagocytic cells
is achieved by a number of agents, both soluble and
particulate, many of which bind to the plasma membrane
through cell surface receptors. This suggests that there
may be a close association between "membrane recognition" of
certain exogenous stimuli and the enzyme which initiates the
primary oxygen-consuming reaction (also thought to be
membrane-bound and probably "NADPH oxidase"). Since
alveolar macrophages bind red cells coated with histamine,
as well as complement and IgG-coated erythrocytes, experiments
were performed to determine whether histamine-coated particles
generate activities associated with the respiratory burst.
It was shown that histamine-coated particles generated
superoxide (O^) and chemiluminescence in alveolar macrophages.
The binding of histamine was achieved by first coupling the
amine to rabbit serum albumin (RSA) and then allowing this
H-RSA conjugate to absorb on to the particle. The majority
of experiments were performed with zymosan although several
other particles which absorbed the coupled histamine also
generated 0g. The amount of Og-dependent cytochrome C
reduction achieved with the H-RSA conjugate was comparable
to that obtained with serum treated zymosan (STZ). Super¬
oxide production was also dependent on the time of incubation
and was attributable to alveolar macrophages and not to
contaminating leucocytes.
Chemiluminescence, which also accompanies the respiratory
burst of phagocytic cells, was initiated by histamine bound
to zymosan. This effect was also time- and dose-dependent.
Chemiluminescence induced by H-RSAZ or STZ was completely
inhibited by superoxide dismutase indicating that light
emission by these cells was closely associated with Og
production. These results suggest that there may be a
direct relationship between histamine and the lung
macrophage and that histamine may be concerned with the
regulation of oxygen-dependent events in the alveolar
macrophage.
SECTION C - THE EFFECT OF HISTAMINE ON THE RELEASE
OF LYSOSOMAL ENZYMES BY ALVEOLAR MACROPHAGES
1
1.0 INTRODUCTION
The discharge of enzymes into phagosomes is an important
event in physiological and pathological mechanisms of
microbial killing by phagocytic cells. Under certain
circumstances, lysosomal products can be released into the
extracellular fluid and in this may contribute to tissue
damage in various acute and chronic inflammatory states.
Two principal mechanisms by which lysosomal enzymes
are detected in the incubation medium without loss of cell
viability have been studied in vitro.
(i) During phagocytosis of a variety of particles, e.g.
opsonized zymosan, microorganisms, immune complexes etc.
the phagolysosome formed can open to the exterior, or
degranulation into the phagocytic vacuole may occur before
the closure to a complete vacuole (Weissmann et al, 1971a;
McArthur et al, 1976; Cardella et al, 1974). This process
has been called "regurgitation during feeding" (Weissmann
et al, 1971b).
(ii) The second mechanism has been named "reverse endocytosis
(Weissmann et al, 1972) or "frustrated phagocytosis" (Henson,
1971) in which phagocytic cells exposed to non-phagocytozable
particles, e.g. a solid surface coated with immune complexes
(Henson, 1971) or cells treated with cytochalasin B, and
exposed to opsonized zymosan, fuse their lysosomes with the
plasma membrane and release their content into the area of
the particle contact (Weissmann et al, 1973).
It has been suggested that cyclic nucleotides might
play a role in controlling lysosomal enzyme release in human
neutrophils (Weissmann et al, 1971b; Ignarro et al, 1974a,b).
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Cyclic GMP and cholinergic agents enhanced enzyme release
(Ignarro and George, 1974) whereas cyclic AMP and agents
which increase the levels of this nucleotide such as
P-adrenergic agonists, prostaglandins E^, E2, and Ag,
histamine and others, inhibited degranulation (Goldstein
et al, 1973; Ignarro et al, 1974a,b; Ignarro, 1974;
Zurier et al, 1974). Histamine-induced inhibition of enzyme
release was apparently blocked by metiamide (an H2-receptor-
dependent antagonist) (Busse and Sosman, 1976).
In macrophages the role of cyclic nucleotides in
modulating enzyme release is unclear, although mouse
peritoneal macrophages, like human neutrophils, were
similarly affected by agents which influence the cyclic
AMP/GMP balance (Weissmann, 1971b). In guinea pig alveolar
macrophages, cyclic nucleotides, adrenergic and cholinergic
agents had no effect on enzyme release (Ackerman and Beebe,
1975).
Following the observation that alveolar macrophages
had well expressed histamine receptors (Section A) and that
histamine conjugated to a protein bound to particles was able
to initiate the metabolic burst in these cells (Section B),
it seemed important to study the effect of histamine on
enzyme release by the guinea pig alveolar macrophage.
<
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2.0 DETECTION OF ENZYME RELEASE BY STIMULATED ALVEOLAR
MACROPHAGES
2.1 Effect of histamine
The release of ^-glucuronidase and lactic dehydrogenase
by cytochalasin B-treated alveolar macrophages stimulated
-4
with STZ in the presence or absence of histamine (10
mol.l""'') is shown in Fig. 23.
STZ significantly increased both the amount of P-
glucuronidase released into the incubation medium (p <0.001)
and the total amount of this enzyme (p <0.01), i.e. residual
and released enzyme. Non-opsonized zymosan (Z) had no
effect on these variables.
Histamine significantly increased (p <0.01) the amount
of p-glucuronidase released from cells stimulated with STZ,
but not in unstimulated cells. However, the total amount
of enzyme was almost identical in STZ-treated cells in the
-4 -1
presence or absence of histamine (10 mol.l ).
The release of LDH during the time of incubation was
insignificant and no differences were found irrespective of
whether cells were unstimulated or stimulated with STZ, or
whether they were incubated in the presence or absence of
histamine. Also, the total amount of LDH was unaffected
by these treatments.
The cell protein was also measured in both the super¬
natant and the pellet. A relatively constant amount was
found in those experiments in which this was measured and
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^-glucuronidase and LDH release from guinea pig
alveolar macrophages. Cells were treated with STZ in
the presence and absence of histamine. As control,
unstimulated cells were also examined in the presence
and absence of histamine.
The bars represent the mean values (± 1 S.E.) of 10
experiments (^-glucuronidase) and six experiments (LDH).
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2.2 Effect of cytochalasin B
The effect of cytochalasin B (5 \ig/ml) on enzyme
release by alveolar macrophages stimulated with STZ in the
presence or absence of histamine is shown in Table X.
Cytochalasin B increased the release of ^-glucuronidase
in STZ-treated cells (p <0.02).
The drug had a slight effect (p <0.05) on the total
amount of enzyme generated by STZ-stimulated cells. The
enhancement of ^-glucuronidase release in STZ-stimulated
cells in the presence of histamine was only detected when
cells were previously incubated with cytochalasin B. In the
absence of cytochalasin B, histamine did not have an observable
effect,on STZ-treated cells.
Cytochalasin B had no apparent effect on unstimulated
cells either in the presence or absence of histamine.
LDH release was not increased by the drug even when
concentrations of 10 pg/ml were used.
2.3 Effect of theophylline
-4 -1
Theophylline at doses of 5 x 10 mol.l had no effect
on enzyme release by the alveolar macrophage either in the
presence or absence of cytochalasin B, under the same
experimental conditions described above (Table X).
2.4 Effect of H-RSAZ
The capacity of H-RSAZ to stimulate the release of
lysosomal enzymes from alveolar macrophages incubated with
cytochalasin B was studied and the results shown in Fig. 24.
STZ was used as a positive control.
H-RSAZ did not enhance the release of ^-glucuronidase

















































































































































































































































































































STZ HRSAZ RSAZ UNST
Fig. 24
The release of ^-glucuronidase and lactic dehydrogenase
by H-RSAZ activated guinea pig alveolar macrophages.
The bars represent the mean values (± 1 S.E.) of four
experiments. The incubation time was 1 hr.
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P-glucuronidase found in the supernatant was similar to
controls (RSAZ and unstimulated cells) and significantly
less (p <0.002) than in STZ-treated cells. Also, the
amount of LDH was not affected by H-RSAZ.
2.5 Effect of histamine - Dose response
-4 -5 -6
Histamine at doses 10 , 10 and 10 increased the
p-glucuronidase release produced by STZ-stimulated cells in
a dose response manner (Pig. 25). However, the enhancement
-4 -5 -1
was only significant (p <0.05) at 10 and 10 mol.l
—6 —1
No effect at 10" mol.l" was detected.
The total amount of p-glucuronidase was not significantly
affected by the different concentrations of histamine.
Also, LDH release was not enhanced by incubation of
the cells with histamine.
2.6 Effect of histamine - Time course
The release of p-glucuronidase and LDH under all
experimental conditions previously described was measured at
30, 60 and 120 min incubation. The results are shown in
Fig. 26.
The amount of (3-glucuronidase found in the supernatant,
in all samples tested, was increased with time of incubation.
However, the enhancement was higher in STZ-treated cells than
controls.
The release produced by STZ was always significantly
higher (p <0.02) than controls and the enhancement observed
in the presence of histamine was paralled during incubation.
The total amount of P-glucuronidase was also increased,
but not much difference was seen between 30 and 60 min. At



































The effect of "free" Hm on (3-glucuronidase release
by unstimulated and STZ activated guinea pig alveolar
macrophages.
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The effect of incubation time on ^-glucuronidase and
LDH release by STZ activated guinea pig alveolar macrophages
in the presence and absence of histamine.
The bars represent the mean values (± 1 SE.) of three
experiments.
1
from controls was statistically significant (p <0.001).
LDH release increased with time of incubation. However,
no difference was observed due to the cell treatment.
2.7 Effect of H-RSA
This experiment was performed to determine whether
H-RSA had the same effect as "free" histamine on enhancement
of ^-glucuronidase by STZ-treated cells. However, the
control RSA produced a dose-dependent increase of this
enzyme in both unstimulated or STZ-stimulated cells (Table XI)
Thus, definite conclusions could not be drawn from these
experiments.
2.8 Effect of histamine agonists and antagonists
In order to determine the specificity of histamine on
the enhancement of ^-glucuronidase release, cells were
incubated in the presence of histamine agonists or pre-
incubated with histamine antagonists before histamine had
been added.
When cells were incubated with one HI histamine agonist,
2-AET, and two H2 histamine agonists, 4-MeHm and Dimaprit, no
significant effect on ^-glucuronidase release was observed
(Table XII).
Cells preincubated with the HI histamine antagonist,
chlorpheniramine, and the H2 antagonist, burimamide, released
higher amounts of p-glucuronidase either unstimulated or
stimulated with STZ than controls (Table XIII). The effect
of the drugs was not toxic since it was not accompanied by
an increase in LDH release and by a decrease in cell viability




































































































































































The effect of histamine agonists, 2-AET (HI),
4-MeHm (H2) and Dimaprit (H2), on [3-glucuronidase and
lactic dehydrogenase release by unstimulated and STZ
activated guinea pig alveolar macrophages. The results





























































































































































"The effect of histamine antagonists on the release
of ^-glucuronidase and LDH by unstimulated and STZ
activated guinea pig alveolar macrophages. The results
































































































































































The effect of histamine either free or conjugate bound
to zymosan on enzyme release by guinea pig alveolar macro¬
phages has been studied.
H-RSAZ, previously shown to stimulate the production
of superoxide radical and chemiluminescence in a similar way
to STZ, had no effect on (3-glucuronidase release or in the
total amount of the enzyme.
Histamine produced a dose response enhancement of
p-glucuronidase release in STZ-stimulated cells. However,
-4 -5 -1
it was significant only at 10 and 10 mol.l and previous
treatment of cells with cytochalasin B was essential. The
effect was not toxic, as there was no release of LDH and no
alteration of cell viability after incubation. The effect
of histamine was not apparently mediated through HI- and H2-
receptors since it was not possible to influence the observed
effect with histamine agonists and antagonists. Moreover,
the histamine antagonist drugs had a non-specific, although
non-toxic, effect on unstimulated cells. Therefore, the
effect of histamine on p-glucuronidase release must be
interpreted with caution since it could be due to a non¬
specific effect and not a pharmacological action of
histamine on alveolar macrophages.
CHAPTER V - DISCUSSION
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1.0 RECEPTORS ON ALVEOLAR MACROPHAGES
One property of the leucocyte plasma membrane is its
capacity to recognize and bind various chemical substances.
These membrane markers have been termed "receptors". All
white cells including alveolar macrophages probably have at
least three types of "surface recognition units". These
include (1) those parts of the membrane which bind opsonized
particles ("immunological receptors"), (2) surface structures
involved in the response to leucoattractants ("chemotactic
receptors") and (3) receptors for drugs such as sympatho¬
mimetic agents and insulin ("pharmacological receptors")
(Rodbell et al, 1971; Hecht et al, 1972; Cuatrecasas, 1969;
Melmoh et al, 1972; Berken and Benacerraf, 1966). The
presence of these receptors has been established by
several methods and of these, the "rosette technique", has
been particularly useful in the study of receptors for
immunoglobulins and complement. Such markers have now been
identified as a feature of a variety of cell types including
neutrophils, eosinophils, lymphocytes and various mononuclear
phagocytes (Lay and Nussenzweig, 1968; Basten et al, 1972;
Anwar and Kay, 1977; Berken and Benacerraf, 1966). In
alveolar macrophages from different species (e.g. human,
rabbit, guinea pig) the presence of receptors for the Fc
portion of immunoglobulin G and the third component of
complement has also been reported (Reynolds et al, 1975;
Rhodes, 1975).
1.1 IgG and complement
Since, at the commencement of the work described in
this thesis, the rosette technique was part of the routine
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technology available in our laboratory, it seemed sensible
to confirm (or otherwise) the presence of markers for IgG
and complement on guinea pig alveolar macrophages. Using
sheep anti-rabbit IgG, receptors for this immunoglobulin
class were demonstrable on approximately 60% of normal
macrophages (Fig. 3) whereas the previous studies had
detected rosettes on almost all of the cells tested
(Reynolds et al, 1975; Rhodes, 1975). This apparent
discrepancy was probably due to differences in technical
details such as time of incubation, temperature etc. In
this study heterologous antibody was used and the concentra¬
tion was evaluated only semi-quantitatively using an
agglutination method. Therefore, the assay was probably
being performed under sub-optimal conditions. The use of
immunofluorescence might have improved the sensitivity.
Also, this study could have been extended to include
experiments with homologous antibody and identification of
the immunoglobulin subclass involved. The latter could be
achieved by using fluorescently labelled IgG^ or IgGg or by
blocking experiments with aggregates of these subtypes.
Fc receptors on the alveolar macrophage were better
expressed at 0°C than 37°C. At the higher temperature the
number of rosettes decreased after 5 min incubation (Fig. 3).
This may have been due either to the shedding of the plasma
membrane markers or to endocytosis of the bound red cells.
The latter seems the most likely explanation since after
60 min incubation red cells were visible in the cytoplasm of
virtually all cells. At 0°C maximal rosette formation
occurred after 15 min incubation after which the percentage
1
of receptors remained practically unchanged. There was no
evidence of endocytosis at this temperature although the
maximal amount of binding was similar to that at 37°C after
5 min (Fig. 3). This suggests that the attachment of IgG
to the receptor on the alveolar macrophage did not require
metabolic energy.
Complement receptors were identified using fresh
guinea pig serum as the complement source. When human
serum was used no rosette formation was observed indicating
that not all species can be used as a source of complement
for detecting these receptors in the guinea pig.
The "number" of receptors on guinea pig cells was
lower .than previously reported for human alveolar macrophages
(Reynolds et al, 1975). One explanation, in addition to
species difference, is that we were using an insufficient
amount of complement. However, it was not possible to
increase the concentration of serum since this produced,
as would be expected, an unacceptable degree of haemolysis.
In order to improve the sensitivity of this assay it will be
necessary to use purified complement components in which the
amount of haemolytic units can be determined by effective
molecular titrations.
Two unusual features of this complement-mediated rosette
formation in guinea pig alveolar macrophages, compared with
granulocytes and other mononuclear phagocytic cells, were that
(1) although the highest percentage of rosettes was obtained
at 37°C binding also occurred at 0°C (Fig. 4); and (2) there
was endocytosis at 37°C. This might be explained by
contamination of the IgM preparation with IgG and, therefore,
Fc receptors were being formed. However, this seems unlikely
since as judged by Immunoelectrophoresis no IgG was detected
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in the preparation. A second possibility is that endocytosis
was complement-mediated, a phenomenon which has been previously
reported for activated macrophages (Ehlenberger and
Nussenzweig, 1977).
In conclusion, we have confirmed the previous finding
that guinea pig alveolar macrophages possess receptors for
IgG and complement. In view of the observed endocytosis
during the formation of rosettes at 37°C it may be suggested
that we were working with a "naturally activated" cell or
that complement receptors are involved in the phagocytic
mechanism of these cells.
1.2 Histamine rosettes
Many low molecular weight agents, including histamine,
produce potent pharmacological effects on leucocytes.
Therefore, such cells are believed to possess "receptors"
for these agents. The initial technique used in the
identification of receptors for histamine required the
"insolubilization" of the amine (Melmon et al, 1972). Thus
the drug waa conjugated to a carrier protein and this complex
was coupled to Sepharose beads. In this way the binding of
human leucocytes to the beads was demonstrated since histamine
could no longer enter the cell. This technique was later
modified by Kedar and Bonavida (1974) who used red cells in
place of Sepharose beads. They demonstrated rosette
formation between various mononuclear cells and erythrocytes
coated with H-RSA (Saxon et al, 1977). The general procedure
involves the chemical conjugation of the histamine primary
amine to carboxyl groups on the carrier protein using a
coupling agent such as cyanogen bromide or, as in the present
study, l-ethyl-3-(3-dimethylaminopropyl) carbodiimide HC1 (ECDI).
1
This coupling agent has been demonstrated to react with the
carboxyl group of the carrier protein to form acid anhydride,
which binds the histamine free amino group in an amide
linkage (Khorana, 1953). It is possible that the highly
reactive carbodiimide may also react directly with histamine
through an amino group forming guanidine or with the carboxyl
group of the protein to form urea (Khorana, 1953). However,
any by-products of the reaction would probably be lost during
the dialysis. Furthermore, it was previously reported that
the histamine in the conjugate was unchanged. Thus the drug
was characterized either by fractionation from the amino
acids and later quantification or by tracing the reaction
with labelled histamine. Both methods gave similar results
demonstrating that between 30-40 moles of histamine were
bound to one mole of RSA (Weinstein et al, 1973). Moreover,
the integrity of the histamine moiety in the conjugate was
confirmed by showing that it retained its biological activity
on the isolated guinea pig ileum (Fig. 27).
In the present study the coupling of the conjugate to
the cell marker was similar to that described by Kedar and
Bonavida (1974), although some modifications were performed.
Their technique used sheep red blood cells as cell markers.
In my experience these were more susceptible to lysis than ox
red cells. Also, formalized ox erythrocytes were even more
resistant to haemolysis than untreated cells. Furthermore,
it was found that with 20 mg/ml ECDI the degree of haemolysis
was consistently less than with the dose recommended in the
original technique (40 mg/ml) for use with sheep cells
(Kedar and Bonavida, 1974). Also, the conjugate was diluted





Bioassay of histamine using the contraction of guinea
pig ileum. Vertical axis = degree of contraction.
Standard doses of 5 and 10 nanograms of histamine per ml
were used throughout the experiment. H-RSA and RSAECDI
were tested at the dilutions shown.
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concentrations produced haemolysis. In preliminary studies,
when the concentration of ECDI was 40 mg/ml, the number of
rosettes formed was over 80% even with dilutions of the
conjugate of 1:80 (Fig. 5). This effect was probably due
to the increase of the concentration of the conjugate and,
therefore, of histamine bound to the red cell. No rosette
formation was observed when the control RSA was bound to the
erythrocytes (Fig. 5) indicating that the high percentage of
rosettes formed was due to an increase in the amount of
histamine. Therefore, all guinea pig alveolar macrophages
possess histamine receptors. However, the affinities of
their receptors for the drug varies. One explanation for
this is that due to the heterogeneity of the alveolar
macrophage population some cells may possess receptors in
greater numbers and with greater avidity than others and,
therefore, are able to bind lower concentrations of histamine.
Also, the receptors for histamine may increase in number or
affinity for the amine in relation to the state of maturity
or degree of activation of these cells. In this respect,
the acquisition of histamine receptors by lymphoid cells
after stimulation with antigen has been reported (Plaut et al,
1973b).
When the amount of ECDI was reduced to 20 mg/ml fewer
rosettes were formed. A dose response with the dilution of
the conjugate was observed. A gradual decrease in the number
of rosettes from the highest concentration of histamine
(dilution of H-RSA 1:20) down to a. dilution of l:80(Figs. 6
and 7). Further small decreases in the concentration of
conjugate produced significantly fewer rosettes indicating
that a minimal threshold of histamine concentration was
required to bind the receptor.
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Apparently there was no metabolic energy requirement
involved in the binding of histamine to the receptor since
the percentage of rosettes formed was the same whether the
incubation was performed at 37°C or 0°C (Fig. 9). Another
characteristic of this binding was that the rosettes were
formed almost instantaneously and their number remained
constant during incubation (Fig. 8). These two features
differentiate the alveolar macrophage histamine receptors
from those for immunoglobulin and complement processes, the
binding to which was temperature- and time-dependent. The
latter are closely involved with the phagocytic process of
the alveolar macrophage. It is not possible to say whether
histamine receptors are involved in the phagocytic function
of these cells since detailed experiments to test phagocytic
ability were not performed. Although in rosette studies no
red cells were observed inside the alveolar macrophage, or
other mononuclear phagocytic cells, and the percentage of
rosettes did not diminish during incubation up to 30 min at
37°C (one experiment) (Fig. 9), later studies using electron
microscopy showed some ingestion of H-RSAZ when cells were
incubated with these particles for 1 hr at 37°C (Plate 4 ).
No definite conclusions can be drawn about whether the
cell membranes of the various leucocytes studied bind free
histamine as opposed to histamine bound as a conjugate. It
is possible that the receptors only recognize histamine in its
"insoluble" form. The conjugate may bind to a "rigid
receptor" on the plasma membrane which, unlike receptors for
complement and IgG, does not readily alter its configuration
with changes in temperature. It is possible that the
structure of histamine changed during conjugation and a new
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Plate 3
Electron micrograph of a guinea pig alveolar macrophage
after 1 hr incubation with STZ at 37°C.
Two zymosan particles (Z) are observed to be contained
within the macrophage. Magnification = x 6000.
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Plate 4
Electron micrograph of a guinea pig alveolar macrophage
after 1 hr incubation with H-RSAZ at 37°C.
Zymosan particles (Z) are observed to be contained
within the macrophage. Magnification = x 6000.
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compound was formed. This has been postulated since no
increase in cyclic AMP was observed when leucocytes were
stimulated with H-RSA bound to Sepharose beads. However,
H-RSA alone produced the same increase in cyclic AMP in human
peripheral blood leucocytes as free histamine (Weinstein et al.
1975). This response was blocked by the histamine antagonists
chlorpheniramine (HI) and burimamide (H2). However, in this
study no change in the physiological properties of histamine
(in the form of H-RSA and H-RSAZ) as assessed by Hl-dependent
contraction of guinea pig ileum was observed. Free histamine
partially inhibited, and conjugated histamine totally inhibited
rosette formation. Substances closely related chemically
such as L-histidine, and any of the histamine catabolites, did
not inhibit the reaction indicating molecular specificity in
receptor binding (Fig. 10). The partial inhibition by free
histamine could be explained by a change of histamine from a
"monovalent" to a "polyvalent" form (Fig. 28) when conjugated
to RSA and to particles (Weinstein et al, 1973). The
specificity of the receptor for the amine and not for the
carrier (RSA) was confirmed by the inability of the carrier
to block histamine rosette formation. Furthermore, when
albumin (RSA) was bound to ox red cells no rosettes were
observed.
The results suggest that histamine rosettes are formed
entirely at Hl-receptor sites since the binding was inhibited
in a dose-dependent fashion by the Hl-antagonists, mepyramine
and chlorpheniramine, whereas the H2-antagonists, burimamide
and metiamide, had no effect. Furthermore, the reaction was
blocked by the histamine Hl-receptor agonist, 2-2AET (Durant
et al, 1975) but not by the H2 agonist, 4-MeHm (Durant et al,
1975) and Dimaprit (Parsons et al, 1977). These findings
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POLYVALENT H-RSA UNIVALENT H-COPOLYMER
H = HISTAMINE
P = RANDOM COPOLYMER OF
A LANENE -TYROSINE
R = RSA
S = SEPHAROSE BEAD
Fig- 28
Schematic representation of the difference between
the polyvalent H-RSA-S (left) and the univalent H-polymer-S
(right).
(Taken from Weinstein et al, 1973.)
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are in agreement with the original description of histamine
rosette formation which was shown to be inhibited by the
classical antihistamines (HI- antagonists) which included
diphenhydramine, tripelennamine, antazoline and pyrilamine
(Melmon et aJL, 1972).
"Pharmacological receptors" are usually defined by
precise criteria which include a high specific binding
affinity, saturability of receptors by the drug and
inhibition by specific antagonists. I found that histamine
possessed a high specific binding affinity, fulfilling one
of these main criteria. The results also demonstrated a
dose response inhibition of rosette formation by Hl-
histaraine antagonists. However, the dose of mepyramine
used in these experiments was higher than those used in
other histamine activities such as inhibition of guinea pig
ileum contraction. This may indicate that when histamine
is bound to particles a different dose response relationship
occurs to that with free histamine.
The histamine receptors of alveolar macrophages may
play a role as recognition units associated with phagocytosis
as it was observed that some ingestion of H-RSAZ occurred
(Plate 4). They may also have a role in chemotaxis of
eosinophils (Turnbull and Kay, 1976; Jones and Kay, 1977;
Clark et al, 1975). Whether the binding of histamine to
one type of receptor leads to events associated with immuno¬
logical, chemotactic and pharmacological receptors as
previously described or whether there are different receptors
for mediating distinct biological events is not clear.
Under the experimental conditions described, guinea
pig peritoneal macrophages and blood monocytes expressed
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fewer histamine receptors than alveolar macrophages (Fig. 13).
The reason for this is unclear but it has been confirmed
that there are differences between and within macrophage
populations (Walker, 1976; Kavai et aJL, 1979). It cannot
easily be explained by differences in the degree of purity
of cells since when peritoneal macrophages were enriched by
centrifugation on Ficoll/Hypaque gradients the percentage
of macrophages in both populations (alveolar and peritoneal)
after Ficoll/Hypaque centrifugation was over 90%. This was
confirmed by identification of the cells with non-specific
esterase stain (Yam et al, 1971). Possible explanations
are that the number of receptors increase with maturation
or activation of the cells as discussed previously. In
that condition alveolar macrophages, due to normal "contact"
with the external environment, would be more active than
non-stimulated peritoneal macrophages and blood monocytes.
It would be of interest to test resting and activated
peritoneal macrophages for their capacity to express
histamine receptors. It would also be of interest to
study mononuclear phagocytic cells from other tissues.
The findings that only 30-40% of lymph node cells
formed rosettes is in agreement with the observation of
Saxon et al (1977). These authors found T and B lymphocyte
sub-populations expressed histamine receptors using the
rosette technique. However, other workers (Roszkowski
et al, 1977) using histamine-induced cyclic AMP elevation
as a marker for functional histamine receptors, found that
only T lymphocytes had receptors for the amine.
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Of particular interest was the apparent inability of
guinea pig eosinophils and basophils to form histamine
rosettes since these cells are known to be associated with
various histamine-related biological events. For instance,
basophils synthesize and release this amine (Galli et al.
1976; Stewart et al, 1979), and the anaphylactic release of
histamine from basophils was inhibited by histamine itself,
an effect that was mediated by an H2-receptor-dependent
mechanism (Lichtenstein and Gillespie, 1973, 1975).
Similarly, eosinophils which respond in directional
locomotion to histamine (Clark et al, 1975; Turnbull and
Kay, 1976; Jones and Kay, 1977) and also presumably have
a membrane recognition unit for histamine-induced chemotaxis,
were unable to bind directly with stabilized histamine under
the conditions described here.
The results in Table III demonstrate the presence of
receptors for histamine on human alveolar macrophages.
Human monocytes have also been shown to possess receptors
for histamine (Smart, L., personal communication). No
conclusion could be drawn from the results due to the small
number of patients studied. It would be of interest to
continue these studies on human cells since histamine
receptors may be related to pathological conditions such as
neoplastic transformation of cells. In this regard, in
lymphoid cell-derived tumours in rats a lower expression or
sometimes absence of histamine receptors was observed
(Saxon et al, 1977).
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2.0 THE RESPIRATORY BURST IN ALVEOLAR MACROPHAGES
The preliminary work in this thesis on the metabolic
stimulation of guinea pig alveolar macrophages was aimed at
optimizing the conditions of maximal production of the
superoxide radical. At the time these studies were started
there were few reports in the literature on superoxide
radical production by alveolar macrophages. There was one
paper in which it was claimed that there was no increase in
superoxide anion during phagocytosis by guinea pig alveolar
macrophages (Drath and Karnovsky, 1975) although superoxide
dismutase had been found in this cell (Rister and Baehner,
1975). Also other metabolic parameters, such as stimulation
of NADPH oxidase, increase in hexose monophosphate shunt and
hydrogen peroxide production, had been reported to occur in
alveolar macrophages during phagocytosis (Rossi et al, 1975).
There have been more recent reports on the capacity of
resting alveolar macrophages to produce superoxide radical
and for this to increase by at least twice during stimulation
with particles (Hoidal et al, 1978a; Lowrie and Aber, 1977).
This work has been confirmed in the present study.
2.1 Measurement of the superoxide radical (0^)
The measurement of 0^ used was superoxide dismutase
inhibitable reduction of cytochrome C (Babior et al, 1973).
This test has been shown to be reproducible and reliable and
is widely accepted as a measure of this radical.
When cells were stimulated with different concentrations
of zymosan, previously opsonized with serum, a dose response
of (>2 production was obtained (Fig. 14). Increasing the
concentration of particles resulted in an increase in super¬
oxide radical production indicating that an optimal cell/
1
particle ratio was important to maximize the observed effect.
The degree of inhibition of cytochrome C reduction in
the presence of superoxide dismutase was always over 90% and
often 100% was observed. These slight differences were
probably due to the competitive activity of superoxide
dismutase and cytochrome C for the radical. However,
cytochrome C can also be reduced by other agents which might
not have been affected by superoxide dismutase. Thus I have
observed a reduction of the cytochrome by serum in a super¬
oxide dismutase non-inhibitable fashion.
In general, the methodology used was the same as
reported by other workers (Babior et al, 1973; Johnston
et al. 1975; Weening et al, 1975). However, the concentra¬
tion of the components of the reaction mixture (cytochrome C,
superoxide dismutase) under the optimal conditions obtained
was different to those in other reports. This was probably
due to differences in the species, type and concentration of
cells and the stimulating agent used. The results agreed
with other reports that unstimulated alveolar macrophages
produce superoxide radical but at a low level (Hoidal et al,
1978a). Using different phagocytic stimuli such as opsonized
zymosan or bacteria the cells can increase their Og generation
by up to four- to six-fold.
The incubation medium used influenced the levels of
superoxide radical produced by unstimulated cells. Thus
resting cells, in a more complete medium such as M199,
produced higher amounts of superoxide radical than in a
simple balanced salt solution (Table VI). Similarly, serum
and ovalbumin slightly stimulated the resting superoxide anion
production (Fig. 15). It is not surprising that an increase
in resting 0~ production occurred as a result of maintaining
the cells in a more nutrient medium. When proteins were
added pinocytosis may also have had an effect on 0^ generation.
However, when cells were fully stimulated with the appropriate
concentration of opsonized zymosan particles, changing the
constituents of the incubation mixture did not affect 0~
generation. Latex stimulation was less effective in
enhancing 0^ production than STZ. However the conditions
necessary to obtain maximal stimulation by latex were not
fully studied.
It was previously reported that the production of
superoxide radical by neutrophils stimulated with bacteria
was dependent on the presence of the serum in the incubation
mixture (Curnutte and Babior, 1974). The results in Fig. 15
show that serum did not affect Og generation caused by zymosan
particles which were already treated with serum and then
washed. Therefore, the effect described by Curnutte and
Babior (1974) might have been due to opsonization of the
zymosan with serum and not to a soluble product of it.
Later it was demonstrated that serine components including
C5a and heat aggregated IgG were also able to stimulate the
production of 0^ in neutrophils (Goldstein et al, 1975a).
After prolonged preincubation at 37°C the alveolar
macrophages were able to respond to STZ stimulation by
increasing their 0^ production (Fig. 16). However, the
amount of 0~ produced at resting levels and after stimulation
was much less than in non-preincubated cells. This decrease
in their capacity to be metabolically activated may be due
to cell deterioration, death or shedding of plasma membrane.
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It has been demonstrated that shedding of plasma membrane
antigens in peritoneal macrophages occurred under certain
conditions (Schroit et al, 1973). This phenomenon of plasma
membrane shedding has also been reported in other cells
(Raff, 1976). It seems unlikely that cell death was the
cause of decrease in 02 production after prolonged pre¬
incubation, since tests of trypan blue dye exclusion have shown
cells to be normal after 2-3 hr of cell incubation. However,
this metabolic test may be more accurate in expressing any
physiological changes of the cell. This was shown to be
the case in bovine neutrophils (Beswick and Slater, 1978).
In conclusion, these preliminary experiments showed
that STZ was able to stimulate the production of 0~ in
guinea pig alveolar macrophages. A reproducible and reliable
method was developed using optimal conditions for the
stimulation of these cells.
2.2 Stimulation by histamine
A series of experiments were carried out to determine
whether histamine has a role to play as a modulator of
oxidative activity. 02 generation was chosen as a suitable
parameter of study of these investigations. At the beginning
of these experiments the effect of preincubation of alveolar
macrophages with histamine on 02 generation was studied.
The results showed a significant dose responsive inhibition
of the enhancement of 02 generation caused by histamine
(Table VII). However, resting and phagocytosing 02 generation
were only significantly affected at the highest concentration
where the former was increased and the latter decreased. It
is possible that free histamine stimulates the respiratory
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burst by a small amount thereby decreasing subsequent
stimulation by STZ to a similar degree.
In a pilot experiment it was shown that when cells
were stimulated with H-RSA bound to ox red cells an increase
in 0" production was obtained. However, this method was
expensive in terms of the quantity of red cells used and the
haemolysis produced interfered with the spectrophotometric
measurements. In addition, it was probable that agents
released from the red cells reduced cytochrome C thereby
adversely influencing the assay system.
Although the degree of stimulation by H-RSA was higher
than RSA, the response was of a much lower magnitude than
even spiall amounts of STZ (Fig. 17). However, an additive
effect was obtained when both H-RSA and STZ were used in
stimulating the cells. It was only when H-RSA was bound
to zymosan that the amount of superoxide radical generated
was comparable to that achieved with STZ (Fig. 18).
Zymosan-treated histamine may be structurally identical to
the ox cells bound conjugate used in the identification of
receptors. Therefore, it is possible that the conjugate
has to be bound to a bigger carrier in order to bring about
respiratory burst activity. In this way the histamine-coated
particles might attach to receptors and trigger the metabolic
events (Fig. 29), while H-RSA alone would probably either
diffuse into the cell or attach only partially or weakly to
the receptor. The different pharmacological activities
found between H-RSA alone and H-RSA bound to Sepharose beads
have already been discussed (Weinstein et al, 1975).










HISTAMINE-COATED PARTICLES GENERATE SUPEROXIDE (0~) AND CHEMILUMINESCENCE
(LIGHT EMISSION) IN ALVEOLAR MACROPHAGES
Fig. 29
A schematic representation of the metabolic burst as
a result of conjugated histamine binding to the cell
membrane. [h] = histamine conjugated to a particle;
Hi = "free" histamine.
guinea pig ileum, although the concentration of H-RSAZ
needed to contract the ileum was higher than that of H-RSA.
Comparisons between these two different agents with regard
to their concentration effect relationship cannot readily be
made. When the histamine was coated on to a particle it
was likely that a considerable proportion of the histamine
was not available to the receptors for guinea pig ileum
contraction as the rigidity of the particle maintained much
of its histamine at a distance from the receptors.
It was of interest that when cells were stimulated
with H-RSAZ at different concentrations of H-RSA, the dose
response obtained was directly related to the concentration
of H-RSA but not to the zymosan particles (Fig. 18). These
results were similar to the dose response found in rosette
formation (Fig. 6). This enhancement in superoxide radical
production when concentration of H-RSA was increased may be
due to the binding of H-RSAZ to cells with a low affinity
receptor.
The characteristic pattern of the time-course of
superoxide radical production when cells were stimulated
with H-RSAZ and STZ, compared to controls RSAZ, H-RSA, may
be another indication that when the activation of the cells
is receptor-mediated a higher and more rapid response occurs
(Fig. 19). • This suggests that both agents (i.e. histamine
and complement) are able to attach to their appropriate cell
receptors when carried by suitable particles. H-RSA alone
may also attach to the cell membrane since it was able to
totally block histamine rosette formation. However, the
attachment is probably not sufficiently strong to trigger
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cellular activation. With the controls (RSA alone or RSAZ)
the mechanism of stimulation of superoxide radical production
is possibly different. Perhaps non-specific (non-receptor-
mediated) attachment occurs and even subsequent endocytosis
of these compounds.
Other carrier particles could substitute for zymosan.
These included Sephadex G-10, Sepharose 4B, Amberlite G-50
and latex (Table IX). These agents, by themselves, or
coated with RSA, gave a lower response than that observed
in the presence of H-RSA. In general, the amount of
superoxide dismutase inhibitable cytochrome C reduction was
higher when zymosan was the carrier. Apparently there was
an inverse relationship between particle diameter and the
amount of superoxide radical produced (except latex).
However, the most probable explanation for the superiority
of zymosan is that the number of particles was less when
larger carriers were used (since the concentration was
calculated by weight). Therefore, it is probable that
using the optimal cell/particle ratio a similar amount of
superoxide radical could have been produced.
Chemiluminescence, which also accompanies the
respiratory burst of phagocytic cells (Babior, 1978), occurs
in alveolar macrophages treated with H-RSAZ (Fig. 22).
This effect was both time- and dose-dependent. No light
emission was observed with the controls. The reaction
started almost instantaneously but the peak of chemilumines¬
cence was observed after 8-10 min of incubation. The light
emitted by phagocytic cells during the stimulation of the
respiratory burst is probably due to the production of
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several different processes (Babior, 1978). The results,
however, showed that superoxide dismutase gave complete
inhibition of chemiluminescence stimulated by H-RSAZ and
STZ, indicating a close relationship between Og and light
emission. This finding is in agreement with some reports
using human neutrophils (Hatch et al, 1978). Only 70%
inhibition of light emission by superoxide dismutase was
found in human monocytes and granulocytes (Johnston et al,
1976; Nelson et al. 1976). Apparently 0g is involved in
chemiluminescence produced at the beginning of the reaction
and HgOg in the later stages (Cheson et al, 1976). Because
of the low level light emission it was necessary to add
luminol to the reaction. This compound amplifies the
levels of chemiluminescence measured but does not modify
the time-course and dose-response of the agents studied.
The stimulation of the respiratory burst by H-RSAZ
was probably through an HI histamine effect since the
reaction was partially blocked in a dose-dependent way by
the HI histamine antagonists, chlorpheniramine and mepyramine.
The inhibition of 0^ production with the H2 histamine
antagonists, burimamide and metiamide, was insignificant
(Fig. 20).
Inhibition of 0production by the HI histamine
antagonists was only observed when cells were stimulated
with H-RSAZ and not with STZ (Fig. 21). This suggests
that it had a specific effect on the histamine receptor
rather than a more general effect on the plasma membrane.
Furthermore, the lack of effect of histamine antagonists on
02 production by unstimulated cells would indicate that it
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was unlikely that the drugs per se affected the respiratory
burst.
In conclusion, evidence has been provided that the
conjugate (H-RSA) bound to a carrier stimulated the
respiratory burst in both human and guinea pig alveolar
macrophages. This increase in the metabolic activity was
demonstrated by the production of Og and chemiluminescence.
The effect was probably mediated through an HI histamine
receptor located in the plasma membrane.
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3.0 THE EFFECT OF HISTAMINE ON ENZYME RELEASE BY
ALVEOLAR MACROPHAGES
The release of lysosomal enzymes by polymorphonuclear
cells and macrophages, when exposed to phagocytic and non-
phagocytic stimuli, has previously been reported (Weissmann
et al, 1971a,c; Zurier et al, 1973a,b; Ackerman and Beebe,
1974; Cardella et al, 1974).
In the experiments described in this thesis
glucuronidase was chosen as the lysosomal enzyme for study
since it had been previously shown to be released by guinea
pig alveolar macrophages during phagocytosis (Ackerman and
Beebe, 1974). Also, the assay for this enzyme is simple
and reliable. Its activity was measured both in the
extracellular medium (as a measure of enzyme release) and
in the "pellet" in order to calculate the percentage
release. The cytoplasmic enzyme, lactic dehydrogenase (LDH),
was also measured in the extracellular fluid as an indicator
of cell damage.
When guinea pig alveolar macrophages were incubated
with serum-treated zymosan there was release of lysosomal
p-glucuronidase but not of LDH, thus confirming previous
reports (Ackerman and Beebe, 1974) (Fig. 23). An increase
in the total amount of ^-glucuronidase, but not LDH, was
also observed. The production of enzymes after endocytic
stimuli was previously shown in peritoneal macrophages
(Cohn and Benson, 1965b). Many workers have expressed
enzyme release in terms of percentage of total enzyme
activity. In view of the finding that endocytic stimuli
could increase the total amount of lysosomal enzyme, it
190
was considered preferable to express enzyme release in
absolute terms. Non-opsonized zymosan had no effect on
the total amount of enzyme or on its release into the
incubation medium. The different effect on lysosomal
enzyme production and release shown by STZ and zymosan
cannot be explained by differences in the phagocytic rate
since all experiments were performed in the presence of
cytochalasin B. This fungal metabolite inhibits endocytosis
but not attachment of the particles to the cell (Malawista,
1971; Allison et al, 1971). Therefore, STZ, but not
zymosan, can bind to the macrophage through their complement
receptors thereby activating the production and release of
lysosomal enzymes. Thus the purified guinea pig complement
component, C3b, has been shown to interact with guinea pig
and mouse peritoneal macrophages in culture to induce a
dose- and time-dependent release of lysosomal enzymes into
the medium (Schorlemmer et al, 1976; Schorlemmer and
Allison, 1976). Previous workers have reported that cyto¬
chalasin B increases lysosomal enzyme release from
macrophages incubated with a phagocytic stimuli. In
unstimulated cells the effect was observed only after 24 hr
of incubation (Davies et al, 1973). These findings have
been confirmed. A significant increase in ^-glucuronidase
release in cytochalasin B-treated cells stimulated with STZ,
and no increase in unstimulated cells, was obtained after 2 hr
incubation (Table X).
In ten experiments performed under the same experi-
-4 -1
mental conditions histamine, at a high dose (10 mol.l ),
increased the release of ^-glucuronidase in STZ-stimulated
i
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cells but not in unstimulated alveolar macrophages (Fig. 23).
The effect of histamine was shown to be dose- and time-
dependent (Figs. 25 and 26). The total amount of (3-
glucuronidase was not changed indicating that histamine
only facilitated the release of the enzyme and did not
stimulate its production (Fig. 23). This increase was
probably not due to cell damage since no increase in LDH
release was observed (Fig. 23). It was of interest to
observe that the increase in ^-glucuronidase produced by
histamine was only demonstrated when cells were previously
treated with cytochalasin B. In the absence of this
fungal metabolite no significant difference in STZ-
stimulated cells in the presence or absence of histamine
was observed (Table X). The effect of histamine on
guinea pig alveolar macrophages was exactly the opposite
to that found in human neutrophils (Zurier et al, 1974).
When neutrophils were pretreated with cytochalasin B,
histamine (through its H2-receptor) decreased the release
of ^-glucuronidase following incubation with serum-activated
zymosan particles (Busse and Sosman, 1976). Several
possibilities, in addition to the difference in cell
types, may explain the apparent discrepancy between the
findings of Busse and Sosman (1976) and those described in
this thesis. The factors which regulate lysosomal enzyme
release from phagocytic cells will be considered first.
The release of lysosomal enzymes from cells during
phagocytosis depends on several events which include
(1) attachment and endocytosis of the particle, (2) intra¬
cellular movement of lysosomes, (3) lysosomal fusion with
1
the phagocytic vacuole. Cyclic nucleotides, acting
probably on microtubules, may influence the fusion of
lysosomes with the phagosome (Weissmann et al, 1975a,b).
This effect has been widely studied in polymorphonuclear
phagocytic cells. Thus cyclic AMP, and substances which
increase its intracellular level including histamine,
decrease lysosomal enzyme release (Weissmann et al, 1971b).
Cyclic GMP and its analogues increase the release (Zurier
et al, 1973; Zurier et al, 1974). Cytoplasmic micro¬
tubules are in a dynamic state of assembly and disassembly
(Weissmann et al, 1975b). Cyclic GMP, and agents which
increase cyclic GMP levels such as phorbol myristate
acetate (PMA), deuterium oxide (DgO) and phagocytosis of
particles, favour microtubule assembly and enzyme release
(Goldstein et al, 1975b; Zurier et al, 1974). Cyclic AMP,
agents which increase cyclic AMP levels and drugs which
disrupt microtubules such as colchicine and vinblastine,
inhibited phagocytosis and enzyme release (Cox and Karnovsky
1973; Weissmann et al, 1971b). The effect of microtubules
on degranulation was demonstrated in cytochalasin B-treated
cells in which the phagocytosis was inhibited. In poly¬
morphonuclear phagocytes, colchicine, vinblastine and cyclic
nucleotides had the same effect on degranulation of particle
stimulated cells (e.g. STZ, bacteria) whether or not the
cells were treated with cytochalasin B (Zurier et al, 1973a,
1974; Goldstein et al^, 1975b; Weissmann et al, 1975b).
This indicates that the effect of microtubules on degranula¬
tion was independent of phagocytosis.
In macrophages, the phenomenon of degranulation has
not been fully analysed, and the literature demonstrates
193
that interpretation of this process is controversial. It
has been shown that colchicine disrupts microtubules and
inhibits phagocytosis and the release of lysosomal enzymes
even from cytochalasin B-treated guinea pig alveolar
macrophages and mouse peritoneal macrophages (Ackerman and
Beebe, 1975; Weissmann et al, 1971b). Contradictory
reports on the effects of cyclic nucleotides on phagocytosis
and enzyme release have been published. Thus in mouse
peritoneal macrophages an inhibition of enzyme release,
without affecting particle uptake by cyclic nucleotides
(3,5 cyclic AMP, dibutyryl 3,5 cyclic AMP, 3,5 cyclic GMP
and 2,3 cyclic AMP), was reported (Weissmann et al, 1971b).
On the other hand, in guinea pig alveolar macrophages the
3,5 adenosine and guanosine cyclic nucleotides and
theophylline had no effect on phagocytosis or release of
^-glucuronidase (Ackerman and Beebe, 1975). Furthermore,
in rabbit alveolar macrophages, phagocytosis of latex
particles increased levels of cyclic AMP and exogenous
dibutyryl cyclic AMP stimulated phagocytosis, oxygen
consumption and hexose monophosphate shunt (Schmidt-Gayk,
et al, 1975; Seyberth et al, 1973). In contrast, in pig
polymorphonuclear leucocytes, the same authors found no
change in cyclic AMP during phagocytosis and a decrease in
hexose monophosphate shunt activity produced by phagocytosis,
when exogenous dibutyryl cyclic AMP was added (Cox and
Karnovsky, 1973; Bourne et al, 1971). Moreover, a
biphasic effect of cyclic AMP on phagocytosis by mouse
peritoneal macrophages has been described. Thus high
-4 -1
concentrations of the nucleotide (10 mol.l ) decreased,
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and low doses (10~10 mol.l-^") increased phagocytosis of
immune complexes (Oliveira et al, 1974).
The finding that histamine increased p-glucuronidase
release in STZ-stimulated alveolar macrophages (Fig. 23),
an opposite effect to that found in polymorphonuclear cells
(Zurier et al, 1974), may be explained by analysing the
effect of histamine on any of the different degranulation
steps previously described. Histamine may act on
phagocytosis, a suggestion supported by the finding that
there is a stimulation of the phagocytic capacity of the
cells of the "reticuloendothelial system" by histamine
(GiJzsy and Kato, 1957, cited by Riley, 1963). The cells
in the experiment described herein were incubated with
cytochalasin B and, therefore, phagocytosis should not
play a role in ^-glucuronidase release. Moreover, the
effect of histamine was observed only when cells were
incubated with cytochalasin B.
Histamine may also act on lysosome/phagosome
interaction by acting on microtubules either directly or
indirectly via cyclic nucleotides. Although it is possible
that histamine has a direct effect on microtubules, there is
no evidence, at this time, to support this view. In poly¬
morphonuclear cells histamine, through an H2-dependent
effect, increased cyclic AMP and, therefore, inhibited
enzyme release (Zurier et al, 1974; Busse and Sosman, 1976).
In our studies histamine may also have acted on intracellular
cyclic nucleotides either increasing cyclic GMP or cyclic
AMP. Cyclic AMP increased phagocytosis in alveolar
macrophages but not in polymorphonuclear cells (Seyberth
et al, 1973; Schmidt-Gayk et al, 1975). These opposing
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effects may also be influencing enzyme release. Thus an
increase in intracellular cyclic AMP leads to an increase
in enzyme release in alveolar macrophages but with poly¬
morphonuclear cells the reverse effect occurs. It should
be noted that when cells were incubated with theophylline
no additive effect of this drug with histamine was observed
(Table X). This would suggest that cyclic AMP is not
involved in enzyme release even though a small but
statistically insignificant decrease in ^-glucuronidase
release was observed.
The most probable explanation for the enhancement of
^-glucuronidase release produced by histamine is that the
amine has a non-specific effect on cell permeability.
Histamine has been previously used as a method for increasing
cell permeability (Diengdoh and Turk, 1967). The view is
supported by the fact that histamine antagonists,
chlorpheniramine (HI) and burimamide (H2), did not
counteract the histamine effect (Table XIII). Histamine
agonists, 2-AET (HI), 4-MeHm (H2) and Dimaprit (H2), were
incapable of simulating the effect (Table XII). Therefore,
the effect of histamine was probably not a specific
receptor-mediated activity.
The effect of histamine on the secretion of other
lysosomal enzymes, besides ^-glucuronidase, was not
studied. It is important to state this since selective
enzyme release has been observed. For instance, when
cytochalasin B-treated human polymorphonuclear cells were
exposed to phorbol myristate acetate extracellular release
of lysozyme but not (3-glucuronidase or lactic dehydrogenase
was observed. However, when cytochalasin B-treated cells
196
were stimulated with opsonized zymosan or C5a the addition
of phorbol myristate acetate resulted in enhanced (3-
glucuronidase release (Goldstein et al, 1975b).
It was of interest to observe that H-RSAZ did not
increase the extracellular release or intracellular
production of ^-glucuronidase (Fig. 24), whether the
experiments were performed in the presence or absence of
cytochalasin B. The reason for this is not clear since
H-RSAZ was shown to attach to the cell membrane and
stimulate the respiratory burst (see Section B), and also
in electron microscopic studies phagocytosis of H-RSAZ
particles by non-cytochalasin B-treated cells has been
observed (Plate 4 ). This may indicate that cell
properties such as attachment, phagocytosis, degranulation
and metabolic activity, although closely interrelated, do
not necessarily all occur together at the same time. It
may be that each of these activities respond to different
signals rather than a "chain reaction".
The results obtained when cells were stimulated with
unbound H-RSA (i.e. in the absence of zymosan) are difficult
to interpret (Table XI). RSA alone per se stimulated the
extracellular release of (3-glucuronidase, but not its
intracellular production. This effect could possibly be
due to pinocytosis of the albumin. However, an inhibition
of pinocytosis by cytochalasin B has been demonstrated in
peritoneal macrophages (Allison et al, 1971). Although the
incubation time used in this set of experiments was only 1 hr
it is unlikely that this could have affected the results
since in the time-course studies effects were observed as
early as 30 min.
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When cells were incubated with H-RSA the extracellular
release of ^-glucuronidase was slightly higher than with
free histamine or with non-treated cells. In STZ-
stimulated cells the same amount of release was obtained.
It was of interest that no increase in the total amount of
^-glucuronidase was obtained when cells were stimulated
with STZ in the presence of H-RSA. An inhibitory effect
on enzyme synthesis may have been produced but the reasons
for this are not clear. A toxic effect cannot be excluded,
even though the cells excluded Trypan blue. Also, an
enhancement of LDH release was not observed at the
concentrations of H-RSA used. At higher concentrations
of H-RSA (1:10) there was release of LDH and loss of cell
viability.
In conclusion,-it was found that histamine-coated
zymosan (H-RSAZ) particles did not stimulate the
production or release of (3-glucuronidase or of cytoplasmic
LDH even though it initiates the respiratory burst
(Section B). In contrast, serum-coated zymosan (STZ)
particles stimulated both the respiratory burst and the
production and release of ^-glucuronidase. When cyto-
chalasin B-treated cells were incubated with STZ in the
presence of histamine, the amine, probably by a non-specific
enhancement of cell permeability, increased the release of
^-glucuronidase but not of LDH.
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4.0 GENERAL CONCLUSIONS AND SUGGESTIONS FOR FUTURE WORK
The aim of the present study was to examine the effects
of histamine on the alveolar macrophage. Since histamine is
a well recognized mediator of inflammation in general and of
type I hypersensitivity reactions in particular and is
present in high concentrations in the airways of patients
with certain pathological conditions such as chronic
bronchitis and asthma, this amine could have a deleterious
action on alveolar macrophages. On the other hand, work
in recent years has heightened our appreciation of the
physiological role of histamine, particularly in terms of
regulation of the immune response. For example,
inhibition of antibody production (Melmon et al, 1974),
inhibition of antigen-induced lymphocyte proliferation
in vitro (Artis et al, 1975), inhibition of T cell-mediated
cytolysis (Henney et al, 1972), inhibition of MIF release
(Rocklin, 1976) have been reported. Although these actions
have been demonstrated in vitro they may also occur jUi vivo.
Thus patients treated with the H2 histamine antagonist,
cimetidine, had an increase in the responsiveness of
lymphocytes to phytohaemagglutinin, suggesting that their
lymphocytes had blocked the H2- histamine receptors
(Robertson et al, 1979). It is known that histamine is
rapidly destroyed following administration in vivo (Schayer,
1959). However, it is not known for certain whether small
amounts of histamine are being constantly released and
destroyed, a mechanism which has been suggested in the
regulation of microcirculation (Schayer, 1965). Histamine
may be transported extracellularly bound to a protein as a
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carrier. The capacity of histamine to bind plasma protein,
a phenomenon called "histaminopexy", has been demonstrated
by a number of workers (Parrot et _al, 1952; Guirguis, 1967;
Freeman, 1969; Geese et al, 1972). Some aspects of the
phenomenon of histaminopexy have recently been studied and
it was found that about 10% of histamine binds spontaneously
to plasma proteins. When the coupling agent (ECDI) was
added, the binding was increased up to 20% (Diaz, P. and
Jones, D.G., unpublished data). It is possible that
histamine exists in vivo in both forms, i.e. free and bound
to a protein and it is suggested that this would be an
important area for future work; that is to say, the
association between plasma proteins and histamine transport.
Histamine may act preferentially through an HI- or
H2-receptor depending on whether it is presented to a cell
in a free or bound form and experiments to test this
hypothesis could be easily designed.
Certain H2-dependent properties of histamine have
exerted their effect by enhancing intracellular cyclic AMP,
e.g. inhibition of enzyme release in neutrophils (Busse and
Sosman, 1976), inhibition of T cell-mediated cytolysis
(Plaut et al, 1973a). It is possible that H2-receptors are
predominantly intracellular (and exert their activity by
an increase in cyclic AMP) whereas Hl-receptors are
predominantly on cell membranes. Therefore, histamine
in its conjugate form (H-RSA) and bound to a particle
would preferentially trigger the HI- cell membrane receptor.
For instance, it has been shown that with human leucocytes,
H-RSA bound to Sepharose beads did not increase cyclic AMP.
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However, when cells were stimulated with H-RSA alone an
enhancement in the cyclic nucleotide was observed
(Weinstein et al, 1975). This finding may suggest that
histamine bound to Sepharose beads did not penetrate the
cells. The experiments demonstrated that alveolar
macrophages only respond to HI histamine-mediated activity
with regard to membrane-associated phenomena such as the
presence of receptors and the activation of the respiratory
burst. On the other hand, it could be that guinea pig
alveolar macrophages possess only Hl-receptors. All -these
suggestions could be put to the test by determining whether
HI- or H2-receptor activity can be detected in various cell
fractions.
In the present study receptors for histamine on the
alveolar macrophage (guinea pig and human) were identified
and shown to be Hl-dependent. It would seem important,
therefore, to explore the relationship between that part
of the membrane which binds histamine-coated particles and
that which is involved in phagocytosis and/or chemotaxis.
Thus an increase in phagocytosis by cells of the "reticulo¬
endothelial system" in the presence of histamine has been
described (Gflzcy and Kato, 1957, cited by Riley, 1963).
It was also found that H-RSAZ was phagocytosed by
alveolar macrophages although the rate or amount of particle
uptake is not known. It is not possible, therefore, to
compare H-RSAZ with STZ or with particles coated with IgG.
A thorough study of the influence of histamine on phagocytosis
would be important to perform, as would a comparison of
H-RSAZ with the normal opsonized particles (IgG and complement)
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and the effect of free histamine on the phagocytic activity
of the alveolar macrophage stimulated with opsonized
particles.
Also, a study of chemotactic and chemokinetic
activities of histamine on alveolar macrophages and other
macrophages would be important to perform.
Further studies are necessary to understand the
expression of histamine receptors on macrophages. It
would be important to characterize biochemically the
receptor on these cells. Also, changes of the receptor
expression with activation or maturation of cells and its
modification on pathological conditions such as neoplasias,
should be studied.
The role of histamine on alveolar macrophage function
has also to be elucidated. However, it is possible only
to say that histamine in its conjugated form may metabolically
activate the alveolar macrophage (human and guinea pig).
This could have physiological significance since 0^ production
has been found to be cytotoxic (Simchowitz and Spilberg, 1979)
and, therefore, it may have a role in the defence against
malignancy. Furthermore, histamine has been found to be
increased in tumour tissue (Kahlson and Rosengren, 1968).
However, Og may also play a role in inflammatory reactions
by its toxic activity. Some anti-inflammatory drugs have
been demonstrated to act by inhibiting Og production
(Oyanagui, 1976). Therefore, in diseases such as chronic
bronchitis, in which macrophages are probably in permanent
contact with high concentrations of histamine (Turnbull
et al, 1977), this could produce a constant stimulation of
0" release with a consequent damage of the tissue.
It was found that histamine did not specifically
affect (3-glucuronidase release. The action was probably
secondary to a non-specific increase in cellular
permeability. However, I am not able to say that other
lysosomal enzymes are not released by stimulation with
histamine either free or as H-RSAZ. It would be of
interest to study the release of neutral proteinases such
as collagenase and elastase under such conditions. These
enzymes may play a role in lung pathologies.
The role of macrophages in the immune response has
been well studied in recent years but the role of alveolar
macrophages is not yet clear. It would be of interest to
study the effect of histamine on the alveolar macrophage
antigen processing activity and its interaction with
lymphocytes. That both cells possess a large number of
histamine receptors may have important implications.
This could have significance in antibody production and
in the interaction with T and B lymphocytes.
In conclusion, the in vitro work described here
indicates that histamine might act as a modulator of
macrophage function which in turn may have important
repercussions on our understanding of certain pathological
conditions. A full understanding of the interaction
between histamine and alveolar macrophages in physiological
and pathological processes is yet to be determined, and a
great deal of further work is necessary for its final
elucidation.
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Histamine receptors on guinea-pig alveolar macrophages:
chemical specificity and the effects ofHI- and H2-
receptor agonists and antagonists
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SUMMARY
Various guinea-pig leucocytes were tested for their capacity to hind histamine coupled as a rabbit
serum albumin conjugate (H-RSA) to formalised ox red cells. The percentage of rosette-forming
target cells was directly related to the concentration of erythrocyte-bound H-RSA. Under
optimal experimental conditions the numbers of rosettes varied from 60 to 81% for alveolar mac¬
rophages, 14 to 73% for peritoneal macrophages, 14 to 30% for blood monocytes, 27 to 48%
for lymph node cells, 7 to 24% for blood lymphocytes and 0 to 29% for peritoneal and blood
neutrophils. Virtually no histamine rosettes were formed with eosinophils or basophils.
Free histamine partially inhibited rosette formation by alveolar macrophages in a dose-depen¬
dent fashion from 10~3 to 10'3 mol/1, and complete inhibition was achieved by the H-RSA
conjugate. In contrast, amines closely related to histamine such as L-histidine and the major
histamine catabolites, imidazoleacetic acid, 1,4-methylhistamine, l-methyl-4-imidazoleacetic
acid and N-acetylhistamine, had no inhibitory effect.
The histamine Hl-receptor antagonists, mepyramine and chlorpheniramine, and the Hl-
receptor agonist, 2- (2-aminoethyl) thiazole, all inhibited rosette formation by alveolar macro¬
phages in a dose-dependent fashion. However, the H2-receptor antagonists, burimamide and
metiamide, and the H2-receptor agonists, Dimaprit and 4—methyl-histamine, were inactive.
These experiments suggest that (1) compared to other leucocytes, histamine receptors are
particularly well expressed on the alveolar macrophage, (2) these receptors have a high degree of
specificity for histamine in that other amines, closely related chemically, did not inhibit rosette
formation, and (3) the binding of histamine to the alveolar macrophage membrane is HI- and not
FI2- receptor dependent.
INTRODUCTION
It has previously been shown that most human peripheral blood leucocytes, but not erythrocytes,
adhered to Sepharose beads coated with a histamine-rabbit serum albumin conjugate, suggesting the
presence of surface receptors for this amine (Melmon et al., 1972; Weinstein et al., 1973). Using the
same conjugate, but with red cells in place of Sepharose beads, Kedar & Bonavida (1974) were able to
develop a rosette technique for demonstrating histamine receptors on mouse leucocytes from a variety of
lymphoid tissues. Subsequently, the same group reported that human monocytes and a proportion of
peripheral blood T and B lymphocytes also expressed receptors for histamine (Saxon, Morledge &
Bonavida, 1977).
The release of histamine and other pharmacological agents from sensitized lung fragments following
challenge with specific antigen is well known. The lung is a major site for histamine storage and high
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concentrations of histamine have been found in the sputum in pulmonary disorders associated with
immediate-type hypersensitivity (Turnbull et at., 1977; Turnbull et at., 1978). For these reasons it
seemed important to establish the presence of histamine receptors on the alveolar macrophage, as well as
other leucocytes associated with biological properties of histamine, such as the neutrophil, eosinophil
and basophil. For instance, histamine was shown to increase chemokinesis of neutrophils (Anderson,
Glover & Rabson, 1977), to promote directional migration of eosinophils (Clark, Gallin & Kaplan,
1975; Turnbull & Kay, 1976; Jones & Kay, 1977), and to be synthesized and formed in the basophil
(Galli et at., 1976; Stewart, Jones & Kay, 1979). By rosette-inhibition experiments we have also examined
the chemical specificity of binding by histamine-coated red cells, as well as the effects of HI- and
H2-receptor agonists and antagonists.
MATERIALS AND METHODS
Materials were obtained as follows. Histamine dihydrochloride, rabbit serum albumin, l-ethyl-3-(3-dimethylaminopropyl)
carbodiimide HC1 (ECDI) and L-histidine (Sigma, London); HEPES (Wellcome Laboratories, Beckenham, Kent);
mepyramine maleate (May & Baker Ltd., Dagenham, Essex); chlorpheniramine (Allen & Hanburys Ltd., London); imidazo-
leacetic acid hydrochloride (ImAA), 1, 4-methylhistamine dihydrochloride (1, 4-MeHm), N-acetylhistamine and 1-methyl-
4-imidazoleacetic acid hydrochloride (1, 4-MeImAA) (Calbiochem, California, USA); sodium diatrizoate (45% Hypaque,
Winthrop, Surbiton-on-Thames, Surrey); Ficoll (Pharmacia, London); burimamide, metiamide, 4-methylhistamine
dihydrochloride (4-MeHm), 2-(2-aminoethyl) thiazole dihydrochloride (2-2-AET) and S [3-(N, N dimcthylamino)
propyl] isothiourea (Dimaprit) were a gift from Smith, Kline & French Laboratories T.imited, Welwyn Garden City, Hert.
All other reagents were B.D.H. (Poole, Dorset) Analar grade.
Preparation ofleucocytes. Dunkin Hartley strain guinea-pigs ofeither sex and weighing 250-400 g were used throughout.
(a) Alveolar macrophages. These were obtained by tracheo-bronchial lavage (Myrvik, Leake & Farris, 1961) using
HEPES buffered saline, pH 7-3-7-4, from guinea-pigs anaesthetized with intraperitoneal sodium pentobarbital (40 mg/kg).
The macrophages were enriched by density centrifugation on Ficoll-Hypaque (d = 1-08 g/ml) (Boyum, 1968) at 650 8
for 30 min at 4"C, washed twice in phosphate buffered saline (PBS), pH 7-2, and brought to a final concentration of 5 X 106
cells/ml in PBS. Such preparations usually contained between 85 and 95% macrophages.
(b) Peritoneal macrophages and eosinophils. These were obtained by lavage of normal guinea-pigs using 20 ml PBS
containing heparin (4 u/ml). They were used either unpurified, or following density centrifugation on Ficoll-Hypaque as
described above.
(c) Peritoneal neutrophils. These were harvested by lavage as described above, 3 hr following the intraperitoneal adminis¬
tration of 20 ml glycogen (1-0 mg/ml) in PBS.
(d) Blood monocytes, neutrophils, lymphocytes and eosinophils. These were obtained by puncture of the abdominal aorta
and collected into heparinised tubes (5 u/ml). Erythrocytes were sedimented in 3% gelatin for 15 min at room temperature.
The leucocyte-rich supernatant was removed, washed three times in PBS and the cell counts again adjusted in PBS to a
final concentration of 5 X 106/ml.
(e) Lymph node cells. These were collected from the paratracheal lymph nodes by gently teasing with a scalpel and
filtering the resultant cell suspension through a stainless steel sieve (120 wires per inch). The cells were then washed twice in
BBS and adjusted to a final concentration of 5 x 106/ml.
(f)Bone marrow basophils. These were obtained from the humeri, tibiae and fibulae of guinea-pigs given whole sheep's
blood (1:1 with Alsever's solution) on 12 successive days as described previously (Dvorak et at, 1974).
If any of the preparations described above contained unacceptable numbers of contaminating erythrocytes, these were
lysed by suspending the cells briefly in 0-82% ammonium chloride, washing several times in PBS and readjusting the cell
counts to 5 x 108/ml.
Preparation ofhistamine-rabbit serum albumin conjugate (H-RSA). The H-RSA conjugate was prepared using the procedure
described by Kedar & Bonavida (1974). Briefly, 1-4 g histamine dihydrochloride, 200 mg rabbit serum albumin (RSA) and
1-2 g ECDI were dissolved in 20 ml ofPBS, pH 7-2. After incubation for 1 hr at room temperature with intermittent shaking,
the solution was dialysed at 4°C against 5 litres of PBS which was changed three times over a 48 hr period. The controls,
which were prepared in parallel under the same conditions, were (1) RSAECdi : 200 mg of RSA and 1-2 g of ECDI in 20
ml of PBS, and (2) RSAU : 200 mg of RSA in 20 ml of PBS without the coupling reagent. These preparations were
stored at —20"C and used for up to 10 weeks after preparation.
Coupling ofH-RSA to ox red cells. Ox red cells were washed three times in PBS and adjusted to a 50% suspension with
0-2% formalsaline. After 20 min at room temperature, the cells were washed three times in PBS. 2-5 ml of various dilutions
(usually 1 : 60—see Fig. 1) of H-RSA (or RSAecdi or RSAU) were mixed with 0-25 ml of formalised ox cells in PBS and
20 mg ofECDI in 1-0 ml of PBS and incubated for 45 min at room temperature with intermittent agitation. The red cells
were then washed three times in PBS and adjusted to a final concentration of 2-5 x 10s cells/ml.
Rosette issay. Duplicate 0-1 ml volumes of leucocyte suspensions (5 X 106/ml) were mixed with an equal volume of red
cells (2-5 X 108/ml), centrifuged at 500 g for 5 min at 4°C and incubated (usually for 15 min—see Fig. 2) at 0°C or,
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where necessary, at 37°C. The resultant cell pellets were resuspended by gentle agitation and 0-2 ml of 2% formalsaline was
added. Smears were made in duplicate from each suspension. Alveolar macrophages were stained with either May Grun-
wald-Giemsa or the non-specific esterase technique described by Yam, Li & Crosby (1971). Other cell types were identi¬
fied by the May Grunwald-Giemsa stain. The percentage of rosettes (those cells binding three or more erythrocytes) was
then counted in 200 random leucocytes, areas ofcell clumping being excluded.
Inhibition of rosette formation was studied as follows: 0-1 ml volumes of suspensions containing alveolar macrophages
were centrifuged at 500 g for 5 min at 0°C and the supernatants discarded. The test agents, freshly prepared, or the PBS
controls, were added to the cell pellets and incubated for 15 min at 37°C or 0°C, prior to the addition of the red cell sus¬
pension. The samples were then treated as described above. The effect of the test agents on cell viability was assessed by
trypan blue exclusion before and after treatment.
[a — b X 100, where a and b represent the percentagea J
of leucocyte rosettes in preparations pre-incubated with PBS or drug, respectively.
RESULTS
The histamine rosette assay
The effect of varying the amount of H-RSA coupled to ox red cells on rosette formation by guinea-
pig alveolar macrophages is shown in Fig. 1. The percentage of rosettes was directly related to the
100 r
1:20 1:40 1:60 680 IhOO
Dilution of H-RSA or RSAecdi
Fig. 1. The effect of dilutions of H-RSA (•) or RSAECDi (o) on rosette formation by alveolar macro¬
phages. Each point represents the mean±s.e. of three experiments.
amount of H-RSA coupled, whereas no rosette formation was seen when the same dilutions of the
control, RSA ECDI, were added to the indicator erythrocytes. Also, although not shown in Fig. 1,
RSAU plus ox cells and the ox cells alone failed to form rosettes. There was little difference in the per¬
centage of rosettes between the 1 : 20 and 1 : 80 dilutions of H-RSA but binding was considerably
less with a 1 : 100 dilution. In general, concentrations of H-RSA greater than 1 : 20 produced an un¬
acceptable degree of lysis of the indicator ox red cells.
The time course of rosette formation using ox cells coupled with three concentrations of H-RSA is
shown in Fig. 2. Rosette formation was virtually instantaneous with only a small increase being observed
from 0 to 30 min with all dilutions. At 1:60, the numbers of rosettes were greater at 0, 5 and 15 min
when compared to the other dilutions, but at 30 min they were virtually identical to the 1:80 dilution.
Since the 1 : 60 dilution showed a slight increase in rosette formation with time up to 15 min, this con¬
centration and incubation time were used in all further experiments.
Free histamine inhibited rosette formation, both at 0°C and 37°C, in a dose-dependent fashion from
10~3 to 10"5 mol/1, although only 44 and 48% inhibition was achieved with the highest concentrations
(Table 1). In contrast, the H-RSA conjugate completely inhibited rosette formation at a 1:60 dilution,
whereas equivalent amounts of RSA ECDI and RSAU gave no inhibition when compared to the diluent
(PBS) control.
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Fig. 2. The effect of incubation time on rosette formation by alveolar macrophages with red cells coated with
H-RSA dilutions of 1:60 (•), 1: 80 (O) and 1: 100 (A). Each point is the msanis.e. of three experiments.
Histamine rosettes by various guinea-pig leucocytes
The capacity of mononuclear phagocytes, lymphocytes, neutrophils, eosinophils and basophils to
form histamine rosettes is shown in Fig. 3. Mononuclear phagocytes were obtained from three sources:
lung washings, the peritoneum and peripheral blood. In general, alveolar macrophages formed greater
numbers of histamine rosettes than all of the other cell types tested, including peritoneal macrophages.
Rosette formation did not appear to depend on the degree of enrichment of cells—at least not by those
leucocytes in which this was examined, i.e. alveolar and peritoneal macrophages, lymph node cells and
eosinophils. The ranges of the percentage of histamine rosettes for the different cell types were alveolar
macrophages, 60-81%; peritoneal macrophages, 14—73%; blood monocytes, 14—30%; lymph node cells,
27-48%; blood lymphocytes, 7-24%; peritoneal and blood neutrophils, 0-26% and 0-29%, respec¬
tively. Virtually no histamine rosettes were formed by eosinophils or basophils.
Inhibition ofrosettes by histamine and related compounds
The capacity of L-histidine, histamine and major histamine catabolites to inhibit histamine rosette
formation by alveolar macrophages is shown in Table 2. Significant dose-dependent inhibition of
rosette formation was achieved by histamine, from 10" 3 to 10" 5 mol/1, but not by L-histidine or themajor
histamine catabolites, ImAA, 1, 4-MeHm, N-AcHm and 1, 4-MeImAA, when the experiments were
performed either at 0°C and 37°C.




Percentage of rosettes ± 1 s.e. (percentage inhibition)
0°C 37°C
PBS 12 62±2 58±3
Histamine: 10~3 mol/1 12 35±2 (44) 30+2(48)
10"4mol/J 12 42±2 (32) 38±2(35)
10~5 mol/1 12 49±2(21) 46±3 (21)
PBS 3 66±0 67±3
H-RSA 1:60 3 1± 1 (98) 1± 1 (99)
RSAecdi 1:60 3 66±2 (0) 69±4 (0)
RSA„ 1:60 3 70±1 (0) 71 ±1 (0)
* Key for abbreviations in the Materials and Methods section.
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Fig. 3. Histamine rosettes by (a) mononuclear phagocytes, (b) lymphocytes, (c) neutrophils, (d) eosinophils
and (e) basophils. In some experiments cells were unfractionated (•) or enriched (O) by centrifugation on
coll-Hypaque. A = alveolar, P = peritoneal, B = blood, LN — lymph node, BM = bone marrow.
Table 2. Inhibition of rosette formation with alveolar macrophages by histamine, L-histidine, ImAA, 1,4-MeImAA
1,4-MeHm and N-AcHm at 0°C or 37X
Percentage inhibition of rosette formation
10"3 mol/1 10~4 mol/1 10~5 mol/1
Drug added 0°C 37°C 0°C 37X 0°C 37°C
Histamine 45±3* 4S±3 32+3 34+2 19+2 20+2
L-histidine 5±2 3±1 1+ 1 1+ 1 4+2 1+ 1
ImAA 13±7 7±3 10+7 3+3 4+3 4+2
1,4-MeHm 1±1 7±6 1+ 1 0+0 3+ 3 2+2
N-AcHm 1±1 2+2 2+1 1+ 1 2+1 0 + 0
1,4-MeImAA o±o 1±1 4+3 0+0 3+2 0+0
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Fig. 4. Inhibition of rosette formation with alveolar macrophages by HI- and H2-receptor agonists (a)
histamine, (b) 2-2-AET, (c) 4-MeHm and (d) Dimaprit at 0°C (O) or 37°C (•). Each point represents
the mean+s.e. of three experiments.
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The effect ofH\- and H2-receptor agonists and antagonists
The HI agonist, 2-2-AET, inhibited the binding of H-RSA conjugated red cells to alveolar macro¬
phages in a dose-dependent fashion, from 10" 3 to 10"5 mol/1 with a degree of inhibition only slightly less
than that achieved by histamine (Fig. 4). In contrast, the H2 agonists, 4-MeHm and Dimaprit, had no
inhibitory effect under the same conditions. Similarly, inhibition of rosettes was demonstrable with the
HI antagonists, mepyramine and chlorpheniramine, at concentrations from 10~4 to 10"6 mol/1 at 0°C
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Fig. 5. Inhibition of rosette formation with alveolar macrophages by HI- and H2-receptor antagonists (a)
mepyramine, (b) chlorpheniramine, (c) burimamide and (d) metiamide at O'C (O) or 37°C (•). Each point
represents the mean±s.e. of three experiments.
DISCUSSION
The technique described here for coupling histamine to erythrocytes has been modified from previously
described methods (Kedar & Bonavida, 1974; Saxon et a!., 1977). We found that, in general, ox cells
were less susceptible than sheep cells to lysis by the various chemical agents employed. Also, formalised
ox erythrocytes were more stable in this respect than untreated cells. In addition, we found that with 20
mg/ml ECDI the degree of haemolysis was consistently less than with the dose (40 mg/ml) recommended
in the original technique for use with sheep cells (Kedar & Bonavida, 1974; Saxon etal., 1977).
Histamine rosettes were formed almost instantaneously (Fig. 2) and no significant differences were
observed at 0°C and 37°C (Tables 1 and 2, Figs 4 and 5). In these respects, the histamine receptor
differs from those for complement (C3b, C3d and C4) and IgG (Fc) on human granulocytes since
complement receptors were expressed better at 37°C and Fc receptors at 0°C and maximal rosette for¬
mation was achieved at 10 min (Wong &Wilson, 1975; Anwar & Kay, 1977).
We are unable to say with certainty that the cell membrane of the various leucocytes studied binds
free histamine, as opposed to histamine bound as a conjugate. However, the receptor is apparently
specific for the histamine moiety of the conjugate in that substances closely related chemically, such as
L-histidine and the major histamine catabolites, imidazoleacetic acid, 1, 4-methylhistamine, N-acetyl-
histamine, and 1, 4-methyl-imidazoleacetic acid, did not inhibit the reaction to any significant extent,
whereas free histamine inhibited binding by 45% at 10"3 mol/1 (Table 2). Furthermore, rabbit serum
albumin treated with the coupling reagent (RSAECD1), RSAU and untreated ox cells were also without
effect, whereas the histamine conjugate completely inhibited binding ofox cells coupled to H-RSA.
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If stabilization of histamine is required for optimal recognition then this may have biological sig¬
nificance in that the binding of histamine to plasma proteins has been demonstrated by a number of
workers (Parrot, Urquia & Laborde, 1952; Guirgis, 1967; Freeman, 1969). Histamine-binding (or
'histaminopexy') is apparently non-covalent since histamine can be easily dissociated from plasma
proteins. Proteins with histamine-binding activity have been identified in a1; a2, [i and y-globulins
(Guirgis, 1967; Freeman, 1969).
The present experiments suggest that histamine rosettes are formed entirely at Hl-receptor sites
since the binding was inhibited in a dose-dependent fashion by HI antagonists including mepyramine
and chlorpheniramine, whereas the H2 antagonists, burimamide and metiamide, had no effect. Further¬
more, the reaction was similarly blocked by the histamine Hl-receptor agonist, 2-2-AET (Durant,
Ganellin & Parsons, 1975), but not by the H2 agonists, 4-MeHm (Durant et al., 1975) and Dimaprit
(Parsons et al., 1977). In this respect, our observations differ from other histamine-dependent properties
of leucocytes. For instance, the histamine-induced inhibition of lysosomal enzyme release from phago-
cytosing human neutrophils (Busse & Sosman, 1976) and increase in neutrophil chemokinesis (Anderson
el al., 1977) appears to be mediated by H2 receptors as was inhibition, by histamine, of macrophage
migration inhibition factor release from sensitized lymphocytes challenged with antigen (Rocklin, 1976)
and T lymphocyte cytolysis (Plaut, Lichtenstein & Henney, 1973). However, our findings are in agree¬
ment with the original description of histamine rosette formation which was shown to be inhibited
by the classical antihistamines (HI antagonists) which included diphenhydramine, tripelennamine,
antazoline and pyrilamine (Mclmon et al, 1972).
Under the experimental conditions described, guinea-pig peritoneal macrophages and blood mono¬
cytes expressed fewer histamine receptors than alveolar macrophages. The reasons for this are unclear
but it would be of interest to examine mononuclear phagocytes from other sources to determine whether
this really is a special property of lung macrophages.
The finding that only 30-40% of lymph node cells formed histamine rosettes is in agreement with the
observations of Saxon et al. (1977) who found that a similar proportion of the total lymphocyte popula¬
tion bound histamine coupled to red cells and that the receptors were expressed in both the T and B
subpopulations. The possible importance of histamine-bearing lymphoid cells in immune tolerance or
suppression has been discussed elsewhere (Melmon etal., 1975).
Of particular interest was the apparent inability of eosinophils and basophils to form histamine
rosettes since these cells are known to be associated with various histamine-related biological events.
For instance, basophils synthesize and release this amine (Galli et al., 1976; Stewart et al., 1979) and the
anaphylactic release of histamine from basophils was inhibited by histamine itself; an effect that was
mediated by an H2-receptor-dependent mechanism (Lichtenstein & Gillespie, 1973). Although certain
cell membranes clearly recognise histamine in order to enable its participation in these histamine-
dependent functions, this does not necessarily mean that these recognition units can be visualized
directly by a procedure such as the rosette technique described here. Similarly, eosinophils, which
respond in directional locomotion to histamine (Clark et al., 1975; Turnbull & Kay, 1976; Jones & Kay,
1977) and also presumably have a membrane recognition unit for histamine-induced chemotaxis,
were unable to bind directly with stabilized histamine under the conditions described here.
We cannot exclude the possibility that the covalent coupling of histamine to albumin somehow pre¬
cludes, possibly by steric hindrance, binding of histamine to H2 receptors. This may explain our inability
to demonstrate rosette formation with eosinophils and basophils. For instance, histamine-induced
eosinophil locomotion was shown to be predominantly H2-dependent (Clark et al., 1975; Jones & Kay,
1977) as was the inhibition of histamine release, by histamine, from basophils (Lichtenstein & Gillespie,
1973).
The precise role of the histamine receptor which we and others have demonstrated by the rosette
technique is unclear, although it may serve as a useful marker for the classification of subpopulations of
certain mononuclear phagocytes, lymphocytes and possibily neutrophils.
We are grateful toMr R. M. Hogg for technical advice. Dr Diaz is a British Council Fellow.
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